Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.7981949179823806,2.5411802807531245,0.0,0.0,0.0,16/29,9.77%,GRID2;GRIK5;GRIK2;GRID1;GLRA3;GABRG3;GABRB1;GRIA4;GABRB3;HTR3A;GABRB2;GABRA2;GRIK1;GRIA2;GABRA3;GABRA1
prerank,glutamate receptor activity (GO:0008066),0.8490054323010207,2.459993361961756,0.0,0.0,0.0,12/19,9.69%,GRID2;GRM5;GRIK5;GRIK2;GRID1;GRIA4;GRM8;GRIA1;GRIK1;GRM1;GRIA2;GRM7
prerank,voltage-gated cation channel activity (GO:0022843),0.5978138117036468,2.4523005906142066,0.0,0.0,0.0,41/97,16.37%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;GRIN2B;KCNA6;KCNH8;KCNQ5;KCNH7;OPRM1;KCNA5;CACNA1B;CATSPER4;CACNA2D1;KCNH4;GRIN2A;KCNH5;CACNA1A;KCNA2;NCS1;CACNB3;TMC1;CACNG8;CACNA1D;CACNG3;CACNA2D3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;KCND1;CACNG5;GRIN3A;KCNC4;KCNS2;CACNA2D4;KCNA4;CACNB1;KCNG2
prerank,ligand-gated ion channel activity (GO:0015276),0.754495620444861,2.406025073282881,0.0,0.0,0.0,12/30,9.05%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ligand-gated channel activity (GO:0022834),0.7580950837063158,2.4007770890068616,0.0,0.0,0.0,12/29,9.05%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7939512935379274,2.232642041871721,0.0,0.0002969770348637985,0.002,9/17,9.05%,GRIA3;GRIK5;GRIK2;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,potassium channel activity (GO:0005267),0.5407157132058359,2.1902260604690267,0.0,0.0003818276162534552,0.003,16/89,4.69%,KCND2;KCNC2;KCNQ3;GRIK5;GRIK2;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNH4;KCNH5;KCNN2;KCNA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7546739001921169,2.148733970277132,0.0,0.00044546555229569776,0.004,9/19,9.77%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,ligand-gated anion channel activity (GO:0099095),0.7793015031168052,2.1463578803801755,0.0,0.000395969379818398,0.004,9/17,9.77%,GLRA3;GABRG3;GABRB1;GABRB3;GLRA1;GABRB2;GABRA2;GABRA3;GABRA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6796600567662011,2.112084674007939,0.0,0.0010691173255096744,0.012,9/28,9.77%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,GABA receptor activity (GO:0016917),0.7124190300780604,2.105957605491738,0.0,0.0011339123149345031,0.014,10/21,14.77%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABBR2;GABRA3;GABRA1;GABBR1;GABRE
prerank,voltage-gated potassium channel activity (GO:0005249),0.5392451479036172,2.092414130936838,0.0,0.001187908139455194,0.016,15/80,4.69%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;KCNH5;KCNN2;KCNA2
prerank,GABA-A receptor activity (GO:0004890),0.724863785008417,2.0820324104939245,0.0,0.0013706632378329162,0.02,7/18,9.77%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,neuropeptide receptor activity (GO:0008188),0.6273662020395102,2.030543454729237,0.0,0.002927345057943157,0.044,9/29,11.53%,NPSR1;OPRM1;SORCS3;SORCS1;GPR37;NPY2R;KISS1R;TACR1;NMUR2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.7783918785792021,1.982055072128423,0.0,0.006592890173976326,0.097,7/12,9.77%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,voltage-gated calcium channel activity (GO:0005245),0.5770770938188701,1.9350816944117102,0.0,0.012417352270242574,0.183,22/37,18.40%,OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;NCS1;CACNB3;TMC1;CACNG8;CACNA1D;CACNG3;CACNA2D3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;CACNG5;CACNA2D4;CACNB1;CACNA1G;CACNA1I
prerank,cadherin binding (GO:0045296),-0.41719375827768496,-1.9305870587348055,0.0,0.14238426955189962,0.109,116/315,18.62%,PTPRB;SPTBN1;CLINT1;TJP1;DOCK9;DAB2IP;ESYT2;PTPRM;CTNNA1;ITGA6;SPTAN1;WASF2;CAST;COBLL1;LIMA1;ITGB1;BSG;MRTFB;STXBP6;ERC1;BAIAP2L1;ASAP1;MPP7;ABI1;CD2AP;MYH9;CDH11;BMPR2;PPFIBP1;PARVA;EIF4H;EPS15;PROM1;IQGAP1;ANXA2;PKP4;TRIM25;PTPN1;F11R;FNBP1L;ZC3HAV1;PAK2;EIF3E;KDR;AHNAK;DDX3X;RAB1A;YWHAE;NOTCH3;PTPRJ;EMD;PDLIM5;GIGYF2;EPS8L2;EGFR;IDH1;LARP1;AFDN;PLCB3;STK24;TMOD3;TRPC4;DLG1;CBL;NCK1;MACF1;EZR;TJP2;CDH5;EPS15L1;FXYD5;MRE11;SNX9;CTNND1;PDLIM1;CDH1;YWHAZ;PICALM;CEMIP2;FLNA;PUF60;SERBP1;CHMP4B;EEF2;ARHGAP1;EHD1;PSEN1;STK38;LRRFIP1;LASP1;NDRG1;CHMP2B;CSNK1D;PDXDC1;PKN2;RPL7A;HCFC1;MARK2;NUMB;SH3GL1;EHD4;CLIC1;CHMP5;ABCF3;SLK;GCN1;SWAP70;CTNNB1;CAPZB;CCS;TES;GIPC1;DBNL;VAPA;ANXA1;FMNL2
prerank,sodium channel activity (GO:0005272),0.569984581194746,1.900150221590299,0.0,0.018395106924210577,0.272,11/37,8.46%,GRIK5;GRIK2;ASIC2;HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;GRIK1;SCN5A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5818311608213137,1.8843817343009799,0.0,0.020689400095511293,0.313,6/32,4.69%,KCNC2;KCNQ3;KCNA6;KCNQ5;KCNA5;KCNA2
prerank,clathrin adaptor activity (GO:0035615),-0.7157721886749487,-1.8763502337865023,0.0,0.14618842942542365,0.201,11/15,21.61%,HIP1;DAB2;STON1;LDLRAP1;AP2B1;AP2A2;AP2S1;AP1G1;HIP1R;AP2M1;STON2
prerank,ligand-gated cation channel activity (GO:0099094),0.4755572357689236,1.855099623203691,0.0,0.02790021090694107,0.419,19/75,14.35%,GRIA3;GRIK5;GRIK2;ASIC2;GRIN2B;GRIA4;HTR3A;KCNJ3;GRIN2A;KCNN2;GRIA1;GRIK1;KCNJ6;GRIA2;KCNN3;P2RX3;P2RX5;ASIC1;GRIN3A
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7241581719015993,1.8510372208450385,0.002173913043478261,0.02788614357371068,0.437,7/13,14.77%,GLRA3;GABRG3;GLRA1;GABRA2;GABRA3;GABRA1;GABRE
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.559233010223688,-1.8479283965834212,0.0,0.14310887143257084,0.276,16/34,22.69%,CYTH3;PARD3;MYO10;FERMT2;IQGAP1;ARAP3;AKT1;FCHSD2;ARAP1;ZFYVE1;HIP1R;GAB2;ZFYVE16;PHLDA3;KIF16B;OGT
prerank,cell adhesion mediator activity (GO:0098631),0.5867878228519673,1.8410974353287173,0.0022222222222222222,0.030037105811938473,0.478,14/24,15.75%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;CNTN2;EMB;JAM3;ROBO3;SIRPA;CD47
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6446661866660313,-1.8228139018206542,0.0,0.1486339607726891,0.366,9/18,15.53%,ENG;FERMT2;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD7;USP15;SMAD6
prerank,ion channel activity (GO:0005216),0.4595813881952071,1.8193757203111485,0.0,0.03616370347273255,0.532,17/80,9.05%,TRPM3;GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;UNC80;GRIN2B;GRIA4;GRIN2A;GRIA1;TMC1;TMEM63A;GRIK1;TRPM1;GRIA2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6428564884771153,-1.777486560109989,0.0017391304347826088,0.2062941554271034,0.546,4/17,1.35%,ATP10A;PITPNC1;ATP8B1;PLTP
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.632865792307339,-1.7751966941083832,0.005494505494505495,0.17553480559260903,0.556,9/18,23.25%,STXBP6;BAIAP2L1;ANXA2;PDLIM5;TMOD3;PDLIM1;ANXA1;CDC42EP1;PPP1CA
prerank,I-SMAD binding (GO:0070411),-0.6943349903543748,-1.7704778494532205,0.003590664272890485,0.16086161750901634,0.58,8/13,19.58%,SMURF1;SMAD1;SMAD2;SMAD4;SMAD7;SMAD6;CTNNB1;SMAD9
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.655057492476372,1.7565386221106074,0.011655011655011656,0.0666261521694435,0.762,5/14,11.03%,SLC7A11;SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.4993842288388664,-1.7209912240892307,0.0071301247771836,0.25338422014722595,0.808,20/44,16.82%,MECOM;NSD1;ASH1L;PRDM16;SETD2;KMT2E;KMT5B;NSD3;SETD5;SUV39H1;SETD3;DOT1L;EHMT1;ASH2L;SMYD1;PRDM9;N6AMT1;KMT2C;KMT5A;WDR82
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7039343415093136,1.7157770496047222,0.02727272727272727,0.09566372735550108,0.896,5/10,7.96%,CACNA1B;CACNA1A;CACNB3;CACNA1D;CACNB4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.40340398994955085,-1.714919519703293,0.0,0.2394809215618464,0.829,53/147,20.21%,RAPGEF5;PREX2;CYTH3;DOCK9;RAPGEF2;DOCK1;FGD5;BCR;AKAP13;RIN3;FGD6;RCBTB2;RAB3GAP1;ARHGEF28;DOCK4;ELMO1;FARP1;EPS8L2;RASGRF2;ARHGEF15;DENND5B;HPS4;PLCE1;CYTH1;RAP1A;MON1A;DENND3;RASGRP2;SH3BP5L;ITSN1;ARHGEF2;EIF2B2;DENND6A;RAPGEF1;ARHGEF11;RAB3GAP2;IQSEC2;ARFGEF1;RIN2;ARHGEF10;DENND2C;ABR;DENND4C;ARHGEF18;HERC2;PREX1;ANKRD27;ALS2;WDR41;RGL2;RGL1;SPATA13;ARHGEF5
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6842650938008976,-1.7066187283307899,0.0057251908396946565,0.2358579121584902,0.849,6/12,11.49%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;LTBP4
prerank,tau-protein kinase activity (GO:0050321),-0.5962664458311004,-1.7060369522084888,0.00929368029739777,0.2156019959488168,0.849,11/20,16.40%,DYRK1A;GSK3B;MARK1;ROCK1;GSK3A;SIK3;PRKAA1;MARK2;ROCK2;MARK3;FYN
prerank,androgen receptor binding (GO:0050681),-0.557775822644276,-1.6944589192399555,0.006993006993006993,0.22263392783623995,0.881,6/25,12.23%,FOXP1;NSD1;ZBTB7A;PRPF6;KDM3A;WIPI1
prerank,amino acid:sodium symporter activity (GO:0005283),0.678253196998625,1.6936507329064823,0.009433962264150943,0.11097437838790422,0.932,4/11,11.03%,SLC6A15;SLC6A11;SLC1A2;SLC1A3
prerank,GTPase binding (GO:0051020),-0.38632618438953426,-1.6932306142418,0.0,0.20810008626816096,0.884,55/194,15.09%,SPTBN1;UNC13B;GNB1;FGD5;AKAP13;RIN3;ERC1;EPS8;CAV1;FGD6;RUSC2;RAB3GAP1;SH3BP4;DOCK4;IQGAP1;DVL3;RALBP1;FNBP1L;RANBP9;PAK2;EXOC4;LRRK2;RANBP2;RASIP1;AFDN;STRN3;HPS4;PLCE1;AMBRA1;BNIP3;RAB11FIP3;USP6NL;TBC1D30;EXOC2;RAF1;ARHGEF2;PICALM;MTSS2;FLNA;PDE6D;ARHGAP1;BRAF;TNFAIP1;EHD1;RAB3GAP2;RASA1;GOLGA4;AP1G1;ANKFY1;LCP1;NDRG1;RTKN;NCKAP1;EXOC8;MLPH
prerank,chloride channel activity (GO:0005254),0.4661042480864424,1.6917522942395817,0.002242152466367713,0.10852226185542115,0.934,13/59,9.77%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;GABRA3;GABRA1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6909679359458158,1.6909784828313337,0.018018018018018018,0.10516286779010287,0.934,4/11,8.28%,DDAH2;PADI1;ARG2;PADI2
prerank,metallocarboxypeptidase activity (GO:0004181),0.5367542971551199,1.690132356808436,0.012448132780082987,0.10213888734779927,0.935,9/26,14.61%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,SH3 domain binding (GO:0017124),-0.4576597804494806,-1.6866854931558781,0.0,0.2068220796544496,0.898,16/62,6.15%,AFAP1L1;DAB2IP;WASF2;SHANK3;AFAP1L2;RUFY1;ABI1;CD2AP;ELMO1;CRK;PTPN12;ADAM9;CNTNAP1;DNM2;CBL;ABL1
prerank,retinoic acid receptor binding (GO:0042974),-0.6202082923780377,-1.6808418885199918,0.0034965034965034965,0.20433773034929104,0.912,9/17,21.05%,TACC1;NSD1;ASXL1;NRIP1;RARG;MED1;ACTN4;NCOA6;PPARG
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.37113668350802825,-1.6793227203034546,0.0,0.1948952620917939,0.914,64/254,15.59%,MECOM;LEF1;KLF7;NFIA;RREB1;ZBTB16;NFIB;ERG;FOXO1;MEF2A;NFAT5;ELF1;KLF4;ETS1;ESR1;TCF12;IRF2;NFATC1;PRDM16;FOSL2;PRRX1;NR3C1;ZSCAN21;MITF;PLAGL1;SOX17;SP1;ELK3;MEOX2;SIX1;PPARA;NFKB1;UBP1;FOXO3;NFYC;E2F4;MEF2C;STAT6;JUN;SMAD1;SMAD2;SMAD4;PRDM2;IRF1;GLIS2;TP53;KLF10;NFIC;GMEB1;FOXF2;CREBRF;FOXJ3;GRHL1;PLSCR1;ZIC3;TFCP2L1;ATF4;MZF1;MYBL2;SMARCD3;FOXC1;TCF3;FOXO4;ETV1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7033929411503798,1.6775744015955443,0.011160714285714286,0.10949236057805978,0.956,6/10,19.51%,GABRG3;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,GTPase activator activity (GO:0005096),-0.3590331086156544,-1.674277429094846,0.0,0.19334083121910392,0.92,123/313,25.49%,RAPGEF5;PREX2;CYTH3;DOCK9;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;FGD5;BCR;AKAP13;RGS3;RALGAPA1;RIN3;ASAP1;FGD6;RCBTB2;RAB3GAP1;RGS5;ARHGEF28;STARD8;DOCK4;IQGAP1;RALBP1;ELMO1;ARHGAP10;ARAP3;FARP1;LRRK2;EPS8L2;RANBP2;RASGRF2;TBC1D1;PLCB1;CHN1;ARHGEF15;DENND5B;HPS4;TBC1D2B;PLCE1;CYTH1;RAP1A;MON1A;JUN;TBC1D8B;DENND3;USP6NL;TBC1D30;RASGRP2;BNIP2;SH3BP5L;ITSN1;TBC1D14;ARHGEF2;SIPA1L3;ARHGAP17;MTSS2;EIF2B2;DENND6A;STARD13;RASA4;TBC1D22B;RAPGEF1;ARAP1;ARHGAP1;TBC1D22A;ARHGEF11;RAB3GAP2;IQSEC2;ARHGAP28;ARFGEF1;RASA1;RIN2;WNT11;LARS1;ARHGEF10;SEC23B;SMAP2;DENND2C;ABR;DENND4C;ARHGAP22;TBC1D20;ARHGEF18;ARHGAP29;HERC2;PREX1;TBC1D8;ANKRD27;ALS2;ARHGAP35;TBC1D17;WDR41;ARHGAP26;RGL2;TBC1D25;RGL1;SPATA13;ARHGEF5;ALDH1A1;PREB;EVI5;NF1;ARHGAP11A;RABIF;ASAP3;TBC1D12;RAPGEF3;ARHGAP42;NUCB2;ADRB1;ARHGAP8;ARFGEF2;ARRB1;SYDE1;VAV2;SIPA1L1;RAB3IL1;SIPA1;ARHGAP27;EEF1B2;RAB3IP
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.38263493907859303,-1.670826697054356,0.0,0.18803418803418803,0.924,49/173,18.02%,FOXP1;KLF12;FOXP2;ZBTB16;ETV6;ZBTB20;ZEB1;ZFHX3;PRDM5;PRDM16;NFATC4;NR3C1;SOX13;ZBTB37;MITF;PLAGL1;ELK3;ZNF148;CTCF;HES1;PPARA;NFKB1;FOXO3;ZBTB4;GTF2IRD1;JUN;MAX;SKIL;DACH1;ZFP90;TBX2;ZBTB39;PPARD;PRDM2;ZNF25;ETS2;LRRFIP1;ZBTB6;ZBTB25;MZF1;ZBTB34;TCF3;SKI;HIC1;ZBTB14;HEY2;HEY1;ZNF692;PATZ1
prerank,thyroid hormone receptor binding (GO:0046966),-0.5412528144326795,-1.6575021825845875,0.008896797153024912,0.20290759505849254,0.945,16/28,29.80%,TACC1;NSD1;MED1;TRIP12;TAF11;JMJD1C;MED13;MED17;HMGN3;TAF7;NCOA6;ZNHIT3;THRAP3;GAS2L1;OASL;BRD8
prerank,calcium:sodium antiporter activity (GO:0005432),0.6739089614200735,1.65433556043176,0.01762114537444934,0.12882863772391578,0.977,6/10,16.66%,SLC24A4;SLC24A2;SLC8A2;SLC8A1;SLC8A3;SLC8B1
prerank,R-SMAD binding (GO:0070412),-0.5879888049365943,-1.6429031590469207,0.014388489208633094,0.2228150783064078,0.96,9/18,22.35%,SMURF1;LDLRAD4;JUN;SMAD2;SMAD4;RGCC;SMAD6;DROSHA;PMEPA1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6893116875483359,-1.6236584625993105,0.015734265734265736,0.25159212442449436,0.978,4/10,8.98%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5784591977517464,-1.6223885189061995,0.022598870056497175,0.24341682723185615,0.98,7/18,11.49%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;ACVR2A;LTBP4
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.536753280429399,1.6179794892472972,0.015151515151515152,0.15461704351499764,0.994,8/22,17.65%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HRH1;HTR1F;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.536753280429399,1.6179794892472972,0.015151515151515152,0.15461704351499764,0.994,8/22,17.65%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HRH1;HTR1F;HRH2
prerank,serotonin receptor activity (GO:0099589),0.536753280429399,1.6179794892472972,0.015151515151515152,0.15461704351499764,0.994,8/22,17.65%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HRH1;HTR1F;HRH2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.48058133974550327,-1.6175468779526936,0.01060070671378092,0.2430409221060138,0.981,18/38,26.36%,HIP1;DAB2IP;PARD3;PLA2G4A;SH3PXD2B;ZFYVE26;TECPR1;SNX12;WIPI1;PLEKHA4;ZFYVE1;WDR45B;SNX13;PHLDA3;KIF16B;ATG2A;PLEKHF1;ATG2B
prerank,protein phosphatase 1 binding (GO:0008157),-0.5536413875862518,-1.613362240153739,0.013157894736842105,0.24183587767402795,0.985,6/21,8.73%,AKAP11;PPP1R3B;SHOC2;PHACTR4;KCNQ1;PPP1R3C
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.36866429119825833,-1.6101680786284753,0.0,0.23820562225186503,0.985,69/188,24.41%,PBX1;SMARCA2;FLI1;ZBTB20;BNC2;KLF4;ETS1;TCF12;PRDM5;RXRA;PRDM16;SOX13;SOX17;PSPC1;SP1;VSX1;CTCF;SIX1;NFKB1;FOXO3;NFYC;MEF2C;GABPB2;JUN;CREB3L2;SUV39H1;SMAD4;IRF1;TAL1;GLIS2;TP53;PER3;YAP1;SOX7;CHD3;SFPQ;HDAC4;GABPB1;ASH2L;GRHL1;ATF4;MZF1;BCOR;FOXC1;PRDM9;SMAD6;TAF7;TFAP4;ZBTB14;RNF10;ARID5B;SOX4;CARM1;BRCA1;TBL1X;NONO;PPARG;KCNH2;RELA;ATF6;GABPA;NFE2L2;CEBPA;YY1;TCF7L2;TAF9;ATF5;DHX9;HMGB1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3212000389520399,-1.6087093177925904,0.0,0.2326808116047778,0.986,170/732,17.62%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;TEF;ERG;ZNF423;ZBTB20;FOXO1;MEF2A;NSD1;NFAT5;ELF1;KLF4;ZEB1;ETS1;NR3C2;DACH2;ESR1;FOXN3;TEAD4;PKNOX2;HIVEP2;TCF12;ZFHX3;PRDM5;KLF2;NRIP1;ZNF260;IRF2;CHD2;RXRA;NFATC1;KLF3;PRDM16;TBX15;FOSL2;PRRX1;TBX1;NFATC4;NR3C1;ZSCAN21;TEAD1;SOX13;THRB;ZBTB37;MITF;PLAGL1;TIPARP;SOX17;MKX;PBX3;NFIX;SP1;ELK3;ZNF148;MGA;MEOX2;CTCF;HES1;SIX1;PPARA;RARG;NFKB1;HDAC1;HOXB6;IKZF2;ZBTB7A;UBP1;FOXO3;NFYC;HIVEP1;ZIC4;E2F4;MEF2C;STAT6;ZBTB4;GTF2IRD1;JUN;SKIL;DACH1;SMAD1;KDM6A;ZNF182;TBX2;SMAD2;ZBTB39;EBF1;PPARD;BACH2;SMAD4;ZIC5;IRF1;HOXC6;HSF5;TAL1;GLIS2;TP53;SP3;ZBTB40;KLF10;KDM6B;GLI3;ETS2;STAT2;NFIC;ZBTB7C;GMEB1;SOX7;MAZ;PRRX2;FOXF2;HDAC4;ZSCAN25;ZNF394;LRRFIP1;PROX2;FOXJ3;ZBTB6;KLF9;GRHL1;ZIC3;TFCP2L1;HIF3A;ZBTB25;ATF4;H3-3A;MZF1;ZBTB34;MYBL2;PGBD1;FOXC1;TCF3;TCF7L1;NR1D2;NR2C1;FOXO4;ETV1;ZNF32;RUVBL2;ZFP1;SKI;HIC1;ZNF235;ZKSCAN1;SIX4;FOXQ1;ZNF691;RARA;HDAC6;TFAP4;ZNF83;CC2D1B;ZBTB14;HOXA2;HLF;NLRC5;HEY2;ZNF250;ZFP28;HEY1;CEBPG;ZNF692
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.32013726522772556,-1.600391852504158,0.0,0.24157421588378555,0.989,170/731,17.62%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;TEF;ERG;ZNF423;ZBTB20;FOXO1;MEF2A;NSD1;NFAT5;ELF1;KLF4;ZEB1;ETS1;NR3C2;DACH2;ESR1;TEAD4;PKNOX2;HIVEP2;TCF12;ZFHX3;PRDM5;KLF2;NRIP1;ZNF260;IRF2;CHD2;RXRA;NFATC1;KLF3;PRDM16;TBX15;FOSL2;PRRX1;TBX1;NFATC4;NR3C1;ZSCAN21;TEAD1;SOX13;THRB;ZBTB37;MITF;PLAGL1;SOX17;MKX;PBX3;NFIX;SP1;ELK3;ZNF148;MGA;MEOX2;CTCF;HES1;SIX1;PPARA;RARG;NFKB1;HDAC1;HOXB6;IKZF2;ZBTB7A;UBP1;FOXO3;NFYC;HIVEP1;ZIC4;E2F4;MEF2C;STAT6;ZBTB4;GTF2IRD1;JUN;MAX;SKIL;DACH1;CREB3L2;SMAD1;KDM6A;ZNF182;TBX2;SMAD2;ZBTB39;EBF1;PPARD;BACH2;SMAD4;ZIC5;IRF1;HOXC6;HSF5;TAL1;GLIS2;TP53;SP3;ZBTB40;KLF10;KDM6B;GLI3;ETS2;STAT2;NFIC;ZBTB7C;GMEB1;SOX7;MAZ;PRRX2;FOXF2;HDAC4;ZSCAN25;ZNF394;LRRFIP1;PROX2;FOXJ3;ZBTB6;KLF9;GRHL1;ZIC3;TFCP2L1;HIF3A;ZBTB25;ATF4;H3-3A;MZF1;ZBTB34;MYBL2;PGBD1;FOXC1;TCF3;TCF7L1;NR1D2;NR2C1;FOXO4;ETV1;ZNF32;RUVBL2;ZFP1;SKI;HIC1;ZNF235;ZKSCAN1;SIX4;FOXQ1;ZNF691;RARA;HDAC6;TFAP4;ZNF83;CC2D1B;ZBTB14;HOXA2;HLF;NLRC5;HEY2;ZNF250;ZFP28;HEY1;CEBPG;ZNF692
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6576821659366106,-1.5998290441715708,0.025362318840579712,0.23407228609540748,0.991,6/11,25.62%,MAP3K20;MAP3K5;EGFR;MAP3K6;MAP3K7;MAP3K15
prerank,retinoid X receptor binding (GO:0046965),-0.6638023572887866,-1.5946153006251251,0.020833333333333332,0.2365700209032878,0.992,4/11,5.51%,TACC1;NSD1;NRIP1;RARG
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.6811880598197022,-1.5885415042888529,0.020036429872495445,0.2415098068277259,0.994,7/10,15.24%,NSD1;ASH1L;SETD2;NSD3;SETD5;SETD3;PRDM9
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6789309979058382,-1.5833977249839866,0.03074141048824593,0.24409733676934872,0.995,6/10,11.17%,MECOM;ASH1L;PRDM16;SETD5;SUV39H1;EHMT1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6511074888920454,1.5807134885649778,0.04524886877828054,0.19584761987400262,0.999,4/10,7.41%,B3GALT1;B3GALT4;B3GALT5;B4GALT7
prerank,sialyltransferase activity (GO:0008373),-0.5521623977280667,-1.5788223789794296,0.021653543307086614,0.24635331752383777,0.996,7/20,9.19%,ST3GAL6;ST3GAL4;ST3GAL1;ST8SIA4;ST6GAL1;ST6GALNAC3;ST3GAL2
prerank,vinculin binding (GO:0017166),-0.6518341488459934,-1.574478777554722,0.011235955056179775,0.24830788992638705,0.996,7/11,23.36%,UTRN;CTNNA1;PXN;ACTN1;SORBS3;RTCB;TLN1
prerank,small GTPase binding (GO:0031267),-0.36692723787155834,-1.5729737414459346,0.0,0.2435621350956271,0.996,53/169,18.47%,UNC13B;FGD5;AKAP13;RIN3;ERC1;EPS8;CAV1;FGD6;RUSC2;RAB3GAP1;SH3BP4;DOCK4;IQGAP1;DVL3;RALBP1;RANBP9;PAK2;EXOC4;LRRK2;RANBP2;AFDN;STRN3;HPS4;PLCE1;RAB11FIP3;USP6NL;TBC1D30;EXOC2;RAF1;ARHGEF2;PICALM;MTSS2;FLNA;PDE6D;ARHGAP1;BRAF;TNFAIP1;EHD1;RAB3GAP2;GOLGA4;AP1G1;ANKFY1;NDRG1;RTKN;NCKAP1;EXOC8;MLPH;TBC1D20;SOD1;RNF152;ANKRD27;ALS2;WASF1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5258438969103897,1.5583392089266197,0.017937219730941704,0.22242731405484614,1.0,7/22,8.46%,HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;SCN5A
prerank,calcium channel activity (GO:0005262),0.38997036902795584,1.5575914521151422,0.00702576112412178,0.21751092995149376,1.0,28/84,15.79%,SLC24A4;SLC24A2;OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;PKD1L2;NCS1;CACNB3;TMC1;CACNG8;CACNA1D;CACNG3;RYR2;CACNA2D3;TMCO1;CACNB4;TRPM1;CACNA1E;PKD1L1;CACNG2;CACNG4;TMC2;CACNG5;CACNA2D4;MCU;CACNB1
prerank,phosphatidate phosphatase activity (GO:0008195),0.6041570645960184,1.5572922697057203,0.04708520179372197,0.21208976133083818,1.0,6/13,8.76%,LPIN1;PLPPR4;PLPPR1;PLPP2;PLPP4;PLPPR5
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.35533952374999656,-1.5484280778782056,0.0016474464579901153,0.2904204337730349,0.999,54/181,19.18%,TACC1;MEF2A;RB1;CREBBP;KLF4;MIER1;NRIP1;GSK3B;RXRA;NFATC1;LMO2;PRRX1;DTX3L;TACC2;SP1;HES1;PPARA;HDAC1;NFKBIA;MED1;JUN;SPEN;LDB1;SMARCE1;ANXA4;PPARD;RBBP8;TAL1;TP53;RNF25;MDFIC;SIN3A;ZFPM1;ACTB;BCAS3;HDAC4;MTDH;RERE;ACTN4;PIAS2;ATF4;SMARCD3;TCF3;TADA3;MAD2L2;GTF2I;MIER2;CTNNB1;HEY2;MIER3;CDK5RAP3;WWP2;PIAS4;ARNT
prerank,nuclear localization sequence binding (GO:0008139),-0.5533928980992032,-1.5477636673219197,0.026690391459074734,0.2838929784979881,0.999,7/18,18.38%,BRAP;KPNA4;NFKBIA;KPNA3;NUP153;KPNA1;NUP214
prerank,insulin-like growth factor I binding (GO:0031994),-0.6139300785160928,-1.546383762067182,0.033391915641476276,0.27909901898341205,0.999,5/13,4.21%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5198312735291213,-1.545560207375177,0.023722627737226276,0.27372789465883474,0.999,4/24,4.22%,DAB2IP;CERT1;PLA2G4A;GOLPH3L
prerank,histone demethylase activity (GO:0032452),-0.4984991460297644,-1.5453499316392902,0.016129032258064516,0.2670994009366619,0.999,10/27,16.60%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;JMJD6;KDM5B
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5364365257523842,1.5399681052487524,0.04367816091954023,0.2331660482937218,1.0,4/19,1.90%,GRM5;NRG3;NRG1;DGKQ
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6450688558500544,-1.5376963384042768,0.025454545454545455,0.27754063534410356,1.0,5/11,12.74%,UBR5;UBE2K;RBX1;UBE4B;UBE4A
prerank,calcium ion binding (GO:0005509),0.32562574666952704,1.5296135124742536,0.0,0.24315565839155934,1.0,71/323,13.68%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;MMP12;SLC25A23;RYR3;SLC25A13;SPOCK1;ASTN2;DNER;SYT12;SYT11;TKT;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;CALM2;NCS1;PITPNM1;CDH12;PADI1;GSN;RYR2;RPH3A;CDH7;GJB2;PADI2;S100A6;PPP3CA;PLA2G4E;ENPP3;CDH24;CDH17;PGS1;CPNE1;TESC;TNNC1;MCTP2;ANXA8;ANXA8L1;SLIT3;SLIT1;CDHR3;C2CD5;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;SRI;HRC;RASGRP1;MYL2;CASQ1;SYT3;RCN3
prerank,phosphatidic acid binding (GO:0070300),-0.54576482549956,-1.527867915059529,0.03544776119402985,0.2916345837535743,1.0,4/19,3.49%,PITPNC1;RAPGEF2;PLTP;MARK1
prerank,GTPase regulator activity (GO:0030695),-0.340231776720846,-1.526237305860729,0.0,0.28849506306153705,1.0,81/212,25.34%,PREX2;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;BCR;RGS3;RALGAPA1;ASAP1;RAB3GAP1;RGS5;SH3BP4;STARD8;IQGAP1;RALBP1;ARHGAP10;ARAP3;LRRK2;RANBP2;TBC1D1;PLCB1;SLIT2;RGS12;CHN1;TBC1D2B;JUN;WASL;TBC1D8B;USP6NL;TBC1D30;BNIP2;TBC1D14;SIPA1L3;ARHGAP17;MTSS2;STARD13;PDE6D;RASA4;TBC1D22B;ARAP1;ARHGAP1;TBC1D22A;RAB3GAP2;GDI1;ARHGAP28;ARFGEF1;RASA1;RIN2;WNT11;LARS1;RTKN;SEC23B;SMAP2;ABR;ARHGAP22;TBC1D20;ARHGAP29;PREX1;TBC1D8;ALS2;ARHGAP35;TBC1D17;ARHGAP26;TBC1D25;ALDH1A1;PREB;EVI5;NF1;ARHGAP11A;ASAP3;TBC1D12;ARL2;ARHGAP42;ARHGAP8;GPS2;ARRB1;SYDE1;SIPA1L1;SIPA1;ARHGAP27
prerank,glycine binding (GO:0016594),0.6150371481379466,1.5260793503560286,0.05855855855855856,0.2430014587773031,1.0,4/11,5.49%,GLRA3;GRIN2B;GLRA1;GNMT
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3823760022247894,-1.5221735395123632,0.00375234521575985,0.29068331259485986,1.0,24/100,14.60%,HIP1;CYTH3;DAB2IP;PARD3;CERT1;MYO10;FERMT2;IQGAP1;ARAP3;PLA2G4A;SH3PXD2B;GOLPH3L;ZFYVE26;TECPR1;AKT1;FCHSD2;SNX12;ARAP1;WIPI1;ANKFY1;PLEKHA4;SNX24;ZFYVE1;HIP1R
prerank,neurexin family protein binding (GO:0042043),0.615766299888945,1.519094790272584,0.06153846153846154,0.24770057710334922,1.0,6/10,19.11%,NLGN1;SYTL2;CPE;NLGN2;SYTL1;NLGN3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.564600524531042,1.518934399963234,0.05454545454545454,0.24203628341399575,1.0,6/15,8.24%,HS6ST3;HS3ST6;HS3ST5;NDST4;HS6ST2;HS3ST2
prerank,lipid phosphatase activity (GO:0042577),0.5810768472466357,1.517533401943033,0.04017857142857143,0.238686658718439,1.0,5/14,8.76%,PLPPR4;PLPPR1;PLPP2;SGPP1;PLPPR5
prerank,phosphatidylinositol binding (GO:0035091),-0.3836383214761569,-1.515651753469851,0.010714285714285714,0.29926881082950446,1.0,25/91,16.59%,PARD3B;PITPNC1;HIP1;ESYT2;PARD3;ITPR1;FCHO2;MCF2L;WDFY1;ITPR2;SNX9;SCARB1;PICALM;WDFY3;SNX12;PLEKHF2;BCAS3;ANKFY1;SNX24;ZFYVE1;HIP1R;EXOC8;TNFAIP8L3;MITD1;SNX8
prerank,DNA-binding transcription factor binding (GO:0140297),-0.34221984053625276,-1.5049825848744283,0.0,0.31667517524935634,1.0,66/189,24.41%,MEF2A;RB1;CREBBP;KLF4;MIER1;TCF12;PRDM5;GSK3B;NFATC1;PRDM16;LMO2;PRRX1;SIK1;NEK6;SP1;HES1;PPARA;HDAC1;ZBTB7A;MEF2C;JUN;SPEN;LDB1;SMAD2;PPARD;YWHAZ;RBBP8;TAL1;TP53;YAP1;ZMYND8;SIN3A;ZFPM1;HDAC4;MTDH;KAT5;RERE;PIAS2;ATF4;HCFC1;TCF3;FOXO4;SKI;MAD2L2;GTF2I;MIER2;CTNNB1;HEY2;MIER3;WWP2;PIAS4;HDAC7;PPARG;PTMA;CREB1;MYOCD;RELA;GABPA;NFE2L2;TCF7L2;TBX3;TAF9;DHX9;CRTC1;TLE6;HMGB1
prerank,5'-nucleotidase activity (GO:0008253),-0.6078815840114731,-1.5034235874126223,0.04601769911504425,0.313122525738761,1.0,7/13,25.86%,NT5C2;NT5E;NT5C1A;NT5C3B;ACP3;NT5DC1;NT5C
prerank,protein kinase C activity (GO:0004697),-0.5719334387330177,-1.497233161189016,0.044444444444444446,0.3205669554212169,1.0,5/14,8.23%,PRKCH;PRKCE;PRKD3;PRKCD;PRKD1
prerank,anion channel activity (GO:0005253),0.40888058531155674,1.4966147546547106,0.015521064301552107,0.26632765497024147,1.0,13/61,10.58%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;LRRC8E;ANO4;GABRA3;GABRA1;VDAC2
prerank,tau protein binding (GO:0048156),-0.4366619425893667,-1.4964746565681517,0.027586206896551724,0.3154056123709303,1.0,17/40,16.80%,DYRK1A;GSK3B;MARK1;ROCK1;SMAD2;GSK3A;PICALM;PRKAA1;DCTN1;ACTB;MARK2;LGMN;ROCK2;MARK3;FYN;PPP2CB;HDAC6
prerank,potassium ion antiporter activity (GO:0022821),0.5440414950893524,1.4958739406212844,0.04405286343612335,0.26147837996307915,1.0,4/15,5.04%,SLC24A4;SLC24A2;SLC9A7;SLC9A9
prerank,protein serine/threonine kinase activity (GO:0004674),-0.3199352763734162,-1.4950758501665253,0.0,0.3121407448409926,1.0,98/334,17.63%,GRK5;PRKCH;SNRK;MAP3K20;ACVRL1;BCR;DYRK1A;NEK7;CSNK1A1;DAPK1;PRKCE;FAM20A;BMPR2;TLK2;GSK3B;CDK13;RPS6KA5;ATM;LIMK2;PAK2;MARK1;MAP3K5;SIK1;MAP4K3;PRKD3;LRRK2;MTOR;PRKD2;TLK1;CAMK2G;CSNK1G3;CDK12;NEK6;EGFR;TGFBR2;STK3;STK24;STK35;MAST2;PRKCD;BRD2;MAST4;ERN1;MAPKAPK2;AAK1;CDK10;CDC42BPA;PLK2;ROCK1;PRKD1;MAPK1;RAF1;GSK3A;AKT3;ACVR2A;LATS2;MYLK;ALPK1;AKT1;WNK4;SIK3;PRKAA1;TAOK3;STK10;STK32C;ILK;GAK;BRAF;STK38;IKBKE;IRAK1;CSNK1G1;RPS6KA1;ULK2;CLK3;MKNK2;MAP3K8;CSNK1D;MAPK8;PKN2;CDK6;MARK2;PKN3;MAPK12;RPS6KA3;TRIO;HIPK1;ROCK2;MARK3;SRPK2;SLK;CDC42BPB;STK16;NUAK1;MAP4K4;IRAK2;RPS6KC1;PLK4
prerank,5'-3' exonuclease activity (GO:0008409),-0.5595286084620382,-1.4942972077838605,0.049557522123893805,0.3074195938935823,1.0,8/14,27.22%,XRN1;MRE11;XRN2;EXOG;DCLRE1B;DCLRE1A;DXO;EXO1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2966861976162611,-1.493610839691318,0.0,0.303245887060916,1.0,184/831,17.62%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;ETV6;NFIB;TEF;ERG;ZNF423;ZBTB20;FOXO1;MEF2A;RB1;NSD1;NFAT5;ELF1;KLF4;ZEB1;ETS1;NR3C2;DACH2;ESR1;CUX1;TEAD4;PKNOX2;HIVEP2;TCF12;ZFHX3;PRDM5;KLF2;NRIP1;ZNF260;IRF2;CHD2;RXRA;NFATC1;KLF3;PRDM16;TBX15;FOSL2;PRRX1;TBX1;NFATC4;NR3C1;ZSCAN21;TEAD1;SOX13;THRB;ZBTB37;MITF;PLAGL1;SOX17;MKX;PBX3;NFIX;SP1;ZBTB46;ELK3;ZNF148;MGA;MEOX2;CTCF;HES1;SIX1;PPARA;LHX6;RARG;NFKB1;HDAC1;HOXB6;IKZF2;ZBTB7A;UBP1;FOXO3;NFYC;HIVEP1;BBX;ZIC4;E2F4;MEF2C;STAT6;ZBTB4;GTF2IRD1;JUN;MAX;SKIL;DACH1;SMAD1;ZFP90;KDM6A;ZNF182;TBX2;SMAD2;ZBTB39;EBF1;PPARD;BACH2;SMAD4;ZIC5;PRDM2;IRF1;HOXC6;HSF5;ZNF25;TAL1;GLIS2;TP53;SP3;ZBTB40;KLF10;KDM6B;GLI3;ETS2;STAT2;NFIC;ZBTB7C;GMEB1;SOX7;MAZ;TWIST2;PRRX2;FOXF2;HDAC4;CREBRF;ZSCAN25;ZNF394;LRRFIP1;ACTN4;PROX2;FOXJ3;ZBTB6;KLF9;CIC;GRHL1;ZIC3;TFCP2L1;HIF3A;ZBTB25;ATF4;H3-3A;MZF1;ZBTB34;MYBL2;PGBD1;FOXC1;TCF3;TCF7L1;NR1D2;NR2C1;FOXO4;ETV1;ZNF32;RUVBL2;ZFP1;SKI;HIC1;ZNF235;ZKSCAN1;SIX4;FOXQ1;ZNF691;RARA;HDAC6;TFAP4;ZNF83;CC2D1B;ZBTB14;HOXA2;HLF;EPAS1;NLRC5;HEY2;ZNF250;ZFP28;ZBTB8A;HEY1;CEBPG;ZNF692
prerank,diacylglycerol kinase activity (GO:0004143),0.5997428692443414,1.489365046151066,0.07126436781609195,0.26669828935268514,1.0,3/11,1.90%,DGKK;DGKI;DGKQ
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.30076255543797986,-1.4840631066411876,0.0,0.318796958192245,1.0,172/597,24.41%,FOXP1;KLF12;LEF1;PBX1;SMARCA2;FLI1;NFIB;MBNL2;TEF;ERG;ZBTB20;BNC2;NFAT5;ELF1;KLF4;ETS1;NR3C2;ESR1;CUX1;PKNOX2;TCF12;PRDM5;KLF2;IRF2;RXRA;NFATC1;KLF3;PRDM16;TBX15;TBX1;NFATC4;NR3C1;TEAD1;SOX13;THRB;ZBTB37;SOX17;PSPC1;NFIX;SP1;VSX1;ELK3;MEOX2;CTCF;HES1;SIX1;LHX6;RARG;NFKB1;HOXB6;ZBTB7A;UBP1;FOXO3;ABL1;NFYC;HIVEP1;BBX;ZIC4;E2F4;MEF2C;GABPB2;JUN;MAX;CREB3L2;SUV39H1;TBX2;PPARD;MCM9;BACH2;SMAD4;ZIC5;IRF1;HSF5;TAL1;GLIS2;TP53;MCM4;SP3;HMBOX1;ELF2;KLF10;GLI3;PER3;ETS2;YAP1;ORC5;NFIC;GMEB1;SOX7;CHD3;SFPQ;PRRX2;HDAC4;FOXJ3;GABPB1;ASH2L;GRHL1;ZIC3;TFCP2L1;ATF4;MZF1;BCOR;MYBL2;FOXC1;PRDM9;TCF7L1;NR1D2;NR2C1;SMAD6;FOXO4;ETV1;ZNF32;ZFP1;HIC1;ORC2;SIX4;FOXQ1;KDM5B;TAF7;RARA;TFAP4;ZBTB14;HOXA2;HLF;HEY2;ZNF250;HEY1;CEBPG;GATA2;RNF10;HOXB9;ORC4;ARID5B;SOX4;ELK4;ARNT;CARM1;ZBTB12;ZIC1;BRCA1;FOXL2;TBL1X;PRDM1;NONO;PPARG;CREB1;HSF4;RARB;KCNH2;MCM3;RELA;ATF6;GLIS1;BCL6;MSX1;GABPA;NFE2L2;ELF4;RXRG;CEBPA;BEND3;YY1;GMEB2;TCF4;TCF7L2;KLF16;TBX3;E2F7;TAF9;ATF5;DHX9;HMGB1
prerank,acetyltransferase activity (GO:0016407),-0.4683723515674807,-1.4762355078121518,0.04059040590405904,0.33066454879084395,1.0,9/31,11.35%,CREBBP;KAT6B;KAT2B;KAT6A;NAA16;NAA80;SMARCE1;NAA15;GNPNAT1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.47920582507896525,1.4750615697501361,0.0378619153674833,0.2850410855264003,1.0,7/24,10.05%,AK9;ITPKA;AK7;AK3;AK5;NME2;IP6K2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.49715670394152883,-1.4708732582955808,0.03860294117647059,0.33796639384307975,1.0,7/23,8.83%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2
prerank,ephrin receptor activity (GO:0005003),0.5194465817333788,1.4702942740309841,0.06918238993710692,0.2813342241090339,1.0,5/17,5.56%,EPHA6;EPHB1;EFNA3;EFNB3;EPHA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5194465817333788,1.4702942740309841,0.06918238993710692,0.2813342241090339,1.0,5/17,5.56%,EPHA6;EPHB1;EFNA3;EFNB3;EPHA5
prerank,insulin-like growth factor binding (GO:0005520),-0.5628774085836646,-1.4687536118514752,0.058098591549295774,0.33628773281952473,1.0,6/15,9.45%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4;IGF2R
prerank,death receptor binding (GO:0005123),-0.5575361736286132,-1.4683839583651481,0.06560283687943262,0.3310977718492169,1.0,6/15,23.52%,DAB2IP;EDA;NGF;FEM1B;CASP8AP2;RIPK1
prerank,peptide hormone receptor binding (GO:0051428),0.5805699336943685,1.464628642983984,0.08874458874458875,0.2850801348471548,1.0,2/11,10.63%,PSMC5;CCK
prerank,AMP binding (GO:0016208),0.5841740078249444,1.4639313916044259,0.07710280373831775,0.28071317489566927,1.0,2/11,2.34%,MPPED2;ACSS2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.45506542324034993,-1.463313968780021,0.036020583190394515,0.33673012133614505,1.0,15/35,25.00%,FOXP1;NR3C1;HDAC1;TP53;KLF10;TAF1B;TAF1C;AGO2;H3-3A;DR1;RUVBL2;UBTF;RELA;SNAPC3;SMARCB1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.527231281370268,-1.4631404940164723,0.0595903165735568,0.3313179633689899,1.0,6/18,15.00%,XIAP;TNFAIP8;BIRC3;GAS6;RPS6KA1;RPS6KA3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.4926215741445073,1.456624031960663,0.06986899563318777,0.28789067981633115,1.0,3/21,7.45%,GRM5;GRIA1;GRM1
prerank,transaminase activity (GO:0008483),0.568139341990344,1.4506779483892194,0.0912863070539419,0.29220859228513635,1.0,2/11,3.09%,GOT1L1;OAT
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5106290733798627,1.449537070628226,0.05399568034557235,0.28872767278424855,1.0,3/18,7.37%,AKR1C1;HSD17B7;HSD17B14
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.4402771999846872,-1.4457214324734446,0.045454545454545456,0.3668757572940977,1.0,16/34,26.43%,PAN3;ERI3;EXOSC2;EXOSC3;XRN2;PDE12;PARN;USB1;EXOSC5;ANGEL2;DIS3L2;CNOT2;CNOT8;EXOSC7;TOE1;CNOT1
prerank,neuropeptide binding (GO:0042923),0.5119392689779236,1.442801547221301,0.07929515418502203,0.295060183093314,1.0,5/18,16.56%,OPRM1;GPR37;SORL1;NMUR2;GPR149
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.44234982617964536,-1.4379982821028499,0.04428044280442804,0.3798906509889169,1.0,13/34,15.96%,SETD2;KMT2E;KMT5B;NSD3;SUV39H1;SETD3;DOT1L;EHMT1;SMYD1;PRDM9;N6AMT1;KMT5A;ANTKMT
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.557244632444962,1.4371164760559327,0.06726457399103139,0.29944830804677225,1.0,4/11,9.99%,PRMT9;FBXO11;PRMT6;PRMT5
prerank,vitamin D receptor binding (GO:0042809),-0.554703065074974,-1.4353991630001517,0.07460035523978685,0.3805763500636996,1.0,6/14,16.73%,RXRA;MED1;TAF11;MED13;MED17;TAF7
prerank,platelet-derived growth factor binding (GO:0048407),0.5790149567013225,1.4353639535584715,0.09111111111111111,0.29727401189866226,1.0,6/11,12.33%,COL2A1;COL1A1;COL1A2;PDGFA;COL3A1;PDGFRA
prerank,transcription cis-regulatory region binding (GO:0000976),-0.301316548752029,-1.433870917340048,0.0,0.3780844054944372,1.0,86/406,15.53%,FOXP1;LEF1;PBX1;RREB1;SMARCA2;FLI1;ETV6;ZBTB20;MEF2A;RB1;BNC2;KLF4;ETS1;CUX1;FOXN3;TCF12;PRDM5;IRF2;RXRA;PRDM16;FOSL2;NR3C1;TEAD1;SOX13;PLAGL1;TIPARP;SOX17;PSPC1;SP1;ZBTB46;VSX1;ELK3;CTCF;SIX1;LHX6;NFKB1;HDAC1;FOXO3;NFYC;BBX;MEF2C;STAT6;ZBTB4;GABPB2;JUN;MAX;DACH1;CREB3L2;ZFP90;SUV39H1;SMAD2;SMAD4;PRDM2;IRF1;ZNF25;TAL1;GLIS2;TP53;SP3;KLF10;GLI3;PER3;YAP1;SOX7;CHD3;SFPQ;TWIST2;XRN2;FOXF2;HDAC4;CREBRF;ACTN4;GABPB1;ASH2L;CIC;GRHL1;HIF3A;AGO2;ATF4;MZF1;BCOR;FOXC1;DR1;PRDM9;TCF3;SMAD6
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5729521063342058,1.4337711532599355,0.0990990990990991,0.29480603033307007,1.0,3/11,8.89%,SLC22A4;SLC22A1;SLC25A45
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5617833932960624,-1.4330191353802444,0.08781362007168458,0.3741533568123163,1.0,8/13,24.59%,PIP4K2A;PIP4K2B;PIK3C2A;PIP5K1B;PIK3CD;PIK3CB;PIP5K1A;PIK3CA
prerank,death receptor activity (GO:0005035),-0.5937160273564286,-1.4328744248396585,0.08,0.3686638506002668,1.0,5/11,19.87%,TNFRSF1B;FAS;TNFRSF19;TNFRSF1A;TNFRSF25
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.3739454219101456,-1.4325428259912147,0.03270223752151463,0.3636944054907594,1.0,16/71,8.20%,PTPRG;PTPRB;PTPRM;PTPN14;PTP4A2;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPDC1;PTPN12;PTPRK;CDC14A;PALD1;MTMR6
prerank,organic cation transmembrane transporter activity (GO:0015101),0.508576733275304,1.4320833206792547,0.07838479809976247,0.29273882023065745,1.0,4/16,8.47%,SLC22A4;SLC22A1;SLC7A8;SLC29A4
prerank,histone deacetylase binding (GO:0042826),-0.37074935408374665,-1.431128638487395,0.01601423487544484,0.3612634421882977,1.0,32/88,22.72%,LEF1;MEF2A;MIER1;KAT2B;YWHAE;SP1;HES1;NIPBL;HDAC1;MEF2C;TAL1;TP53;GLI3;SFPQ;HDAC4;MAPK8;PKN2;BCOR;PHF6;HIC1;HDAC6;TFAP4;MIER2;HDAC10;HEY2;MIER3;CCND1;PRDM1;NACC1;HSP90AA1;SUDS3;RELA
prerank,kinase binding (GO:0019900),-0.3004792780753666,-1.4304844053407786,0.0,0.35729902436830224,1.0,136/434,24.21%,UTRN;DAB2IP;TTC28;SLC12A7;GHR;SP100;ACVRL1;RB1;FERMT2;PPP2R5A;CAV1;ESR1;RAC1;RHOBTB1;LIMS1;GSK3B;IQGAP1;KAT2B;KIF13B;PTPN1;CRK;WWC2;PAK2;SIK1;NR3C1;RND3;LRBA;SPRED2;NBEAL1;SLC12A2;PLCG1;TFRC;PTPRJ;NEK6;CDKN1B;TAX1BP1;EGFR;NISCH;MSN;HNRNPA0;AP2A2;RICTOR;DLG1;FAS;FOXO3;CEP250;IRGM;PRKCD;PTPRK;CCND3;PTK2;ZBTB4;CNTLN;ACTA2;SMAD1;MAML1;EXOC2;TBC1D14;PLCG2;NBEAL2;PRKRIP1;CSPG4;YWHAZ;CTBP2;ADAM10;BCAR1;MYOM1;TP53;FLNA;FRMD5;TRIM14;PPP1R12A;EEF2;RGCC;ILK;PEBP1;DCTN1;ACTB;IRAK1;CEACAM1;MTCP1;RPTOR;JAK2;RHOA;DUSP3;RHOG;CHP1;RHOC;GYS1;PIK3IP1;PARN;ATF4;KIF11;GRB2;SKI;MAVS;CTNNB1;TNS2;TRPV4;CDK5RAP3;CEP152;IKBKB;NOD2;RPS3;CCND1;RAD23A;SASH1;CACUL1;PRKAB1;PTPRC;ERCC6L2;VRK2;PRC1;HDAC7;TOM1L2;SIKE1;CDKN2C;PTPN11;WARS1;MAP2K3;RPS7;PARP16;CDC25A;GADD45A;RELA;BECN1;IFNAR2;TRIM68;CEBPA;FZD5;CCNK;PIP5K1A;TCF7L2;PDGFRB;ATF5;TPCN2
prerank,voltage-gated ion channel activity (GO:0005244),0.532180948235966,1.430166883751553,0.08314087759815242,0.2911711338322112,1.0,4/14,10.58%,KCND2;HCN1;CACNA1E;VDAC2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4694819384167328,-1.4272022845672634,0.0549645390070922,0.36010049491858404,1.0,7/26,10.76%,ABCG2;SLC6A6;SLC5A6;SLC16A12;SLC16A9;SLC16A1;SLC16A6
prerank,protein kinase binding (GO:0019901),-0.29593278358765,-1.426951788274429,0.0,0.35541722246924556,1.0,141/479,21.67%,UTRN;GRK5;DAB2IP;SLC12A7;GHR;ITGB1;ACVRL1;FERMT2;CAV1;ESR1;RAC1;CAVIN2;BMPR2;RHOBTB1;LIMS1;GSK3B;IQGAP1;KAT2B;KIF13B;PTPN1;CRK;PAK2;SIK1;NR3C1;RND3;LRBA;SPRED2;NBEAL1;SLC12A2;PRKD2;PLCG1;ACE;TFRC;PTPRJ;NEK6;CDKN1B;PDLIM5;NISCH;MSN;ADAM9;HNRNPA0;AP2A2;RICTOR;PPEF2;DLG1;FOXO3;PARD6G;ABL1;IRS1;CEP250;KCNQ1;GCH1;IRGM;PRKCD;PTPRK;CCND3;EZR;TJP2;PTK2;ZBTB4;CDH5;CNTLN;EPHA4;MAPKAPK2;ACTA2;ADCY4;SMAD1;MAML1;EXOC2;TBC1D14;PLCG2;NBEAL2;PRKRIP1;CSPG4;YWHAZ;GSK3A;CTBP2;ADAM10;BCAR1;TP53;FRMD5;TRIM14;PPP1R12A;EEF2;RGCC;ILK;PEBP1;DCTN1;ACTB;STK38;IRAK1;NEDD9;CEACAM1;MTCP1;RPTOR;JAK2;RHOA;DUSP3;PRKCSH;RHOG;CSK;RHOC;GYS1;PARN;ATF4;KIF11;TCF3;GRB2;TPR;SKI;MAD2L2;RARA;NOX4;MAVS;HINT1;TRPV4;CDK5RAP3;CEP152;IKBKB;NOD2;RPS3;DUSP16;DUSP22;CCND1;SASH1;PPM1D;CACUL1;PRKAB1;PTPRC;ERCC6L2;VRK2;PRC1;HDAC7;TOM1L2;SIKE1;CDKN2C;PTPN11;WARS1;MAPK7;MAP2K3;SPAG9
prerank,transcription coregulator binding (GO:0001221),-0.40022605489762547,-1.4208252669545292,0.03590664272890485,0.3640969178541432,1.0,14/50,11.17%,ZBTB16;ESR1;LMO2;THRB;NEK6;VGLL4;CTCF;ZBTB7A;SUZ12;PPARD;CTBP2;SMAD4;PER3;EHMT1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5503580253665169,-1.4152839715076218,0.08022388059701492,0.3721647110070134,1.0,7/13,26.91%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,protein phosphatase binding (GO:0019903),-0.3415251672185263,-1.4148512090950232,0.008620689655172414,0.36796189252836653,1.0,28/117,13.15%,DAB2IP;FOXO1;MFHAS1;IQGAP1;MTMR3;MAP3K5;JAK1;ITGA1;CDKN1B;AKAP11;EGFR;STRN3;PXN;PPP1R3B;SHOC2;PHACTR4;PIK3R1;KCNQ1;STAT6;PTK2;CDH5;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3;CTTNBP2NL
prerank,transforming growth factor beta binding (GO:0050431),-0.4679672703528475,-1.4132810492997514,0.0599250936329588,0.3664798087159319,1.0,8/23,18.43%,ENG;ACVRL1;THBS1;TGFBR3;TGFBR2;LTBP4;NRROS;HYAL2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.31620169875784687,-1.4120592042983489,0.010657193605683837,0.3646265206958848,1.0,60/228,18.91%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRIM25;UBE2K;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;RNF43;CBL;UBE4B;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;HECTD1;TRIP12;SH3RF1;ZNRF2;UBE2D3;PDZRN3;UBR2;RNF25;TRIM14;AREL1;UBE4A;ASB1;RC3H1;TRIM59;UBR4;RNF167;DTX3;RFWD3;HERC2;MYLIP;PELI2;TRIM13;RNF152;RNF10;UBR1;TRIM3;RNF2;SIAH1;HUWE1;WWP2
prerank,sodium channel regulator activity (GO:0017080),0.4150546846871409,1.4096932920017995,0.058165548098434,0.3214654690501084,1.0,10/37,13.94%,FGF14;FGF12;SCN1B;ATP2B4;PKP2;GPD1L;GPLD1;SGK1;FXYD4;SCN2B
prerank,transcription coactivator binding (GO:0001223),-0.48676741448382305,-1.3995340911206482,0.07651245551601424,0.38900976565716455,1.0,5/20,9.26%,ESR1;THRB;VGLL4;PPARD;SMAD4
prerank,phospholipase C activity (GO:0004629),-0.4621195739741342,-1.396425410697568,0.06642728904847396,0.391456631797368,1.0,7/25,8.83%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.5629875244009803,-1.3953319854826796,0.08007448789571694,0.3891253255415105,1.0,7/12,30.97%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4092844244981679,-1.3943355658219063,0.046242774566473986,0.3864496914741468,1.0,16/42,15.42%,CRK;SHE;LDLRAP1;YWHAE;YES1;ABL1;PIK3R1;IRS1;NEDD4;PLCG2;SHB;NCK2;RASA1;PTPN3;PIK3R3;GRB2
prerank,BMP receptor binding (GO:0070700),-0.5503749003118615,-1.3885200241522488,0.1038961038961039,0.39523363720334526,1.0,7/12,26.91%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.44191381979575867,-1.3858154735429693,0.08163265306122448,0.3969504965169705,1.0,8/30,15.00%,CAST;XIAP;TNFAIP8;BIRC3;GAS6;BIRC6;RPS6KA1;RPS6KA3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5500325509080906,-1.3849966192505345,0.10431654676258993,0.39415658597846565,1.0,6/12,15.06%,ATM;PIK3C2A;PIK3CD;PIK3R6;PIK3CB;PIK3R3
prerank,histone methyltransferase activity (GO:0042054),-0.42880017424351263,-1.38397589570661,0.0740072202166065,0.39200078083484263,1.0,13/32,15.48%,SETD2;KMT2E;KMT5B;SUZ12;NSD3;SUV39H1;DOT1L;EHMT1;SMYD1;PRDM9;N6AMT1;KMT2C;KMT5A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3758531772901289,-1.3783900111461056,0.03484320557491289,0.4007397605837609,1.0,14/60,9.45%,FLT1;TEK;IGF1R;NRP2;TIE1;CRIM1;INSR;ROR1;KDR;MERTK;EGFR;EPHA4;FLT4;IGF2R
prerank,methyl-CpG binding (GO:0008327),0.45237491534429014,1.376815563583057,0.09111617312072894,0.3800108558212815,1.0,11/22,24.59%,ZCWPW1;CXXC4;UHRF1;ZBTB21;PRMT5;TET1;CXXC5;CHTOP;ERH;WDR77;LHX4
prerank,estrogen receptor binding (GO:0030331),-0.4280461656887962,-1.376527075420622,0.07427536231884058,0.4001225706428018,1.0,12/32,18.45%,LEF1;TACC1;NSD1;ESR1;NRIP1;MED1;WIPI1;DCAF13;RERG;CTNNB1;NCOA6;WBP2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.44705037986929813,-1.3758021999698986,0.09107468123861566,0.3970392069678027,1.0,10/25,22.45%,HIP1;ARAP3;AKT1;FCHSD2;PLEKHA4;ZFYVE1;HIP1R;GAB2;PHLDA3;KIF16B
prerank,G protein-coupled receptor activity (GO:0004930),0.2971407063587247,1.3703915934592186,0.004796163069544364,0.3871449193538737,1.0,38/239,11.79%,GRM5;ADGRB3;HCRTR1;PROKR1;ADGRL3;OPRM1;NPFFR2;GRM8;GPR101;GABBR2;ADGRG4;CNR1;GPR135;GPR37;MTNR1B;ELOVL4;MTNR1A;GPR22;NPY;TRHR;KISS1R;GRM1;ADRA2C;C3AR1;GIPR;ADRB3;GPR83;GPR65;ADRA2A;VIPR2;TSHR;LGR5;GPR45;ADRA1D;ADRA1A;NMUR2;CELSR2;GABBR1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.5874824197122472,-1.3689006106065964,0.11265164644714037,0.40900405922586325,1.0,3/10,10.14%,NAA16;NAA80;NAA15
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3699142111252731,-1.3669470997397064,0.043478260869565216,0.4090877341824123,1.0,14/60,9.46%,FLT1;TEK;IGF1R;ACVRL1;TIE1;INSR;ROR1;KDR;MERTK;EGFR;TGFBR2;EPHA4;FLT4;ACVR2A
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.30375154234168295,-1.3659713535964695,0.0189328743545611,0.40708215997233343,1.0,60/232,18.97%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;RNF43;CBL;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;HECTD1;TRIP12;SH3RF1;ZNRF2;UBE2D3;PDZRN3;UBR2;RNF25;TRIM14;AREL1;NSMCE2;ASB1;RC3H1;PIAS2;TRIM59;UBR4;RNF167;DTX3;RFWD3;HERC2;MYLIP;PELI2;TRIM13;RNF152;RNF10;UBR1;TRIM3;RNF2;SIAH1;HUWE1;WWP2;PIAS4
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.518392493819645,-1.3657486554628366,0.10185185185185185,0.40289899963862424,1.0,7/15,15.87%,ATM;PI4KB;PIK3C2A;PIK3CD;PIK3CB;PIK3R3;PI4K2B
prerank,sequence-specific DNA binding (GO:0043565),-0.2776684509751978,-1.3649721822823542,0.0,0.40031838567484035,1.0,120/590,17.59%,FOXP1;KLF12;LEF1;PBX1;FOXP2;FLI1;NFIB;MBNL2;TEF;ERG;ZNF423;ZBTB20;FOXO1;MEF2A;CBFB;NFAT5;ELF1;KLF4;NR3C2;ESR1;CUX1;PKNOX2;TCF12;PRDM5;KLF2;IRF2;STN1;RXRA;NFATC1;KLF3;PRDM16;TBX15;TBX1;NFATC4;NR3C1;TEAD1;SOX13;THRB;ZBTB37;KDM2A;NFIX;SP1;VSX1;ELK3;ZNF148;MEOX2;CTCF;HES1;SIX1;PPARA;LHX6;RARG;HOXB6;ZBTB7A;UBP1;FOXO3;ABL1;HIVEP1;BBX;ZIC4;E2F4;MEF2C;ZBTB4;JUN;UPF2;MAX;TBX2;PPARD;BACH2;SMAD4;ZIC5;PRDM2;HSF5;GLIS2;SP3;HMBOX1;ELF2;KLF10;GLI3;ETS2;NFIC;GMEB1;SOX7;PRRX2;SNAPC1;FOXF2;HDAC4;FOXJ3;SIRT3;CTC1;GRHL1;MECP2;ZIC3;TFCP2L1;ATF4;MYBL2;FOXC1;PRDM9;TCF7L1;NR1D2;NR2C1;FOXO4;ETV1;ZNF32;ZFP1;HIC1;TERF2;SIX4;FOXQ1;KDM5B;RARA;TFAP4;ZBTB14;HOXA2;HLF;EPAS1;HEY2;ZNF250;HEY1;CEBPG
prerank,acylglycerol lipase activity (GO:0047372),-0.5565075160285134,-1.3649274526849933,0.10357142857142858,0.3959790024707766,1.0,3/11,14.21%,ABHD2;MGLL;LIPE
prerank,growth factor activity (GO:0008083),0.352854514541263,1.364565013290953,0.05755395683453238,0.393109429102444,1.0,11/74,10.01%,NRG3;NRG1;OSGIN1;CLEC11A;FGF6;GRN;FGF5;FGF20;VEGFA;PDGFA;IL12A
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.43697230168116624,-1.3626409713596481,0.10918544194107452,0.3976764767164365,1.0,17/29,33.60%,NFATC1;ACE;PTPRJ;ABL1;GCH1;MAPKAPK2;TPR;CDK5RAP3;DUSP16;PPM1D;MAPK7;DUSP1;TNIP1;MAPK14;DUSP6;DIRAS1;ATF7
prerank,calcium-activated potassium channel activity (GO:0015269),0.5283855351925881,1.3625959379906598,0.11185682326621924,0.39066643604713774,1.0,3/11,11.96%,KCNMA1;KCNN2;KCNN3
prerank,syntaxin-1 binding (GO:0017075),0.45686163516558914,1.3594525432583167,0.09544468546637744,0.3906462914510666,1.0,7/22,8.02%,SYT1;SNAP25;SNPH;SYNPR;PRRT2;SYP;STXBP2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5669371367520654,1.3546940139333417,0.11290322580645161,0.3944963146255661,1.0,2/10,1.89%,DPP10;DPP6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.44091680061908756,1.3509489186275307,0.1053864168618267,0.3964774434711797,1.0,7/23,10.35%,PDE4B;PDE3B;PDE1B;PDE10A;CNP;PDE1A;PDE11A
prerank,nuclear receptor binding (GO:0016922),-0.33399929630388714,-1.3498603250512873,0.04,0.4227233874819182,1.0,31/111,18.45%,FOXP1;LEF1;TACC1;NSD1;ESR1;ASXL1;NRIP1;RXRA;TACC2;ZBTB7A;PRPF6;MED1;SMARCE1;TRIP12;TAF11;KDM3A;JMJD1C;MED13;MED17;BCAS3;WIPI1;ACTN4;HMGN3;SMARCD3;TADA3;DCAF13;RERG;TAF7;CTNNB1;NCOA6;WBP2
prerank,bHLH transcription factor binding (GO:0043425),-0.4786674367682433,-1.3456784062969491,0.0965391621129326,0.4285056557839733,1.0,4/19,4.74%,CREBBP;TCF12;LMO2;SP1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.425486927287838,-1.3436437359254947,0.09874326750448834,0.4290863515688584,1.0,10/30,20.88%,SLC39A10;SLC40A1;SLC31A1;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC25A28;SLC39A6;SLC30A1
prerank,SH2 domain binding (GO:0042169),-0.4143348098287988,-1.3401059383928013,0.09683098591549295,0.4334024998764883,1.0,8/31,7.03%,AFAP1L2;RUFY1;CRK;SH3PXD2B;ARHGAP5;ABL1;IRS1;PTK2
prerank,DNA binding (GO:0003677),-0.27006539325564494,-1.3394513799756902,0.001607717041800643,0.4305815948745453,1.0,220/694,27.25%,MECOM;KLF12;LEF1;PBX1;FOXP2;SMARCA2;FLI1;ZBTB16;NFIB;ERG;ZNF423;FOXO1;MEF2A;CREBBP;CBFB;ETS1;CUX1;HIVEP2;PDS5B;PRDM5;KLF2;IRF2;CHD2;STN1;RXRA;APP;PRDM16;TBX1;TEAD1;SOX13;THRB;RBMS1;DDX3X;KAT6A;PLAGL1;PARP4;SP1;EGFR;CRLF3;ZNF148;DMC1;ZMYM6;TOP3A;RBM5;MEOX2;CTCF;HES1;SIX1;PPARA;RARG;SAMHD1;RYBP;XRCC4;ZBTB7A;FOXO3;ABL1;NFYC;ZIC4;E2F4;ZBTB4;JUN;MAX;XRN1;MRE11;TSHZ2;POLR2G;TBX2;NABP1;SMAD2;PPARD;MCM9;SMAD4;ERCC2;PRDM2;IRF1;RBBP8;CLSPN;SPTY2D1;TP53;MCM4;HMBOX1;WDR76;BCLAF3;ETS2;RTF2;DDX60;CHD3;SFPQ;ENDOV;SNAPC1;FOXF2;HDAC4;ZNF638;RAD18;OGG1;RTF1;LRRFIP1;JRKL;RPA3;YAF2;ZMYM4;DNA2;FOXJ3;ZBTB6;RPA1;XPC;NHEJ1;SIRT3;ARID3B;CTC1;ERCC3;GRHL1;PNKP;MECP2;ZIC3;ATF4;HNRNPA1;POLR3F;FOXC1;TRIM16;PRDM9;CGAS;TCF3;TCF7L1;NR2C1;FOXO4;PALB2;HIC1;RPS27;DNMT1;KDM5B;TFAP4;ZBTB14;HLF;EPAS1;HEY2;FANCG;ZMYND11;CEBPG;WRN;TSHZ1;PATZ1;SMARCAD1;RPA2;RPS3;ARID5B;SDE2;HUWE1;RAD23A;ELK4;ARNT;RNF4;ZDHHC1;FUBP1;PRKDC;LIG4;BRCA1;TIMELESS;RAD51AP2;TRIM28;FOXL2;DCLRE1B;BLM;PPARG;TAF4B;TERT;RBM6;RARB;MBD6;MCM3;RPS15;RELA;ATF6;BCL6;NFE2L2;TOP1;TSHZ3;MAU2;PCBP1;CEBPA;NR2F2;NTHL1;MSH3;YY1;RFC1;TCF4;TCF7L2;TBX3;ARID3A;TAF9;GTF3C4;ATF5;DHX9;ERCC6;HIC2;HMGB1;SNAPC3;DCLRE1A;POLR2H;SMARCB1;THRAP3;FOXF1;MLF1;USF2;CRY2;E2F3;TBX6;POU6F1;HNRNPU;SP7;ERF;MCM7;MCM5;MCM10;POLL;SLTM;INO80;KHDRBS1;EXO1;IRF7
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.31778268442398266,-1.338763999204047,0.029310344827586206,0.4279402586586732,1.0,24/134,9.53%,ABCC4;ABCG2;SLC6A6;SLC26A7;SLCO2A1;SLCO1C1;SLC7A1;SLC7A5;SLC26A2;SLCO3A1;SLC25A32;SLC5A6;SLC16A12;SLC38A5;SLC19A2;SLC16A1;SLC25A25;SLC39A8;SLC1A5;SLC13A3;SLC35A3;SLCO2B1;MFSD2A;SLC52A1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5211938294890149,-1.3381077293522745,0.15492957746478872,0.4254071768522636,1.0,6/14,19.61%,USP9X;MINDY1;USP13;USP15;ATXN3;USP7
prerank,histone acetyltransferase binding (GO:0035035),-0.46879616379089206,-1.3377442186525603,0.13080895008605853,0.42204436539696655,1.0,10/21,23.20%,MEF2A;ZBTB7A;TP53;GLI3;BCAS3;TAF7;EPAS1;CITED2;KANSL1L;TRIM68
prerank,actin monomer binding (GO:0003785),-0.4650110801214687,-1.3345089805989157,0.11730769230769231,0.4254955508890151,1.0,5/22,6.15%,LIMA1;NOS3;PRKCE;TMSB4X;ABL1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.449732591288666,-1.3344832401628353,0.10108303249097472,0.4213879613403585,1.0,11/25,25.41%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;PARP16;PARP6;PARP9
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.5444709824419239,-1.334273969210613,0.11678832116788321,0.4177505716312607,1.0,6/11,18.57%,STN1;RPA1;CTC1;HNRNPA1;TERF2;RPA2
prerank,histone acetyltransferase activity (GO:0004402),-0.43260597578818355,-1.332934043578267,0.10128913443830571,0.41695264372009594,1.0,9/30,15.73%,CREBBP;KAT6B;KAT2B;KAT6A;BAZ1A;SRCAP;KAT5;MCM3AP;TADA3
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2816907904753293,-1.3263832526909012,0.019639934533551555,0.42889185316930983,1.0,97/346,21.88%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRAF5;TRIM25;UBE2K;TRIM56;RNF139;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;FBXL3;RNF213;BIRC3;RBX1;LMO7;RNF43;CBL;CUL3;NEDD4;LTN1;RNF40;RNF115;RNF144B;CUL2;UHRF2;BIRC6;HECTD1;UBE2J2;TRIP12;SH3RF1;UBA7;ZNRF2;UBE2D3;PDZRN3;UBR2;MIB1;RNF25;FBXW8;TRIM14;AREL1;TNFAIP1;RMND5A;TSPAN17;KLHL13;OBI1;ASB1;UBE2E2;RC3H1;FBXW11;TRIM59;UBR4;RNF168;BCOR;RNF167;DTX3;UBE2M;ERCC8;MIB2;RFWD3;HERC2;MYLIP;UBE2L3;TNFAIP3;PELI2;TRIM13;RNF152;KCTD10;RNF10;AKTIP;UBR1;TRIM3;RNF2;SIAH1;HUWE1;WWP2;TRIM47;RNF4;RNFT2;FANCL;BRCA1;TRIM28;SH3RF2;HACE1;RNF216;UBE2R2;MDM2
prerank,double-stranded DNA binding (GO:0003690),-0.27227224172042747,-1.3255166137571581,0.001652892561983471,0.42702976305332074,1.0,140/531,23.92%,FOXP1;KLF12;LEF1;PBX1;FLI1;NFIB;MBNL2;TEF;ERG;ZBTB20;NFAT5;ELF1;KLF4;NR3C2;ESR1;CUX1;PKNOX2;TCF12;KLF2;IRF2;RXRA;NFATC1;KLF3;TBX15;TBX1;NFATC4;NR3C1;TEAD1;THRB;RBMS1;ZBTB37;NFIX;SP1;EGFR;VSX1;ELK3;DMC1;MEOX2;HES1;SIX1;LHX6;RARG;HOXB6;ZBTB7A;UBP1;FOXO3;ABL1;HIVEP1;BBX;ZIC4;E2F4;MEF2C;JUN;MAX;MRE11;TBX2;SMAD2;PPARD;BACH2;ZIC5;HSF5;RBBP8;GLIS2;SP3;HMBOX1;ELF2;KLF10;GLI3;ETS2;NFIC;DDX60;GMEB1;SOX7;PRRX2;ZNF638;FOXJ3;GRHL1;PNKP;MECP2;ZIC3;TFCP2L1;ATF4;MYBL2;POLR3F;CGAS;TCF7L1;NR1D2;NR2C1;FOXO4;ETV1;ZNF32;ZFP1;HIC1;TERF2;SIX4;FOXQ1;KDM5B;RARA;TFAP4;ZBTB14;HOXA2;HLF;HEY2;ZNF250;HEY1;ZMYND11;CEBPG;GATA2;HOXB9;RPS3;SOX4;ELK4;ARNT;ZBTB12;ZIC1;PRKDC;RAD51AP2;FOXL2;PRDM1;PPARG;CREB1;HSF4;RARB;ATF6;GLIS1;BCL6;MSX1;GABPA;TOP1;ELF4;MAU2;RXRG;NTHL1;MSH3;YY1;GMEB2;TCF4;KLF16;TBX3;E2F7
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3625414448722253,-1.3250049958781225,0.08963093145869948,0.4243187349448491,1.0,15/60,10.93%,PPM1H;MTMR3;LRRK2;CAMK2G;PPEF2;PPM1L;LRRK1;CDC14A;ILKAP;PPM1F;MTMR6;PPP1R3C;CTDSPL2;PPM1B;UBLCP1
prerank,phosphatase activity (GO:0016791),0.3432971725274111,1.3239426956967582,0.07640449438202247,0.44834493832937716,1.0,23/73,19.23%,ATP1A2;BPNT2;LPIN1;PLPPR4;PPP5C;PLPPR1;PLPP2;DUSP4;SBF1;PLPP4;PLPPR5;HDHD2;APTX;OCRL;DUSP8;NUDT16;DUSP15;PSPH;PTPRO;FRA10AC1;PGP;DUSP18;ACP2
prerank,metallopeptidase activity (GO:0008237),0.3184390053238375,1.3210674959541748,0.03597122302158273,0.448876545667562,1.0,21/113,9.82%,ADAM12;OMA1;ADAM23;ADAM29;MMP12;MME;ADAM11;MMP16;PAPPA2;MMP28;MMP24;MMP25;ADAMTS15;METAP2;ADAM2;ADAMTSL4;MPND;ADAM19;DPEP1;PSMD14;ADAMTS16
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4802274437493598,1.3207348796672096,0.1447661469933185,0.43717494340575,1.0,8/16,23.24%,ATP6V1B2;ATP6V0C;ATP6V0A2;ATP6V0D2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4802274437493598,1.3207348796672096,0.1447661469933185,0.43717494340575,1.0,8/16,23.24%,ATP6V1B2;ATP6V0C;ATP6V0A2;ATP6V0D2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,actin binding (GO:0003779),-0.30355854228889306,-1.3196264905902029,0.02276707530647986,0.4323457888005094,1.0,30/170,8.17%,UTRN;ABLIM1;MYRIP;SORBS1;LIMA1;ITGB1;NOS3;FERMT2;PARVB;EPS8;PHACTR2;MYH9;PRKCE;TMSB4X;PARVA;SYNE2;MICAL2;SYNE1;LRRK2;EMD;PDLIM5;EPS8L2;ABL1;PHACTR4;MACF1;EZR;PTK2;FXYD5;MYO1F;PDLIM1
prerank,damaged DNA binding (GO:0003684),-0.38507695303761624,-1.317913205076421,0.09187279151943463,0.4324975784911088,1.0,19/44,25.74%,CREBBP;ERCC2;RBBP8;RAD18;OGG1;RPA3;RPA1;XPC;ERCC3;PNKP;FANCG;RPA2;RPS3;SDE2;DCLRE1B;NTHL1;HMGB1;DCLRE1A;CRY2
prerank,metalloexopeptidase activity (GO:0008235),0.36531107488914394,1.3169656834599006,0.07392197125256673,0.43919242095651995,1.0,14/51,14.61%,AGBL4;CPB2;TRHDE;MMP16;CPA2;CPE;METAP2;AGBL1;DPEP1;CPN1;AEBP1;NUDT16;CPA4;CPA3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.39670970718055065,-1.3154645892800163,0.10193321616871705,0.43431648633960773,1.0,13/37,21.48%,WARS2;YARS1;NARS2;CARS2;FARS2;TARS3;LARS1;DARS2;HARS2;VARS2;FARSA;IARS2;WARS1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5348433330890511,1.3151234969298322,0.1632183908045977,0.43709802367825157,1.0,1/11,0.61%,HCN1
prerank,RNA binding (GO:0003723),-0.2550542554019194,-1.3136573081009708,0.0,0.43474154456813413,1.0,478/1321,30.40%,SPTBN1;MBNL1;TNS1;CTNNA1;RBPMS;MBNL2;CAST;MAP3K20;MSI2;SRSF11;EIF3H;ANKHD1;FNDC3A;MYH9;ZCCHC7;FNDC3B;ANKRD17;ZNFX1;TUT7;TNRC6B;YARS1;HADHB;ERI3;TMSB4X;EIF4H;RBFOX2;IFIH1;SUGP2;ZNF326;CHD2;ANXA2;CDK13;TRIM25;TENT4B;PTPN1;PRPF3;ANXA11;TRIM56;DEK;NUP42;RPS21;ZC3HAV1;CNOT4;EIF3E;METTL14;DAP3;SYNE1;DIAPH1;RRBP1;RBMS1;UTP11;AHNAK;DDX3X;RPL37;ARCN1;MAP4;YWHAE;FBRSL1;TFRC;PSPC1;SARNP;RPL31;RAE1;ZC3H4;GIGYF2;SUCLG1;MSN;RTRAF;HNRNPA0;EIF3C;PPIG;RBM5;LARP1;THOC2;RPL9;SAMHD1;NOVA2;RPS14;HNRNPR;WDR75;PRRC2B;HOXB6;SORBS2;KHNYN;MACF1;UPF3B;RBM33;NOL10;PRPF6;RPF1;EIF3B;NUP98;FARS2;SF3B6;AATF;FUS;EZR;DDX10;TCP1;ACIN1;ZCCHC9;JUN;SPEN;SNTB2;MYO18A;XRN1;RBM19;RBMS2;FAM120C;HNRNPM;PUM1;S100A16;ZGRF1;TOP3B;SAMD4A;SECISBP2;ZC3H7B;RPSA;POLR2G;AGFG1;DDX50;HNRNPAB;GTF2E2;ADK;PTCD3;PRKRIP1;NOP2;DDX39B;EXOSC1;EXOSC2;PHF5A;YWHAZ;RPL3;ZNF106;MRPL32;GPATCH8;SF3B1;SRPRA;RPL26;CELF1;PPP1R10;TASOR;FLNA;HNRNPA3;ESF1;NAA15;PRPF31;RPS11;PUF60;CPSF7;TDRD3;SERBP1;SRP9;SNIP1;NDUFV3;SLC25A11;DNTTIP2;FAM120A;HELZ2;EXOSC3;DDX60;EEF2;EFTUD2;PEBP1;PRRC2C;OTUD4;STRBP;HNRNPUL1;DICER1;DHX38;DBR1;MAZ;HNRNPF;MRPS23;CHD3;SFPQ;ENDOV;TUT4;XRN2;RBM39;RPL13;SPATS2L;ZNF638;LLPH;RPL38;MTDH;MTCL1;PA2G4;ACTN1;RTF1;LRRFIP1;SON;KCTD12;CLK3;ACTN4;TIAL1;DNA2;EIF5A;RPL27;RPS16;UTP3;LARP4B;RPS4X;PKN2;RPL10;NIP7;RRP1;NUFIP2;MRPL2;MRPS24;RC3H1;RPL7A;MECP2;RBM20;RPUSD4;FAU;PARN;AGO2;HNRNPA1;ALDH18A1;LARP1B;N4BP1;SF3A1;XPOT;MARK2;CCDC9;LBR;PDIA3;PHF6;GSPT1;FAM98A;MRPL12;DARS2;RPL5;MRPS27;JMJD6;HARS2;PABPC4L;GRB2;KMT2C;CCDC9B;CAVIN1;ALG13;TPR;APOBEC1;USP10;ZC3H14;ROCK2;PUS10;DCAF13;UTP14A;TEP1;PSTK;SUMO1;RPS27;SRPK2;TRMT9B;SRP14;GCN1;SRSF12;UBE2L3;SYNCRIP;API5;MOV10;EDC3;ADARB1;RPL27A;LSM10;CCDC86;ATP5F1C;PPHLN1;RPL7L1;TES;HMGN2;DIDO1;COA6;RPS3;TNRC6A;RPL35A;HUWE1;NCOA5;RPL36A;TXN;STAU1;FUBP1;BUD13;DHX57;FARSA;RBM4B;BOP1;RPL37A;UTP4;SRRM1;RTCB;MRPS14;FIP1L1;NQO1;PRKDC;DDX31;DROSHA;RNPS1;DCP1A;BRCA1;SRSF3;MRPS21;RPL32;TRIM28;DUSP14;CDK11B;SRSF10;STRAP;CAPRIN1;CWC22;FASTKD5;NONO;RRS1;PRPF38B;MEX3A;PES1;NKAP;SLC3A2;ARHGEF1;TRA2B;LSM3;PSMD4;RBM3;BZW1;MEX3B;PTBP3;TERT;UBTF;RBM6;RPS7;MRPL54;RPL36;EBNA1BP2;RPS8;HSP90AA1;RPL28;KTN1;RPS15;RBM25;RPS23;RPL30;RPL13A;MRPL13;RBM15;TOP1;NPM3;MRPL9;TPD52L2;METTL16;GLRX3;EIF3A;PCBP1;YY1;POLDIP3;RPL22;AKAP1;SF3B5;RPS17;MRPS28;MRPS35;ALKBH5;TRMT1;HSPA1B;IMMT;NOP16;SRBD1;TAF15;NXF1;DHX9;ELAC2;HMGB1;NOL8;EIF3I;NOA1;FXR1;NCBP3;FAM32A;MRPL43;WDR46;THRAP3;PRPF40B;RTCA;UBAP2;SMG6;EXOSC7;EIF2AK4;RPL34;RPS2;NAF1;NEMF;TUFM;ENDOU;RPS15A;RPS26;MRPS31;RPL15;MRPL11;TRNT1;RAN;TOE1;RPP30;RBM28;PINX1;HNRNPU;HNRNPL;RPL39;EMG1;NANOS1;RDX;ZCCHC24;RBPMS2;CNOT1;HNRNPD;PABPC1;PEF1;LARP6;SCG3;DXO;SLTM;KHDRBS1;BYSL;BST2;SELENOH;RPL22L1;PCDH20;HTATSF1;SCAF11;LSM2;RBM47;SMG1;TDRD7;UBE2I;BAG4;NUFIP1;UTP23;EIF5B;HDLBP;UTP20;LARP7;KHDC4;PPIE;RPUSD2;CACTIN;GAR1;POP4;RAD51AP1;OASL;NMD3;RPL19;DMGDH;NUDT7;CEBPZ;DDX28;DHX40;RPS13;UBA1;SUGP1;RPL8;IBA57;RPL18;DQX1;SSB;MTIF2;EIF4A2;FCF1;TRIM32;SECISBP2L;MRPL39;RPS19BP1;TDRD9;DDX4;SRSF6;IGF2BP2;HELZ;ZC3H7A
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5181972225412884,-1.3132864073024126,0.1497326203208556,0.43167510075024523,1.0,4/13,6.97%,IL1R1;PDGFD;PTPRJ;ERN1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4205179458859651,1.3132195990059794,0.12217194570135746,0.4352020259708049,1.0,7/26,11.87%,B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3;EXTL2;CHSY1
prerank,store-operated calcium channel activity (GO:0015279),-0.5625193535959647,-1.3112533742446837,0.14209591474245115,0.4325296111065204,1.0,4/10,16.36%,STIM2;TRPC4;TRPC6;TRPC3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5517872167438527,-1.309844802732314,0.14492753623188406,0.431786446997886,1.0,5/10,15.06%,ATM;PIK3C2A;PIK3CD;PIK3CB;PIK3R3
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5385648529829635,-1.3079871573619442,0.13345521023765997,0.43279525199605623,1.0,2/11,0.69%,ATP10A;ATP8B1
prerank,signal sequence binding (GO:0005048),-0.3914847848113271,-1.3062471405778864,0.09380530973451327,0.4330745550598052,1.0,18/35,31.56%,BRAP;KPNA4;AP2B1;NFKBIA;KPNA3;KDELR3;CAT;NUP153;KPNA1;BABAM2;NUP214;AP2M1;RANBP6;TOMM20;SEC61A1;TOMM70;TNPO2;KDELR1
prerank,syntaxin binding (GO:0019905),0.35023425218510856,1.3027874401353035,0.09643605870020965,0.45279228835319274,1.0,11/61,8.02%,STXBP5L;SYT1;SYT5;SNAP25;SNPH;SYNPR;SYT12;CACNA1A;PRRT2;SYP;STXBP2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4585805156209007,1.301902187363188,0.15086206896551724,0.44860116696250646,1.0,7/17,17.51%,AK9;AK7;AK3;AK5;NME2;CLP1;AK1
prerank,metal ion binding (GO:0046872),0.2640028960674634,1.2987561508442749,0.012315270935960592,0.45026287362811296,1.0,95/477,14.43%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;IGFBP3;MMP12;SLC25A23;GEM;RYR3;SLC25A13;SPOCK1;ASTN2;RP2;DNER;GNAI1;SYT12;SYT11;TKT;HPCA;CLEC3B;OXSR1;DCHS1;CDH19;PCDHA4;STK11;CALM2;NCS1;PITPNM1;MAP2K7;CDH12;SPHK1;TRIM27;PADI1;GSN;NUDT18;SRPK1;RYR2;RPH3A;CDH7;GJB2;PADI2;S100A6;PPP3CA;PLA2G4E;ENPP3;ATP4A;CDH24;STK26;CDH17;PGS1;HMGCLL1;CPNE1;TESC;TNNC1;MCTP2;ANXA8;ANXA8L1;SLIT3;SLIT1;CDHR3;C2CD5;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;SRI;HRC;IDH3A;TPPP;RASGRP1;POSTN;HMGCL;MYL2;CASQ1;APOE;SYT3;RCN3;ACVR1C;BRSK2;GALNT3;NUDT16;CISD3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5065483151904108,1.2987390030650545,0.15536105032822758,0.4445858988000252,1.0,5/12,16.93%,AKR1C1;DCXR;CBR1;NDUFS7;CRYZL1
prerank,zinc ion binding (GO:0008270),-0.2805782546005299,-1.2950311802240557,0.012773722627737226,0.4564341564489778,1.0,100/293,25.42%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;KLF4;CLIP1;ZEB1;TAB3;MSRB3;IFIH1;LIMS1;RXRA;PTPN1;TNFSF10;KAT6A;KDM2A;RNF125;WDFY1;ACE;CTCF;SAMHD1;TET2;PDE2A;SEC24A;GCH1;SIRT5;ECE1;NAPEPLD;PDXK;PAM;CRIP2;ARHGEF2;PHF5A;SEC24D;PRDM2;TP53;ZCCHC4;ZMYND8;ENPEP;RASSF1;ACER3;CHD3;HDAC4;ADAM33;SLU7;SIRT3;PLSCR1;RC3H1;ZFYVE1;SLC30A5;KDM7A;SKI;TAB2;RPS27;KDM5B;ERAP1;HPF1;HDAC10;ZMYND11;SOD1;KDM1B;TES;GDA;RNF2;SIAH1;NUDT12;CZIB;PIAS4;NPEPPS;TRIM28;BAZ1B;TET3;BLM;PPARG;APIP;SEC24C;CALB1;MDM2;RABIF;PGGT1B;USP16;RCHY1;BBOX1;MSRB2;ACE2;RBAK;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ADA;QPCTL;TIMM10;POLR2L
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.39935293301561825,-1.2928205058929332,0.14528301886792452,0.45779794158357895,1.0,14/33,26.02%,ERI3;XRN1;EXOSC2;EXOSC3;XRN2;PDE12;PARN;USB1;EXOSC5;ANGEL2;DIS3L2;CNOT8;EXOSC7;TOE1
prerank,peptidase activator activity (GO:0016504),-0.4371835902681178,-1.2922165690584226,0.14548802946593,0.4554670838247853,1.0,13/22,38.56%,CAV1;PSME2;VSIR;APH1A;PSME1;ADRM1;CASP8AP2;PCOLCE2;NLRC4;MAL;CLPX;VCP;PSME3
prerank,CoA-ligase activity (GO:0016405),0.47481995516586273,1.2918973261845066,0.1540130151843818,0.4545641862013373,1.0,3/14,7.87%,ACSS2;ACSBG1;ACSS1
prerank,cytokine receptor binding (GO:0005126),-0.33036704153081575,-1.2908454611002098,0.059931506849315065,0.4549956359204914,1.0,20/83,18.50%,KITLG;OSMR;CCL25;JAK1;SPRED2;TGFBR3;IL6ST;IL6R;TGFB2;SMAD2;IL34;LIFR;SOCS2;VEGFC;USP15;JAK2;MIF;ERAP1;CLCF1;CCL19
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5098400839658583,-1.2899104481768602,0.15467625899280577,0.4534989737301876,1.0,5/13,13.15%,GSK3B;KCNQ1;EZR;GSK3A;CSK
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.44223736171113204,1.2892702991870009,0.17270788912579957,0.45502381315853624,1.0,5/20,5.40%,DLG2;AK9;AK7;AK3;AK6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.36678422807153677,-1.286667182087234,0.1135593220338983,0.45721190798420014,1.0,17/49,18.98%,TAB3;EPS15;UIMC1;RNF169;MINDY1;IKBKE;RAD18;ZFAND6;RNF168;BABAM2;TAB2;AGAP3;HDAC6;TNFAIP3;BRCC3;IKBKG;RAD23A
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4220717133757045,-1.2855881321453302,0.13162393162393163,0.456110374057646,1.0,7/27,8.21%,ITPR1;CNNM2;SLC12A2;ITPR2;SLC9B2;CNNM4;ATP2A3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4286543857564991,1.2848162605303788,0.1359447004608295,0.4593401744976881,1.0,6/21,10.35%,PDE4B;PDE3B;PDE1B;PDE10A;PDE1A;PDE11A
prerank,filamin binding (GO:0031005),-0.5395581859466708,-1.2848050817501977,0.1512455516014235,0.4542903177995477,1.0,8/11,38.45%,NEBL;SYNPO2;CEACAM1;CRMP1;RFLNB;RFLNA;FBLIM1;DPYSL4
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5005178521937917,-1.2800895370604177,0.16820702402957485,0.4616293661380366,1.0,5/14,18.79%,FHIT;NUDT13;ENPP4;NUDT6;NUDT12
prerank,miRNA binding (GO:0035198),-0.4057062229747379,-1.2795407037730437,0.13450292397660818,0.4593458350683784,1.0,7/30,14.36%,TUT7;PUM1;ZC3H7B;TUT4;RC3H1;AGO2;HNRNPA1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5001063370827818,1.2789834562038365,0.1829787234042553,0.4666010142829322,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.48487605656279087,1.2787005419452135,0.14883720930232558,0.46143867424230056,1.0,4/14,9.62%,AK9;AK7;AK5;NME2
prerank,carboxypeptidase activity (GO:0004180),0.37553442593380865,1.2775142603317489,0.1257995735607676,0.4587037403556851,1.0,9/35,14.61%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,neuropeptide receptor binding (GO:0071855),0.48155794626696247,1.277154861552957,0.1860986547085202,0.4542091087175017,1.0,5/14,23.57%,SHANK1;NPY;NTS;GAL;AGRP
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5323104545129125,-1.2764213017443546,0.17805755395683454,0.4627125033114747,1.0,2/11,2.95%,SGMS1;SGMS2
prerank,protein kinase activator activity (GO:0030295),-0.3475635938773993,-1.275069086339591,0.1146384479717813,0.462256373202905,1.0,17/60,14.68%,AFAP1L2;ABI1;FAM20A;IQGAP1;PAK2;DDX3X;GPRC5C;GAS6;RICTOR;STK3;IRGM;RPLP1;RGCC;MTCP1;RPTOR;WNT11;MARK2
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.27967503222867074,-1.2726225522147425,0.033444816053511704,0.46471414800491295,1.0,94/269,26.32%,FOXO1;SNCAIP;RB1;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;DTX3L;FHIT;YWHAE;NEK6;FZD4;MAP1LC3B;EGFR;MID1;RBX1;TNFRSF1B;NFKBIA;CUL3;AMBRA1;RNF40;TCP1;JUN;CUL2;SNX9;ARRDC1;SMAD2;UBE2J2;YWHAZ;USP2;DET1;USP13;TP53;CASP8;GABARAP;STAT2;AXIN2;TXNIP;SMAD7;SPOPL;IKBKE;RAD18;ATXN3;PA2G4;ERLIN2;MAGEC2;CD40;RPL5;SLF2;SMAD6;SKI;SUMO1;HERC2;UQCRC1;HDAC6;UBE2L3;IKBKG;PATZ1;CDK5RAP3;NDUFS2;RPA2;SPOP;WASHC1;PIAS4;USP7;FANCL;BRCA1;UCHL1;VCL;TRIM28;DBT;DIO2;MDM2;LTBR;HSP90AA1;KCNH2;RELA;BECN1;RALB;FZD5;RIPK1;HSPA1B;APBB1;ARRB1;TRIB3;APC;PARP9;PSMA3;UBXN7;CCT2;RNF34
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.47305934309297354,1.2699462759752917,0.18032786885245902,0.46442087958993544,1.0,8/13,25.87%,TRMT10B;TRMT10A;TRMT11;FTSJ1;THUMPD3;TRMT5;THUMPD2;TRMT1L
prerank,Wnt-activated receptor activity (GO:0042813),-0.4845460447241262,-1.2674626166730532,0.17077464788732394,0.47358028069455366,1.0,4/15,4.75%,LRP5;ROR1;FZD6;FZD4
prerank,phosphotyrosine residue binding (GO:0001784),-0.38202607385485493,-1.266189576504259,0.12548262548262548,0.47300185437237013,1.0,14/37,15.42%,CRK;SHE;LDLRAP1;YES1;ABL1;PIK3R1;IRS1;PLCG2;SHB;NCK2;RASA1;PTPN3;PIK3R3;GRB2
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2795167341853507,-1.265271105364727,0.03350083752093802,0.4715511420713733,1.0,90/254,26.32%,FOXO1;SNCAIP;RB1;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;FHIT;YWHAE;NEK6;FZD4;MAP1LC3B;EGFR;MID1;RBX1;TNFRSF1B;NFKBIA;CUL3;AMBRA1;RNF40;TCP1;JUN;CUL2;SNX9;ARRDC1;SMAD2;UBE2J2;YWHAZ;USP2;DET1;USP13;TP53;CASP8;GABARAP;AXIN2;TXNIP;SMAD7;SPOPL;IKBKE;RAD18;ATXN3;PA2G4;ERLIN2;MAGEC2;CD40;RPL5;SLF2;SMAD6;SKI;SUMO1;HERC2;UQCRC1;HDAC6;UBE2L3;IKBKG;PATZ1;NDUFS2;RPA2;SPOP;WASHC1;PIAS4;USP7;FANCL;BRCA1;UCHL1;VCL;TRIM28;DBT;DIO2;MDM2;LTBR;HSP90AA1;KCNH2;RELA;BECN1;RALB;FZD5;RIPK1;HSPA1B;APBB1;ARRB1;TRIB3;APC;PSMA3;UBXN7;CCT2;RNF34
prerank,symporter activity (GO:0015293),0.5175232975085693,1.2632540225665427,0.17865429234338748,0.47357037895871723,1.0,4/10,9.18%,SLC5A12;SLC4A4;SLC28A2;SLC46A2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.47271882962073714,-1.2599728636895169,0.17712177121771217,0.48068890174153334,1.0,7/15,18.11%,WDFY1;SNX9;SCARB1;PICALM;WDFY3;ZFYVE1;ZFYVE16
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35213828079553644,1.2553436932663844,0.11764705882352941,0.4862281529462164,1.0,13/49,11.33%,SYT1;PCLO;SYT5;SYT12;SYT11;RPH3A;CPNE9;PLA2G4E;CPNE1;MCTP2;ANXA8;C2CD5;SYT4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4900532617275504,-1.2550848711310179,0.18081180811808117,0.4891711591737473,1.0,5/13,20.27%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,Notch binding (GO:0005112),-0.4347077422731287,-1.254348450973225,0.18345323741007194,0.4871981511673226,1.0,10/22,21.18%,JAG2;CUL3;AAK1;NOTCH4;GALNT11;TCIM;CCN3;JAG1;KCTD10;DLL4
prerank,ATP hydrolysis activity (GO:0140603),-0.37010529672515347,-1.2543161746646723,0.1551094890510949,0.4836957311455782,1.0,18/41,30.25%,DDX3X;RNF213;TOR1B;MYO18A;ABCB10;CHD3;DNA2;RUVBL2;KIF26A;TOR3A;HSP90AA1;HSPA1B;DHX9;KIF14;ABCG4;CHD1L;TDRD9;DDX4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.49876548904749607,-1.252942923854049,0.18871252204585537,0.4834416810282808,1.0,7/12,31.83%,CDK13;CDK12;MAPK1;CDK6;CCNK;BRD4;CDK4
prerank,mRNA 5'-UTR binding (GO:0048027),-0.41470250097891614,-1.2521884373771706,0.17657342657342656,0.4817736134649932,1.0,14/24,31.75%,DDX3X;LARP1;RPS14;RPL26;RPL5;SYNCRIP;RPS7;CCT5;LARP6;UTP23;SHMT1;RPS13;IGF2BP2;RPL41
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3431519201551762,1.2508533952261356,0.13073394495412843,0.4909921317403181,1.0,18/49,19.50%,ATP1A2;MPPED2;PPP5C;PLCXD3;SMPDL3B;DUSP4;SBF1;HDHD2;DUSP8;DUSP15;PTPRO;FRA10AC1;PGP;SMPD1;ENPP6;DUSP18;ACP2;APEX1
prerank,chemokine activity (GO:0008009),0.3844052688870432,1.2506313622502532,0.14831460674157304,0.4860665554906485,1.0,7/31,12.36%,CXCL16;CCL28;CCL7;PF4;CCL13;CCL5;CCL2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4172480891217656,1.2497366016385363,0.14382022471910114,0.4824585612037317,1.0,5/22,11.17%,CPSF1;EXOSC9;CPEB1;ELAVL4;CPEB3
prerank,amino acid binding (GO:0016597),0.38629066243360016,1.248931551984347,0.1531322505800464,0.4791389160875123,1.0,5/31,5.49%,GLRA3;GRIN2B;DDAH2;GLRA1;GNMT
prerank,regulatory RNA binding (GO:0061980),-0.3692647493305881,-1.2488001506471638,0.15526802218114602,0.48604104710895574,1.0,8/38,14.36%,TUT7;PUM1;ZC3H7B;DICER1;TUT4;RC3H1;AGO2;HNRNPA1
prerank,phosphatidylglycerol binding (GO:1901611),-0.4853509274571079,-1.2476300129665947,0.19818181818181818,0.4854030362700883,1.0,2/13,1.35%,PITPNC1;PLTP
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3741279272099656,-1.2449319107062122,0.17117117117117117,0.48864375761436396,1.0,10/35,16.40%,DYRK1A;LYN;YES1;BMX;ABL1;PTK2;FRK;PKDCC;CSK;FYN
prerank,transcription corepressor binding (GO:0001222),-0.40455133024066725,-1.2447737303654152,0.16544117647058823,0.48555469967177206,1.0,8/27,11.17%,ZBTB16;ESR1;NEK6;ZBTB7A;SUZ12;CTBP2;PER3;EHMT1
prerank,calcium channel regulator activity (GO:0005246),0.36860783102621103,1.2446730905720127,0.15638766519823788,0.48322586634561393,1.0,11/37,12.99%,NRXN1;GEM;CALM2;NPY2R;CACNB3;CACNG8;NPY;INAFM2;CACNG4;SRI;SGK1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.35680823891637903,1.2440009940037653,0.1504424778761062,0.47983673648861846,1.0,10/42,8.58%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;CNTN2;EMB
prerank,potassium channel regulator activity (GO:0015459),0.34118318313325224,1.2388721622105958,0.13849765258215962,0.4864391025745624,1.0,6/49,6.56%,KCNIP4;KCNIP1;DPP10;DPP6;WNK2;WNK3
prerank,triglyceride lipase activity (GO:0004806),-0.42459069460974697,-1.2329737003415582,0.1694290976058932,0.5106923114926671,1.0,7/20,29.56%,LPL;LIPE;DAGLB;LCAT;DDHD2;PNPLA2;LIPH
prerank,outward rectifier potassium channel activity (GO:0015271),0.49337638335364686,1.232574052399508,0.2119815668202765,0.49505459388011985,1.0,2/11,2.49%,KCND2;KCNA5
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5088987851398196,-1.2259420918771688,0.2277580071174377,0.5248985831837469,1.0,4/11,14.10%,AKAP13;IQGAP1;SH3RF1;KSR1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3790574188718554,-1.2254136317488915,0.15714285714285714,0.5227028104444887,1.0,11/32,23.69%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,carboxylic acid binding (GO:0031406),0.35504442821098664,1.2218999517785336,0.15058823529411763,0.5147672646456999,1.0,10/38,14.35%,GLRA3;GRIN2B;AKR1C1;GLRA1;EPDR1;GNMT;GRM7;MAG;GLUD1;GRIN3A
prerank,exopeptidase activity (GO:0008238),0.3420933619889984,1.220504949148577,0.16744186046511628,0.5128613406016065,1.0,10/50,10.31%,DPP10;DPP6;MME;TRHDE;CPA2;CPE;METAP2;KDM8;DPEP1;JMJD7
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5052162266959163,-1.2188305454133552,0.2459016393442623,0.5359547588544342,1.0,4/11,8.22%,ITPR1;ITPR2;TRPC4;TRPC6
prerank,ephrin receptor binding (GO:0046875),-0.42128148371717045,-1.2175271242350167,0.20812182741116753,0.5353920630551514,1.0,7/21,6.15%,ANKS1A;LYN;PTPN1;CRK;CBL;CHN1;ABL1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.5067266398067802,-1.2169924173503528,0.21525423728813559,0.5330597382620504,1.0,3/11,10.14%,NAA16;NAA80;NAA15
prerank,phospholipase binding (GO:0043274),0.4527019180863422,1.2154356770143957,0.23076923076923078,0.5201879440377781,1.0,2/13,1.90%,BLNK;DGKQ
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.46366667650497834,1.2152246474349981,0.2425629290617849,0.5155050866566451,1.0,3/12,3.64%,PDE4B;PDE3B;PDE1B
prerank,amyloid-beta binding (GO:0001540),0.3097471081351799,1.21374158518342,0.16591928251121077,0.5140672473492353,1.0,19/79,14.56%,GRIA3;NLGN1;GRIN2B;GRIA4;CACNA1B;GRIN2A;APBA2;CACNA1A;ITM2C;GRIA1;SORL1;BACE1;PGRMC1;GRIA2;GSAP;APOE;CLU;LDLR;CST3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.32102346226205813,-1.2128720995294395,0.15480427046263345,0.5398697374489748,1.0,11/72,6.50%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;ANXA2;SVIL;MARK1;LDLRAP1;PLCB1;KCNQ1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.42613523643731843,-1.2127536131321537,0.22867513611615245,0.5365314625430232,1.0,10/20,32.86%,MRE11;RBBP8;ENDOV;DNA2;RPS3;EXOG;EXO1;APLF;RAD50;ENDOG
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.31151965850448327,1.2111931558572226,0.14153132250580047,0.5151052253351669,1.0,10/73,10.97%,HCRTR1;NPSR1;SORCS3;SORCS1;GPR37;KISS1R;GIPR;VIPR2;TSHR;LGR5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3228812156746245,1.2108325571049081,0.14532019704433496,0.5110003883545841,1.0,11/55,9.03%,SLC24A4;SLC24A2;ATP2B4;ATP2B2;PKD1L2;SLC8A2;CACNA1D;RYR2;TMCO1;TRPM1;PKD1L1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.48754133610805456,1.2090522934524652,0.2449438202247191,0.5102574562448395,1.0,2/11,2.79%,AKR1D1;AKR1C1
prerank,lipase activity (GO:0016298),-0.3524989455473895,-1.2077179396371074,0.18397085610200364,0.5455892259858114,1.0,18/43,35.99%,ABHD2;LIPA;MGLL;LPL;LIPE;SMPD2;DAGLB;LCAT;DDHD2;PNPLA8;PNPLA2;LYPLA1;ABHD15;LIPH;SEC23IP;PLBD1;PLB1;ABHD12
prerank,phospholipid transfer activity (GO:0120014),-0.41776826843834036,-1.2064097091217,0.21503496503496503,0.5454965039692754,1.0,3/21,1.35%,PITPNC1;CERT1;PLTP
prerank,semaphorin receptor activity (GO:0017154),-0.5025159119278549,-1.2040055540783474,0.2211895910780669,0.5478984769475532,1.0,3/11,8.20%,NRP2;PLXNA4;PLXND1
prerank,cyclic nucleotide binding (GO:0030551),0.40987754798087156,1.2012703306781243,0.226457399103139,0.5233799988953415,1.0,5/21,10.35%,PDE4B;HCN1;PDE10A;SLC19A1;PDE11A
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3747844816157927,-1.2012451632369896,0.19464285714285715,0.5514690832609908,1.0,11/33,28.43%,ZNF326;RTRAF;RPRD2;SPTY2D1;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,water transmembrane transporter activity (GO:0005372),0.4892649807677116,1.200077311265798,0.2288888888888889,0.5212446549394948,1.0,2/11,4.55%,PDPN;AQP4
prerank,phosphatase binding (GO:0019902),-0.29876036126892863,-1.1998244295339386,0.10909090909090909,0.5518871788496998,1.0,26/105,12.54%,CTSC;IQGAP1;MTMR3;MAP3K5;JAK1;ITGA1;CDKN1B;EGFR;PXN;DLG1;CHCHD3;SHOC2;PIK3R1;MAST2;STAT6;PTK2;CDH5;MAPK1;SMAD2;FLT4;CNST;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4421126686066179,1.1994875316499378,0.22875816993464052,0.5176144730434418,1.0,4/14,8.42%,SPOCK3;SPOCK1;TIMP1;FETUB
prerank,transition metal ion binding (GO:0046914),-0.25169853451602875,-1.1991806582672087,0.057692307692307696,0.5501400432480913,1.0,127/397,25.57%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;NOS3;KLF4;CLIP1;ZEB1;TAB3;MSRB3;IFIH1;LIMS1;RXRA;ATOX1;PTPN1;XPNPEP3;TNFSF10;KAT6A;KDM2A;RNF125;WDFY1;ACE;LOXL3;CTCF;SAMHD1;TET2;PDE2A;ABL1;SEC24A;GCH1;SIRT5;ECE1;NAPEPLD;PDXK;PAM;CRIP2;ARHGEF2;AOX1;PHF5A;SEC24D;PRDM2;TP53;ZCCHC4;FDX1;ZMYND8;ENPEP;RASSF1;KDM3A;ACER3;CHD3;HDAC4;ADAM33;SLU7;SIRT3;PLSCR1;RC3H1;ZFYVE1;CYP2R1;SLC30A5;KDM7A;JMJD6;SKI;TAB2;XPNPEP1;RPS27;MGAT2;COX17;KDM5B;ERAP1;HPF1;HDAC10;AOC3;ZMYND11;SOD1;WRN;CCS;KDM1B;TES;GDA;GALNT1;COA6;RNF2;LARGE1;SIAH1;NUDT12;B4GALT1;CZIB;PIAS4;NPEPPS;GYG1;TRIM28;BAZ1B;DOHH;TET3;BLM;PPARG;APIP;SEC24C;CALB1;NOS1;MDM2;ABCE1;RABIF;PGGT1B;USP16;RCHY1;BBOX1;PIM1;MSRB2;XYLT2;ACE2;RBAK;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ADA;QPCTL;TIMM10;POLR2L;ENDOU
prerank,dynactin binding (GO:0034452),0.4688983654571227,1.1987723168600972,0.24107142857142858,0.5146312312594811,1.0,7/12,19.05%,BICD1;BBS4;MAPT;HTT;BICDL1;SNX5;HOOK3
prerank,nuclease activity (GO:0004518),-0.33152366857775123,-1.198121387720201,0.16225749559082892,0.5493082244306425,1.0,20/52,23.49%,RNASE7;SAMHD1;MRE11;N4BP2;RNASE3;XRN2;OGG1;DNA2;PNKP;PLSCR1;PDE12;RNASE12;PARN;N4BP1;WRN;EXOG;REXO1;REXO5;DIS3L2;NTHL1
prerank,E-box binding (GO:0070888),-0.36964384148780244,-1.197960628217555,0.2014519056261343,0.546223700610179,1.0,9/34,23.73%,ZEB1;MITF;HES1;MAX;TAL1;TCF3;TFAP4;PPARG;TCF4
prerank,SUMO binding (GO:0032183),-0.46720454665092737,-1.197652671358782,0.2605633802816901,0.5435334409050191,1.0,7/13,19.48%,RNF111;UBA2;SERBP1;SIMC1;HERC2;RNF4;CASP8AP2
prerank,phospholipase inhibitor activity (GO:0004859),-0.504844753075993,-1.196207467173222,0.23392857142857143,0.5436823773528976,1.0,4/10,20.24%,ANXA2;ANXA4;ANXA1;ANXA9
prerank,low-density lipoprotein particle binding (GO:0030169),-0.4388391954463812,-1.1953748574422551,0.23985239852398524,0.5423982624284207,1.0,5/16,10.82%,PLTP;THBS1;SCARF1;SCARB1;STAB1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.46339779005524867,-1.1943822496582936,0.26103646833013433,0.541378244011513,1.0,13/14,53.70%,RDH10;RDH12;ADH1A;RDH11;DHRS9;AKR1A1;RDH16;DHRS3;HSD17B6;SDR9C7;ADH4;ADH7;RDH5
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.36797467249682014,-1.1942969473414666,0.20037105751391465,0.5383169615943828,1.0,13/34,24.86%,FAM20A;IQGAP1;DDX3X;RICTOR;STK3;IRGM;MTCP1;ALS2;IGF2;PARP16;CAB39L;CCNK;CAB39
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4824156240950407,1.19172269515025,0.259825327510917,0.5259409291613351,1.0,3/11,8.91%,SLC25A23;SLC35B2;SLC19A1
prerank,death domain binding (GO:0070513),-0.49737516856135966,-1.1894463356926617,0.23381294964028776,0.5472158056396038,1.0,6/11,23.52%,MCL1;IRGM;DAPL1;CRADD;DAP;RIPK1
prerank,histone deacetylase activity (GO:0004407),-0.43047202682363267,-1.1885038006435742,0.2578268876611418,0.54624442138893,1.0,9/19,22.25%,MIER1;HDAC1;HDAC4;SIRT3;HDAC6;MIER2;HDAC10;MIER3;SUDS3
prerank,protein tyrosine kinase activity (GO:0004713),-0.29422957501691865,-1.1883419629444274,0.14335664335664336,0.5433401011783907,1.0,18/108,8.63%,FLT1;TEK;IGF1R;TIE1;DYRK1A;INSR;ROR1;LYN;JAK1;KDR;MERTK;EGFR;YES1;BMX;ABL1;PTK2;EPHA4;FLT4
prerank,neuropeptide hormone activity (GO:0005184),0.3903262274218526,1.1843717727614749,0.21923937360178972,0.5391417407793571,1.0,4/22,10.63%,PNOC;NPY;PENK;CCK
prerank,nucleotidyltransferase activity (GO:0016779),-0.4178034917582256,-1.1842351425598243,0.2423146473779385,0.5499337770287201,1.0,9/19,21.70%,TUT7;TENT4B;TENT4A;TUT4;REV1;TENT2;CGAS;TERT;MOCS3
prerank,FMN binding (GO:0010181),-0.4812189275932889,-1.1833865786170705,0.2687385740402194,0.5487306527768956,1.0,6/11,22.74%,NOS3;NOS1;POR;MTRR;PPCDC;PNPO
prerank,protein homodimerization activity (GO:0042803),-0.24014342062260385,-1.1827011582808828,0.045454545454545456,0.5470658447366044,1.0,127/589,18.15%,HIP1;ABCG2;DAB2IP;FOXP2;RBPMS;CPQ;ZBTB16;PECAM1;GHR;ZHX3;SRR;MCL1;EXT1;PKD2;MYH9;NOD1;F11R;ATG7;XPNPEP3;ST6GAL1;TBX1;MAP3K5;SYNE1;LRRK2;TFRC;CAMK2G;ZDHHC3;SP1;FZD4;IDH1;ANO1;CEP57;ZHX2;MID1;PIP4K2A;IL6R;HES1;RASIP1;PDE2A;SLIT2;GCH1;HPS4;LRP6;TGFB2;RABEP1;ERN1;RNF40;BNIP3;ZBTB4;PIP4K2B;ECE1;ABCD3;ABCB9;RAB11FIP3;SPPL3;TPST2;PDXK;ABCB10;S100A16;SNX9;PEX7;TRPC6;LDB1;FLT4;TPD52;AOX1;STARD3;ST3GAL2;SMAD4;ADAM10;MYOM1;AKT1;TPD52L1;FLNA;FBLN5;GSTM2;SYT6;CHMP4B;CHMP4A;TRIM14;STK10;TBC1D22A;MGLL;SFPQ;IRAK1;TMEM192;TMEM266;CAT;MTCL1;ACTN1;CEACAM1;S100A1;LRRFIP1;ACTN4;GBP4;LPL;TPM1;GRHL1;MZF1;ABCB7;CYP2R1;HIP1R;STARD3NL;DARS2;PRDM9;TCF3;COQ9;TPR;XPNPEP1;TERF2;HOGA1;ACOX1;MGAT2;DGAT2;SLK;TFAP4;GBP5;CASQ2;IRAK2;HPGDS;WRN;IKBKG;DEFA6;PLN;ALS2;NRF1;PEX11A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3644248973670501,-1.178778405445214,0.2257495590828924,0.5538345292170521,1.0,11/33,28.43%,ZNF326;RTRAF;RPRD2;LLPH;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.4443876646212126,-1.1787267095243035,0.25,0.550760990878626,1.0,5/15,20.27%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,chemokine receptor binding (GO:0042379),0.3536010885067761,1.1766411437809805,0.21382289416846653,0.5526875197848712,1.0,7/35,12.36%,CXCL16;CCL28;CCL7;PF4;CCL13;CCL5;CCL2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.492883123044887,-1.1747894166792743,0.2787769784172662,0.557758084845059,1.0,5/11,19.12%,DAB2IP;PPEF2;STK38;TCF3;SASH1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.4590861316823176,-1.1744503385707112,0.2697841726618705,0.5554387549108388,1.0,4/13,12.97%,ZGRF1;DICER1;ENDOV;DNA2
prerank,mannose binding (GO:0005537),0.4461307565199595,1.1731843674006392,0.25103734439834025,0.5558542814583892,1.0,5/12,20.33%,CD207;MBL2;LMAN1;ACR;COLEC11
prerank,nuclear export signal receptor activity (GO:0005049),-0.4820376676233607,-1.171603630446078,0.27514231499051234,0.5592115014080332,1.0,5/11,18.38%,NUP42;CSE1L;XPO7;XPO4;NUP214
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.44893850726745677,-1.1704117204494902,0.2591943957968476,0.5590655458863552,1.0,7/14,31.88%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1;MAL;RPS27L
prerank,poly(U) RNA binding (GO:0008266),-0.4083947278044453,-1.1692255639685292,0.23351158645276293,0.5587236302554222,1.0,11/20,32.93%,RBMS1;RBMS2;PABPC4L;DIS3L2;PABPC1;KHDRBS1;SSB;ATXN1;RBM11;PABPC5;PABPC1L
prerank,peptidoglycan binding (GO:0042834),-0.5001013058684689,-1.1687609189512222,0.27191413237924866,0.5567153093360598,1.0,4/10,18.60%,NOD1;RNASE7;PGLYRP1;NOD2
prerank,glucuronosyltransferase activity (GO:0015020),-0.4129262817667847,-1.1660504405790375,0.26788990825688075,0.5601640679253201,1.0,2/19,3.41%,EXT1;CSGALNACT1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.46352592845469043,-1.1652813506124584,0.27207207207207207,0.5589412937234812,1.0,2/12,6.05%,ENTPD1;ENTPD6
prerank,nucleosomal DNA binding (GO:0031492),-0.40289662647681657,-1.16461032137955,0.25688073394495414,0.5574120734043662,1.0,6/21,14.40%,HDAC1;SMARCC1;SMARCE1;SMARCC2;ACTB;H3-3A
prerank,cation channel activity (GO:0005261),0.28427010727784824,1.162349856068437,0.19069767441860466,0.5765496524475527,1.0,14/94,9.03%,TRPM3;HCN1;SLC24A4;SLC24A2;UNC80;KCNA2;PKD1L2;TMEM63A;CACNA1D;RYR2;TMCO1;TRPM1;CACNA1E;PKD1L1
prerank,ligand-gated calcium channel activity (GO:0099604),0.39761843210431236,1.1616743609998856,0.251131221719457,0.5731088642891572,1.0,4/19,7.56%,GRIN2B;RYR3;GRIN2A;RYR2
prerank,nucleotidase activity (GO:0008252),-0.44190135204158254,-1.158854382540635,0.2743055555555556,0.5685282402300893,1.0,8/15,25.86%,NT5C2;NT5E;NT5C1A;BPNT1;NT5C3B;ACP3;NT5DC1;NT5C
prerank,double-stranded RNA binding (GO:0003725),-0.3088483630201229,-1.1575994730877293,0.21052631578947367,0.5684143434254595,1.0,15/70,14.28%,MBNL1;EIF4H;IFIH1;DDX3X;TFRC;MSN;PRKRIP1;DDX60;STRBP;DICER1;MTDH;ACTN1;LRRFIP1;RC3H1;AGO2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.409443511636417,-1.157171174803405,0.27052238805970147,0.5662526123058673,1.0,7/20,20.88%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.42297413596544015,1.1526734997852748,0.2748267898383372,0.5896504628689242,1.0,4/15,11.03%,SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,adenylate cyclase binding (GO:0008179),0.47356849692719466,1.151938739565431,0.29777777777777775,0.5861032152931207,1.0,2/10,5.51%,AKAP6;CALM2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3673382853597831,-1.1504016064790734,0.23679417122040072,0.5801580090346111,1.0,3/28,2.70%,DAB2IP;EDA;TRAF5
prerank,protein kinase C binding (GO:0005080),-0.3336395553788666,-1.1490607881794686,0.2624521072796935,0.5802709779588392,1.0,9/43,7.75%,GRK5;CAVIN2;PRKD2;PDLIM5;ADAM9;PARD6G;ABL1;IRS1;ADCY4
prerank,cAMP binding (GO:0030552),0.45878629284199324,1.149055706274102,0.26200873362445415,0.5879918782395263,1.0,3/11,5.29%,PDE4B;HCN1;PDE10A
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.46777800701775885,-1.147083939880553,0.2857142857142857,0.5821241141024844,1.0,6/12,26.43%,PAN3;PARN;CNOT2;CNOT8;TOE1;CNOT1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4511633888448945,1.1435251461144065,0.31346578366445915,0.5968564587321902,1.0,3/12,8.91%,SLC25A23;SLC35B2;SLC19A1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.4726326620864394,-1.1434147805380257,0.3103448275862069,0.5881016108829777,1.0,5/11,25.03%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.48553791693606274,-1.1389446389542888,0.32974910394265233,0.596622927763009,1.0,5/10,25.03%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4528136113370842,-1.138765750920269,0.2918918918918919,0.5940125195102717,1.0,5/12,21.14%,SLC6A6;SLC38A5;SLC36A4;SLC1A4;SLC3A2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4332175961959367,1.1375882585220674,0.29916317991631797,0.6066721112456392,1.0,6/14,19.92%,ISCA2;ACO1;NFU1;CIAO3;EXO5;ACO2
prerank,ribosomal small subunit binding (GO:0043024),-0.41198594764975155,-1.1343533602734817,0.29307282415630553,0.6016750784624226,1.0,4/17,8.74%,EIF4H;DDX3X;LARP1;PTCD3
prerank,actinin binding (GO:0042805),-0.39439307432356185,-1.1319189115880044,0.2828096118299446,0.6046537133302863,1.0,11/21,22.72%,PKD2;PROM1;PDLIM5;NFKB1;CSRP2;SYNPO2;RARA;MAGI1;PKD2L1;PPARG;RELA
prerank,PDZ domain binding (GO:0030165),0.3015651431815012,1.1312358513422422,0.2616822429906542,0.6172679941422352,1.0,9/61,5.10%,GRID2;NLGN1;SLC22A4;ATP2B4;ATP2B2;CXXC4;KIDINS220;GRIA1;CXADR
prerank,lipoprotein particle binding (GO:0071813),-0.3938917689951483,-1.1271134873870698,0.30458715596330277,0.6138510119723992,1.0,6/20,13.17%,PLTP;THBS1;SCARF1;SCARB1;STAB1;LPL
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4515341435504244,-1.1258092828714164,0.3263525305410122,0.6139367768646873,1.0,5/12,25.03%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1
prerank,G protein-coupled receptor binding (GO:0001664),0.2645459409293848,1.1238531805098968,0.2073732718894009,0.6308449464764565,1.0,25/132,14.58%,GNAO1;BICD1;WNT7B;PACRG;GNAI2;GIP;TAFA5;PSMC5;PNOC;GNAI1;CALCA;GNAL;GNAT3;NPY;HOMER1;PENK;CCL5;ARR3;WNT6;RSPO1;BBS1;WNT2;NTS;DVL2;WNT4
prerank,NF-kappaB binding (GO:0051059),-0.37637016334432993,-1.1228436951731144,0.3083778966131907,0.6182067937028906,1.0,9/24,22.72%,GSK3B;HDAC1;NFKBIA;ANXA4;RNF25;MTDH;CDK5RAP3;TAF4B;RELA
prerank,semaphorin receptor binding (GO:0030215),-0.3864667496179972,-1.1228267345824445,0.3020257826887661,0.6150699456168555,1.0,12/23,24.61%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A;PLXNB1
prerank,N-acetyltransferase activity (GO:0008080),-0.3969380790928228,-1.1192650460615408,0.30272108843537415,0.6213257794595533,1.0,4/19,11.35%,KAT2B;NAA80;SMARCE1;GNPNAT1
prerank,BMP binding (GO:0036122),-0.45872916273768566,-1.118841338549617,0.3379174852652259,0.6193470206850096,1.0,3/11,9.37%,ENG;BMPR2;GREM2
prerank,muscle alpha-actinin binding (GO:0051371),-0.42431267150555496,-1.1143120006137595,0.3333333333333333,0.6280871059291098,1.0,5/15,12.98%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3
prerank,ATP binding (GO:0005524),-0.2423919072380622,-1.1142742624776276,0.19152542372881357,0.6250619730737081,1.0,43/266,10.46%,SNRK;MAP3K20;ACVRL1;SRR;INSR;PEX1;MYH9;DAPK1;TLK2;PRKACB;RPS6KA5;MARK1;MAP3K5;SIK1;MAP4K3;TLK1;NEK6;UBA2;CARS2;STK3;ABL1;MAST2;ABCC6;ERN1;PIP4K2B;ABCD3;ABCB9;MYO18A;PRAG1;MYO1F;TAP2;CDC42BPA;PDXK;N4BP2;AKT3;LATS2;SMC4;PXK;NOL9;EIF2B2;AKT1;WNK4;SIK3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.23197665580235907,-1.1141564828337849,0.15436241610738255,0.6222355614841164,1.0,124/431,24.75%,SNRK;MAP3K20;ACVRL1;SRR;INSR;PEX1;MYH9;RAC1;MFHAS1;DAPK1;RHOJ;RHOBTB1;TLK2;PRKACB;RPS6KA5;ARF3;MARK1;MAP3K5;SIK1;RAB7A;MAP4K3;RND3;LRRK2;TLK1;NEK6;RASL12;UBA2;RAB2A;CARS2;STK3;DNM2;ABL1;MAST2;RHOQ;GCH1;ATL2;ABCC6;RAP1A;ERN1;PIP4K2B;ABCD3;ABCB9;GBP6;MYO18A;PRAG1;MYO1F;TGM2;RAB27A;TAP2;CDC42BPA;PDXK;RAP1B;RAB5A;N4BP2;RRAS;AKT3;LATS2;SMC4;PXK;NOL9;EIF2B2;AKT1;WNK4;SIK3;STK38;ARL4A;RHOA;GBP4;RHOG;DRG1;MKNK2;RHOC;KCNJ8;PNKP;KSR1;CDK6;MARK2;DARS2;ABCF2;RAB32;ABCF3;SRPK2;RERG;LSG1;GBP5;CDC42BPB;MAP4K4;GALK1;HSPA14;NRAS;KRAS;RAP2C;RRAS2;RAP2A;LIG4;MTHFD1L;ARHGEF5;CDK11B;ARL5C;P2RY1;BLM;PNPLA8;ABCE1;PMVK;TUBD1;MAP3K6;HSP90AA1;PRPS2;TUBE1;TOP1;MTG2;ARL2;ARL4C;RALB;PIM1;HSPA13;ARF5;HSPA1B;RHEB;DHX9;REM1;ERCC6;NOA1;GBP3
prerank,hormone activity (GO:0005179),0.3006495277518586,1.1119831988643147,0.2681818181818182,0.6562395702835434,1.0,8/54,13.35%,PNOC;CHGB;TRH;NPPC;NPY;PENK;CCK;METRNL
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.28830364485383625,-1.110347351924866,0.2580071174377224,0.6289922847596905,1.0,28/78,25.03%,USP9X;CTSC;CASP12;USP24;USP2;USP13;CASP8;CAPN2;CFLAR;USP15;USP40;USP18;PDIA3;LGMN;USP34;USP10;CTSZ;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;GPAA1;USP12;CASP1
prerank,phosphatase activator activity (GO:0019211),-0.42917365866638024,-1.1089104106901615,0.3238938053097345,0.6296019108358146,1.0,7/14,28.03%,PPP2R5A;PHACTR4;BMP2;FRS2;PPP2R5E;PPP2R5D;PPP2R5C
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4076188004988386,-1.1060205683532578,0.3180987202925046,0.6307286414392841,1.0,3/16,0.36%,PTPRG;PTPRB;PTPRM
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4076188004988386,-1.1060205683532578,0.3180987202925046,0.6307286414392841,1.0,3/16,0.36%,PTPRG;PTPRB;PTPRM
prerank,calcium channel inhibitor activity (GO:0019855),-0.4482038330629073,-1.09666380454428,0.35664335664335667,0.6524863203278543,1.0,2/11,6.13%,ITPR1;MCUB
prerank,MHC class II protein complex binding (GO:0023026),0.4395707661515809,1.0959842556800639,0.34573304157549234,0.6946101247377238,1.0,4/11,9.27%,MS4A1;ATP1B1;CD81;PKM
prerank,SUMO transferase activity (GO:0019789),-0.4154565238099907,-1.0959430816573283,0.3502722323049002,0.6512605626472846,1.0,7/16,21.88%,RANBP2;HDAC4;NSMCE2;PIAS2;PIAS4;TRIM28;MDM2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4183088706957273,-1.0954808822513735,0.3382084095063985,0.6493272968936872,1.0,3/15,7.12%,SLC26A7;SLC26A2;SLC39A8
prerank,RNA polymerase II complex binding (GO:0000993),-0.3419640832814636,-1.0946345628613365,0.31305903398926654,0.6483479837192598,1.0,11/32,28.43%,ZNF326;RTRAF;RPRD2;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;BRD4;ELP2
prerank,acid-thiol ligase activity (GO:0016878),0.4090008412192242,1.0931526814423205,0.328159645232816,0.6966225944044305,1.0,3/13,12.15%,ACSS2;ACSS1;AASDH
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3107166207922942,-1.0929522742519568,0.29225352112676056,0.6495310456369172,1.0,8/48,5.06%,SLC12A7;PIEZO2;PKD2;TRPM6;SLC12A2;TRPM7;ABCC9;TRPM4
prerank,translation initiation factor activity (GO:0003743),-0.3332208269792321,-1.0899193772284943,0.33213644524236985,0.654434539983673,1.0,15/36,33.29%,EIF3H;EIF3E;EIF3C;EIF3B;EIF2B2;AGO2;EIF3F;EIF3A;EIF3I;EIF5B;COPS5;EIF4A2;EIF2B4;EIF4G3;EIF2B5
prerank,guanyl ribonucleotide binding (GO:0032561),-0.24672328157272366,-1.0884315180734452,0.2603448275862069,0.6550624219856885,1.0,59/196,24.75%,RAPGEF2;INSR;RAC1;MFHAS1;RHOJ;RHOBTB1;GNAI3;ARF3;RAB7A;RND3;LRRK2;RASL12;MIEF1;RAB2A;RAB5B;PDE2A;DNM2;RHOQ;GCH1;ATL2;RAP1A;PIP4K2B;GBP6;TGM2;RAB27A;RAP1B;RAB5A;RRAS;EIF2B2;ARL4A;RHOA;RAB8B;GBP4;RHOG;DRG1;RHOC;RAB32;RERG;LSG1;GBP5;NRAS;KRAS;RAP2C;RRAS2;RAP2A;ARHGEF5;ARL5C;TUBD1;TUBE1;MTG2;ARL2;ARL4C;RALB;ARF5;RHEB;REM1;RAB9B;NOA1;GBP3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4356799504342759,1.088209689967909,0.35412026726057905,0.7050588351755699,1.0,2/10,4.98%,ADARB2;CDA
prerank,ion channel inhibitor activity (GO:0008200),-0.32465636277469306,-1.088102445767825,0.318739054290718,0.6527928089167047,1.0,9/35,16.97%,ITPR1;NEDD4L;MCUB;NEDD4;STX8;WNK4;RASA1;SCN3B;KCNMB2
prerank,thioesterase binding (GO:0031996),-0.43683530280656535,-1.0874270776221566,0.3734513274336283,0.6515089416660693,1.0,2/11,2.70%,RAC1;TRAF5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.30456905711624566,-1.0860191703377746,0.3009009009009009,0.6523143780990467,1.0,11/55,8.35%,SLC6A6;SLC7A1;SLC7A5;SLC25A32;SLC38A11;SLC16A12;SLC38A5;SLC19A2;SLC16A9;SLC16A1;SLC13A3
prerank,cGMP binding (GO:0030553),-0.45518986972590963,-1.0852955706113419,0.39664804469273746,0.6510446790591972,1.0,2/11,5.81%,RAPGEF2;PDE2A
prerank,GTPase inhibitor activity (GO:0005095),-0.4169579414036793,-1.0844876727367196,0.376599634369287,0.6500534302396859,1.0,6/13,24.29%,IQGAP1;SLIT2;PDE6D;RTKN;ARL2;GPS2
prerank,protein phosphatase 2A binding (GO:0051721),-0.36680737774404093,-1.0831223698552623,0.3377609108159393,0.6506240356697192,1.0,6/23,13.15%,DAB2IP;FOXO1;MFHAS1;STRN3;TP53;CTTNBP2NL
prerank,poly-pyrimidine tract binding (GO:0008187),-0.36339649743879,-1.082496360287606,0.3339253996447602,0.649379563416791,1.0,12/23,32.93%,RBMS1;RBMS2;PABPC4L;DIS3L2;HNRNPU;PABPC1;KHDRBS1;SSB;ATXN1;RBM11;PABPC5;PABPC1L
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.335592889449458,-1.0818475380671693,0.3333333333333333,0.6480174175161901,1.0,10/33,21.23%,DCUN1D3;RNF125;UBA2;PPARA;RNF144B;DCUN1D2;RPS3;SIAH1;FOXL2;DCUN1D5
prerank,Hsp70 protein binding (GO:0030544),0.3315252022128795,1.0817145663003123,0.3340961098398169,0.7172696912515529,1.0,12/31,20.81%,PACRG;GPR37;DNAJC8;RNF207;PPID;METTL21A;CYP1A1;IQCG;HIKESHI;DNAJB1;DNAJB2;DNAJC18
prerank,protein heterodimerization activity (GO:0046982),0.24326411234850145,1.079143024127636,0.23529411764705882,0.7187238666328352,1.0,34/178,14.20%,TENM4;ATP1A2;TENM1;QTRT2;NPAS3;TENM3;NPAS1;PHB2;BCL2;ADCY8;RRAGA;GABBR2;TENM2;ADD2;ATP1B1;NAE1;HSF1;NOLC1;ADRA2C;PIK3R2;FXR2;ADRA2A;PDGFA;PRMT5;IL12A;BUD23;ADRA1A;ARNT2;FZD9;SRI;MIGA2;BDKRB2;PSMF1;TAF1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.28437003235487285,-1.0788184147821571,0.325,0.6526159774714688,1.0,11/69,10.14%,CREBBP;KAT6B;KAT2B;ZDHHC6;PLA2G4A;KAT6A;ZDHHC3;NAA16;CERS4;NMT1;NAA15
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2748755057521706,-1.0784249617743022,0.30935251798561153,0.6507793754936275,1.0,27/91,23.62%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;ANXA2;SVIL;MARK1;LDLRAP1;SH3PXD2B;PLCB1;KCNQ1;PICALM;WIPI1;PLEKHA4;HIP1R;CGAS;GSDME;TULP1;WDR45B;OSBPL2;ANXA9;PHLDA3;AMER1;KIF16B;FZD7;TULP3
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.43804898674993004,-1.078085322572667,0.37222222222222223,0.6488222326372616,1.0,3/12,11.70%,DDI2;SPPL3;PSEN1
prerank,endopeptidase activator activity (GO:0061133),-0.45828879992151894,-1.0749720299814018,0.3781818181818182,0.6538524678963779,1.0,5/10,19.40%,PSME2;VSIR;APH1A;PSME1;ADRM1
prerank,tubulin binding (GO:0015631),0.2252335310061646,1.0738962327147414,0.2458628841607565,0.7275661096456213,1.0,75/295,19.05%,AGBL4;NAV3;TRIM36;KIF21A;SNPH;PACRG;EML2;NEFM;KIF17;APC2;CCDC88A;CDK5;TTLL12;KIF26B;UNC5C;MTUS2;SYBU;DNM1;RCC2;MAP1S;ARHGEF7;TERF1;MAP2;AGBL1;PAK1;EML5;BBS4;NEFH;MAPT;TPGS1;ARL3;DCX;GAS2L3;KIF5A;KIF3A;STMN2;MAP1B;TPPP3;SGIP1;GJB6;DYNC1I1;TTLL5;KIF1C;TPPP;MAPRE3;TUBGCP2;GOLGA2;STMN4;HDGFL3;KIF3C;RACGAP1;CLASP2;TOGARAM2;HTT;HOOK1;GAS8;KIF21B;IFT81;PPP1R42;CETN3;FSD1;DLGAP5;KATNA1;NUMA1;CCDC170;KIF22;KRIT1;WHAMM;REEP4;MAP6;MAP1A;PDCD5;MAP6D1;CDK5RAP2;HOOK3
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.43189961648415837,-1.0737014226147097,0.4064272211720227,0.6543300549803439,1.0,7/12,24.43%,INSR;PIK3R1;IRS1;SOCS2;IGF1;IGF2;ARRB1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.23860564524091624,-1.0725514623225643,0.26855123674911663,0.6543058368877251,1.0,92/248,28.54%,GNB1;DNM3;MYH9;RAC1;RHOJ;RHOBTB1;GNAI3;RAB7A;RND3;DDX3X;LRRK2;RAB1A;RASL12;RNF213;RAB2A;GNA12;RAB5B;DNM2;RHOQ;TOR1B;GCH1;ATL2;IRGM;RAP1A;GBP6;MYO18A;RAB27A;ABCB10;RAP1B;RAB5A;RRAS;SRPRA;EEF2;EFTUD2;GNA14;CHD3;RHOA;RAB8B;GBP4;RHOG;DNA2;DRG1;RHOC;RAB23;RAB24;GSPT1;RAB32;RUVBL2;AGAP3;KIF26A;RERG;KIF15;LSG1;RAB11A;MYL6;GBP5;TOR3A;GPN2;NRAS;KRAS;RAP2C;RRAS2;RAP2A;GFM2;NKIRAS2;HSP90AA1;SAR1A;MTG2;ARL2;KIF18B;RALB;RAB19;GNG3;HSPA1B;RHEB;DHX9;GNB2;GBP3;GNA11;GNGT2;RAB6B;RAN;RND1;KIF14;ABCG4;RAB38;RAB22A;RAP2B;GPN3;RAB18;CHD1L;RHOT2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.35838376364299585,-1.0712537201947778,0.3692022263450835,0.6550176567057225,1.0,8/23,22.45%,HIP1;SH3PXD2B;WIPI1;PLEKHA4;HIP1R;WDR45B;PHLDA3;KIF16B
prerank,protein tyrosine kinase binding (GO:1990782),-0.28049714675782267,-1.0677970684600948,0.34601449275362317,0.6607172122183199,1.0,27/71,23.84%,ITGB1;PTPN14;BMPR2;DOCK4;PTPN1;CRK;GAS6;CBL;NCK1;TJP2;CDH5;EPHA4;GRB14;TP53;NEDD9;CEACAM1;DUSP3;ELMO2;ANGPT1;NOX4;HYAL2;DUSP22;TOB1;PTPN11;HSP90AA1;CD247;MAP3K7
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3498276872453659,-1.065958274123292,0.35727109515260325,0.6624338995802337,1.0,8/27,20.14%,SLC26A7;SLC26A2;ANO1;SLC39A8;SLC25A11;SLC26A11;ANKH;SLC5A5
prerank,GTP binding (GO:0005525),-0.24604070741719633,-1.0655399114710684,0.3137931034482759,0.6605901075446977,1.0,52/172,24.75%,INSR;RAC1;MFHAS1;RHOJ;RHOBTB1;ARF3;RAB7A;RND3;LRRK2;RASL12;RAB2A;DNM2;RHOQ;GCH1;ATL2;RAP1A;PIP4K2B;GBP6;TGM2;RAB27A;RAP1B;RAB5A;RRAS;EIF2B2;ARL4A;RHOA;GBP4;RHOG;DRG1;RHOC;RAB32;RERG;LSG1;GBP5;NRAS;KRAS;RAP2C;RRAS2;RAP2A;ARHGEF5;ARL5C;TUBD1;TUBE1;MTG2;ARL2;ARL4C;RALB;ARF5;RHEB;REM1;NOA1;GBP3
prerank,solute:sodium symporter activity (GO:0015370),0.3433168219898537,1.0642225980539768,0.36941176470588233,0.7494443918660927,1.0,4/27,7.74%,SLC34A1;SLC4A4;SLC4A5;SLC28A2
prerank,anion transmembrane transporter activity (GO:0008509),-0.4290011667779188,-1.0639929230156915,0.38530465949820786,0.6614512515492661,1.0,3/12,8.98%,ABCG2;SLC39A8;SLCO2B1
prerank,kinase inhibitor activity (GO:0019210),-0.33403096386881176,-1.062537178386131,0.3550185873605948,0.6619285232001995,1.0,9/33,15.32%,PARVA;CDKN1B;NCK1;LRP6;SH3BP5L;PRKRIP1;TAOK3;SPRY4;GMFB
prerank,acetylcholine receptor activity (GO:0015464),0.3534700083840282,1.0609316762367376,0.36877828054298645,0.7531904354212464,1.0,2/22,5.50%,CHRM2;CHRM3
prerank,cytokine receptor activity (GO:0004896),-0.27401614555280296,-1.0605374700785994,0.3368606701940035,0.6643880890442581,1.0,28/83,30.02%,IL1R1;OSMR;GHR;IL17RD;IFNAR1;IL6ST;FZD4;IL6R;CCR9;LIFR;IL4R;IL17RA;IL17RE;IL10RB;IL20RB;CMKLR1;IFNGR2;F3;IL13RA1;IL3RA;IFNAR2;IL15RA;IL12RB2;GFRA4;IL2RA;IL2RG;IFNLR1;IL22RA1
prerank,GTPase activity (GO:0003924),-0.2410029660802201,-1.060049958449099,0.30927835051546393,0.6627448261326552,1.0,72/192,27.99%,GNB1;DNM3;RAC1;RHOJ;RHOBTB1;GNAI3;RAB7A;RND3;DDX3X;LRRK2;RAB1A;RASL12;RAB2A;GNA12;RAB5B;DNM2;RHOQ;GCH1;ATL2;IRGM;RAP1A;GBP6;RAB27A;RAP1B;RAB5A;RRAS;SRPRA;EEF2;EFTUD2;GNA14;RHOA;RAB8B;GBP4;RHOG;DRG1;RHOC;RAB23;RAB24;GSPT1;RAB32;AGAP3;RERG;LSG1;RAB11A;GBP5;GPN2;NRAS;KRAS;RAP2C;RRAS2;RAP2A;GFM2;NKIRAS2;SAR1A;MTG2;ARL2;RALB;RAB19;GNG3;RHEB;GNB2;GBP3;GNA11;GNGT2;RAB6B;RAN;RND1;RAB38;RAB22A;RAP2B;GPN3;RAB18
prerank,protein kinase inhibitor activity (GO:0004860),-0.3126632865319369,-1.0593751250671422,0.351493848857645,0.6615893863559492,1.0,10/42,15.32%,PARVA;SPRED2;CDKN1B;NCK1;SH3BP5L;PRKRIP1;TAOK3;RPTOR;SPRY4;GMFB
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.45378546992480945,-1.059315412273568,0.4064748201438849,0.6589036156862992,1.0,4/10,16.84%,STAMBP;OTUD4;ATXN3;TNFAIP3
prerank,Toll-like receptor binding (GO:0035325),-0.42850174895010207,-1.0573438646396192,0.40852575488454707,0.661104035356999,1.0,1/11,0.26%,DAB2IP
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3090937037238689,1.0523651211279625,0.37089201877934275,0.7720255495187696,1.0,5/38,4.05%,MAGI2;GRIP1;BLNK;SHANK1;CD3G
prerank,histone methyltransferase binding (GO:1990226),0.41302649570724903,1.0506278240427855,0.37962962962962965,0.7712180988007727,1.0,7/11,29.02%,NOP56;LCOR;HSP90AB1;LCORL;PRDM4;CBX3;PHF1
prerank,magnesium ion binding (GO:0000287),-0.24871271930772285,-1.0474020416692977,0.35727109515260325,0.6829968916747289,1.0,32/135,19.81%,SNRK;MAP3K20;SRR;PRKACB;MARK1;MAP3K5;SIK1;LRRK2;NEK6;IDH1;UBA2;STK3;PDE2A;ABL1;MAST2;ERN1;CDC42BPA;PDXK;SIK3;ENDOV;STK38;PLSCR1;MARK2;MAPK12;SRPK2;CDC42BPB;HPRT1;HPGDS;WRN;NUDT12;CLYBL;RAP2A
prerank,myosin V binding (GO:0031489),0.3771276514466144,1.0466485315010277,0.37155963302752293,0.7765993786618908,1.0,6/15,20.87%,RAB27B;RAB3C;RAB3A;RAB6A;RAB3B;RAB8A
prerank,microtubule binding (GO:0008017),0.22622715310798217,1.045773691637104,0.332541567695962,0.7734403901096132,1.0,61/222,19.05%,NAV3;KIF21A;SNPH;EML2;NEFM;KIF17;APC2;CCDC88A;CDK5;KIF26B;MTUS2;SYBU;DNM1;RCC2;MAP1S;TERF1;MAP2;EML5;NEFH;MAPT;TPGS1;ARL3;DCX;GAS2L3;KIF5A;KIF3A;MAP1B;SGIP1;GJB6;DYNC1I1;KIF1C;TPPP;MAPRE3;TUBGCP2;CLIP4;GOLGA2;HDGFL3;KIF3C;MAPRE1;RACGAP1;CLASP2;TOGARAM2;HOOK1;GAS8;KIF21B;CETN3;FSD1;DLGAP5;KATNA1;NUMA1;CCDC170;CAMSAP3;KIF22;KRIT1;WHAMM;REEP4;MAP6;MAP1A;MAP6D1;CDK5RAP2;HOOK3
prerank,3'-5' exonuclease activity (GO:0008408),-0.30346271215460835,-1.0452454303998013,0.3879472693032015,0.6853333300120107,1.0,15/45,26.02%,ERI3;MRE11;EXOSC2;EXOSC3;XRN2;PDE12;PARN;WRN;USB1;EXOSC5;ANGEL2;DIS3L2;CNOT8;EXOSC7;TOE1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.366958346462832,-1.044490492623529,0.42003853564547206,0.684366769548282,1.0,6/20,20.27%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;DGAT2;LCLAT1
prerank,adenyl ribonucleotide binding (GO:0032559),-0.22519846930976398,-1.0430491950061394,0.3484848484848485,0.6852605273125504,1.0,46/291,10.46%,RAPGEF2;SNRK;MAP3K20;ACVRL1;SRR;INSR;PEX1;MYH9;DAPK1;TLK2;PRKACB;RPS6KA5;MARK1;MAP3K5;SIK1;MAP4K3;TLK1;NEK6;UBA2;MIEF1;CARS2;STK3;PDE2A;ABL1;MAST2;ABCC6;ERN1;PIP4K2B;ABCD3;ABCB9;MYO18A;PRAG1;MYO1F;TAP2;CDC42BPA;PDXK;N4BP2;AKT3;LATS2;SMC4;PXK;NOL9;EIF2B2;AKT1;WNK4;SIK3
prerank,NAD+ binding (GO:0070403),-0.42485092210915837,-1.043042435793589,0.4025974025974026,0.6824261425753284,1.0,3/12,13.66%,ZC3HAV1;SIRT5;SIRT3
prerank,galactosyltransferase activity (GO:0008378),-0.4314501776815565,-1.0424706233989058,0.3916083916083916,0.6811377447215597,1.0,4/11,18.89%,A4GALT;B4GALT4;B4GALT5;B4GALT1
prerank,RNA stem-loop binding (GO:0035613),-0.4248568582873612,-1.0412282897671181,0.42463235294117646,0.6815730529424957,1.0,5/12,26.90%,DDX3X;RC3H1;METTL16;DHX9;LARP6
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.3942901132521268,-1.0353030470170286,0.39723661485319517,0.6943304492342679,1.0,7/15,25.36%,SETD3;ASH2L;PRDM9;KMT2C;WDR82;WDR5;RBBP5
prerank,Tat protein binding (GO:0030957),-0.43214470404676764,-1.0327300937773984,0.4192377495462795,0.6981465181300028,1.0,4/10,30.08%,MDFIC;ACTB;SMARCB1;TRIM32
prerank,epidermal growth factor receptor binding (GO:0005154),0.3360811350189558,1.03265809218789,0.4147982062780269,0.8059978562750172,1.0,4/25,8.98%,ERBB4;CCDC88A;EFEMP1;SHC1
prerank,solute:anion antiporter activity (GO:0140323),0.39390912372711817,1.032302232726795,0.4253393665158371,0.8011031385496368,1.0,3/14,5.62%,SLC7A11;SLC26A5;SLC4A2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.42683198573422726,-1.027880135345844,0.42018348623853213,0.7075737364754706,1.0,8/11,52.33%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,DNA secondary structure binding (GO:0000217),-0.31979833482758546,-1.027505409893072,0.4076782449725777,0.7056155512311464,1.0,14/31,29.61%,ABL1;MEF2C;RBBP8;CLSPN;RAD18;XPC;FANCM;WRN;BLM;YY1;HMGB1;RAD51AP1;XRCC2;RAD51D
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.34429332525094447,1.027196144686381,0.432967032967033,0.8102566474683949,1.0,3/21,12.91%,GRIK2;P2RX3;P2RX5
prerank,3'-5' DNA helicase activity (GO:0043138),-0.37679775554106243,-1.026018479298078,0.4105461393596987,0.7068593608310185,1.0,8/16,26.75%,NAV2;ERCC3;FANCM;WRN;BLM;DHX9;MCM7;MCM5
prerank,single-stranded RNA binding (GO:0003727),-0.2984028245309296,-1.0257039018920644,0.4136690647482014,0.7048193763146058,1.0,11/43,15.31%,EIF4H;IFIH1;DDX3X;POLR2G;DDX60;STRBP;HNRNPF;ENDOV;AGO2;HNRNPA1;JMJD6
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.41045235434821414,-1.0221129652083198,0.4283246977547496,0.7112605108443258,1.0,3/12,10.35%,DAB2IP;CDH5;VEGFC
prerank,glutamate receptor binding (GO:0035254),-0.36569774129003374,-1.0216176127349255,0.431858407079646,0.7097215603767432,1.0,2/17,0.73%,HIP1;SHANK3
prerank,snoRNA binding (GO:0030515),0.31222896791239785,1.0191490534380898,0.39643652561247217,0.8281172569295562,1.0,10/30,25.39%,NOP56;XRCC5;TBL3;NUDT16;TSR1;UTP6;NOP10;ISG20;RRP9;WDR3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.33444572676758005,-1.0183922982647229,0.4166666666666667,0.7153847722248492,1.0,8/27,21.23%,DCUN1D3;RNF125;PPARA;RNF144B;DCUN1D2;SIAH1;FOXL2;DCUN1D5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.4360911157701755,-1.017693496339917,0.4631956912028725,0.7142326272761056,1.0,2/10,4.65%,KAT2B;CDKN1B
prerank,adrenergic receptor binding (GO:0031690),0.35942874420340276,1.0169079182539058,0.44759825327510916,0.8288586617757923,1.0,7/16,19.65%,MAGI2;ADRA2C;ADRA2A;DLG4;ARRDC3;APLP1;PDE4D
prerank,ankyrin binding (GO:0030506),0.359003840068014,1.0166033348173902,0.4245939675174014,0.8238522066740744,1.0,6/19,12.07%,NRCAM;FLNC;CACNA1D;SCN5A;SPTBN4;SLC8A1
prerank,sterol binding (GO:0032934),0.27790514406711864,1.0145714136354957,0.42725173210161665,0.8242743999774589,1.0,19/56,21.40%,INSIG1;SULT2B1;SYP;CD81;ERLIN1;OSBPL6;OSBPL5;VDAC2;OSBPL11;SIDT1;GRAMD1B;OSBPL9;GPR183;SOAT2;VDAC1;SOAT1;GRAMD1C;SCARB2;ABCG1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.42280326100534504,1.014279395203709,0.42572062084257206,0.819326410989515,1.0,4/10,23.96%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.28446974598730357,1.0135964043270818,0.4238875878220141,0.8157711666846158,1.0,8/46,11.67%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;PIGP;MGAT5B;HEXB;EXTL2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.35312235904199063,-1.0126314518629176,0.4322916666666667,0.7246389665942713,1.0,3/20,1.75%,SENP1;EIF3H;USP9X
prerank,voltage-gated anion channel activity (GO:0008308),0.3703144864184169,1.0113969371160616,0.42042755344418054,0.8166274504684731,1.0,7/15,25.12%,CLCNKA;CLCN2;VDAC2;CLCN5;VDAC1;CLCN1;CLCN6
prerank,TBP-class protein binding (GO:0017025),-0.35021305122276847,-1.007125045327592,0.4470802919708029,0.7360292785658308,1.0,6/21,15.81%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2
prerank,cation:chloride symporter activity (GO:0015377),-0.42531802681108943,-1.0068967779032785,0.4581005586592179,0.7337910213181167,1.0,2/10,4.10%,SLC12A7;SLC12A2
prerank,mannosyltransferase activity (GO:0000030),-0.3520875250747315,-1.0041653823235293,0.4648648648648649,0.7382311627380339,1.0,5/21,12.06%,TMTC1;TMTC2;ALG12;ALG8;PIGV
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.38598878199679676,-1.002119016029327,0.4647887323943662,0.7405894628639622,1.0,4/14,16.50%,SLC26A7;SLC26A2;SLC25A11;SLC26A11
prerank,calcium-release channel activity (GO:0015278),-0.36527919382327134,-1.0018855320630238,0.44939965694682676,0.7384140794545418,1.0,3/17,5.12%,ITPR1;PKD2;ITPR2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.29634412219884665,-1.0015177836481088,0.44623655913978494,0.7365104338870457,1.0,19/42,33.11%,KAT2B;CDKN1B;CCND3;CCNY;CCNC;CCND1;CNPPD1;CDKN2C;CCNYL1;CCNG1;CCNK;CCNE2;CCNJ;CDKN2B;CCND2;CCNH;CDK5R1;CCNE1;CCNL1
prerank,single-stranded DNA binding (GO:0003697),-0.2503863941163181,-0.9950262565574072,0.44945848375451264,0.7500337409313558,1.0,41/93,33.10%,STN1;RBMS1;DMC1;TOP3A;SAMHD1;POLR2G;NABP1;MCM9;RBBP8;MCM4;RTF1;RPA3;RPA1;XPC;CTC1;HNRNPA1;RPA2;RAD23A;FUBP1;RAD51AP2;BLM;MCM3;TOP1;PCBP1;MSH3;DHX9;HMGB1;POLR2H;CRY2;HNRNPU;MCM7;MCM5;MCM10;RAD51AP1;RAD51D;TDP1;JCHAIN;MEIOB;SUB1;NUP35;MCM2
prerank,chloride channel regulator activity (GO:0017081),0.37445491371609685,0.9931366557332986,0.46697038724373574,0.8653381932718317,1.0,5/14,18.17%,WNK2;WNK3;VTI1B;SGK1;SGK3
prerank,pentosyltransferase activity (GO:0016763),-0.30468051565254795,-0.9903960308570896,0.4589285714285714,0.758836553876928,1.0,13/36,27.11%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;LARGE1;PARP16;PARP6;PARP9;PNP
prerank,MHC class I protein binding (GO:0042288),-0.3845741862352104,-0.9890269483947217,0.4649910233393178,0.7596169578630732,1.0,2/13,7.78%,ABCB9;TAP2
prerank,lysine-acetylated histone binding (GO:0070577),-0.3398257032953228,-0.9887695300593367,0.4457831325301205,0.7546058672244733,1.0,4/20,10.63%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,acetylation-dependent protein binding (GO:0140033),-0.3398257032953228,-0.9887695300593367,0.4457831325301205,0.7546058672244733,1.0,4/20,10.63%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,exoribonuclease activity (GO:0004532),-0.39815097035657065,-0.988568517464971,0.46846846846846846,0.7522634212625086,1.0,6/12,25.31%,EXOSC1;EXOSC2;EXOSC3;EXOSC8;EXOSC5;EXOSC7
prerank,kinesin binding (GO:0019894),-0.321697328019711,-0.9883231422272996,0.4706959706959707,0.7500525040305518,1.0,9/27,23.23%,NEK6;TOR1B;CROCC;ACTB;AP1G1;ARHGEF10;PRC1;SPAG9;KIF18B
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2759492868316077,-0.9839001396959862,0.4802158273381295,0.7586013905572183,1.0,15/53,21.77%,NOS3;DLD;MICAL2;AOX1;ACADL;ACADVL;ACOX1;NOX4;AGPS;KDM1B;ACOX3;KMO;NOS1;POR;MTRR
prerank,chemorepellent activity (GO:0045499),0.31598156053857973,0.9830926210390788,0.5021739130434782,0.8895189484868391,1.0,4/25,5.91%,NRG3;NRG1;SEMA6D;SEMA3B
prerank,MHC protein binding (GO:0042287),0.33415826952665795,0.98132145828336,0.4606741573033708,0.8890408858965193,1.0,3/20,9.65%,COL2A1;CD81;KIR3DL2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4055360281195081,0.9796265891310032,0.4700460829493088,0.8881566614200506,1.0,10/10,59.47%,USP22;NAA40;BRCA2;EP300;NAA50;KAT8;MSL3;ATF2;HAT1;NAA60
prerank,N-acyltransferase activity (GO:0016410),0.29844163594299694,0.9791989084868775,0.4742990654205608,0.883518557801195,1.0,7/32,13.37%,CERS6;NAT8;CERS1;PLA2G4E;CERS3;CERS2;SIRT7
prerank,voltage-gated chloride channel activity (GO:0005247),0.3969373257733026,0.9739010043643713,0.45662100456621,0.8937160018189924,1.0,2/10,7.65%,CLCNKA;CLCN2
prerank,ribonuclease activity (GO:0004540),-0.27240386389183874,-0.9732397125540382,0.5099099099099099,0.7832245971361085,1.0,21/56,25.57%,RNASE7;SAMHD1;KHNYN;ERN1;RNASE3;EXOSC1;EXOSC2;EXOSC3;DICER1;RNASE12;AGO2;N4BP1;EXOSC8;EXOSC5;EXOG;DIS3L2;RCL1;ELAC2;SMG6;EXOSC7;ENDOU
prerank,MAP kinase kinase activity (GO:0004708),0.3567356195829893,0.9717803654549064,0.48758465011286684,0.8941548684566933,1.0,3/15,6.17%,MAPK10;PAK3;MAP2K7
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3636205469971824,-0.9716064658606297,0.49016100178890876,0.7844821749767157,1.0,2/16,2.51%,SLC26A7;SLC26A2
prerank,disordered domain specific binding (GO:0097718),-0.3271467115107989,-0.9715448656952582,0.482078853046595,0.7817558566870685,1.0,6/23,22.22%,RB1;SMAD2;TP53;FYN;MDM2;HSP90AA1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3322503383270171,-0.9712553237217203,0.5212014134275619,0.7796529757597422,1.0,8/22,17.91%,TAB3;UIMC1;RNF169;IKBKE;RNF168;TAB2;TNFAIP3;IKBKG
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.359973016847952,0.9694658104058198,0.47300215982721383,0.8950771369212588,1.0,3/14,9.15%,QDPR;PYCR2;ALDH1L2
prerank,aminopeptidase activity (GO:0004177),0.3151601775690789,0.9682999239198684,0.48283261802575106,0.8926319730637973,1.0,5/26,10.31%,TRHDE;MMP16;METAP2;KDM8;JMJD7
prerank,amino acid transmembrane transporter activity (GO:0015171),0.27218118969598376,0.9660936498609032,0.49884526558891457,0.8932935090042152,1.0,8/47,9.84%,SLC7A11;SLC22A4;PDPN;SLC7A4;SLC7A8;SLC36A2;SLC7A14;SLC7A6
prerank,calcium activated cation channel activity (GO:0005227),0.3441365167525627,0.9643541536620267,0.49095022624434387,0.8926101670577409,1.0,3/17,6.10%,KCNMA1;KCNN2;TMEM63A
prerank,nuclear receptor coactivator activity (GO:0030374),-0.27377477026331787,-0.9635086077746525,0.5059422750424448,0.7963095975545953,1.0,14/52,19.77%,TACC1;ETS1;ZMIZ1;MED1;HELZ2;MED13;MED17;ACTN1;FGF2;ACTN4;NCOA6;CARM1;RNF4;SS18
prerank,microtubule plus-end binding (GO:0051010),-0.33366591946041807,-0.9627595227390139,0.5280701754385965,0.7953272554766164,1.0,6/20,19.09%,CLIP1;DST;DCTN1;PAFAH1B1;FBXW11;CLIP2
prerank,deubiquitinase activity (GO:0101005),-0.24487321853786292,-0.9617705626372197,0.5538194444444444,0.7951701991008349,1.0,27/88,20.89%,USP53;EIF3H;USP9X;USP24;OTULIN;MINDY1;STAMBP;JOSD1;USP2;USP13;OTUD1;OTUD4;USP15;USP40;ATXN3;USP18;USP34;USP10;VCPIP1;TNFAIP3;BRCC3;BAP1;USP7;JOSD2;UCHL1;USP1;EIF3F
prerank,retinoid binding (GO:0005501),0.31990846127133243,0.9613918430489038,0.5254988913525499,0.8959702563167278,1.0,3/22,10.18%,PTGDS;CYP26B1;ALDH1A2
prerank,protein kinase regulator activity (GO:0019887),-0.24239126348952345,-0.9603124934034779,0.5335753176043557,0.796089369474642,1.0,37/95,33.11%,PARVA;GPRC5C;CDKN1B;NCK1;CCND3;SH3BP5L;PRKRIP1;RPLP1;CCNY;TAOK3;RGCC;RPTOR;WNT11;SPRY4;MARK2;GMFB;CCNC;CCND1;CNPPD1;CCNYL1;CCNG1;CCNK;CAB39;APC;CCNE2;CCNJ;CXCL10;DNAJC3;CCND2;WNK1;CCNH;PPP1R1B;CDK5R1;DUSP19;PRKAG2;CCNE1;CCNL1
prerank,receptor ligand activity (GO:0048018),0.20624126109112087,0.9601479389633191,0.594272076372315,0.8940268082396274,1.0,36/245,14.58%,NRG3;NRG1;TAFA1;OSGIN1;CLEC11A;WNT7B;FGF6;TAFA2;TAFA5;GDF1;NBL1;CHGB;SEMA6D;SEMA3B;NPPC;NPY;COLEC10;TIMP1;GRN;FGF5;FGF20;VEGFA;PDGFA;IL12A;CCK;HMGB2;CCL5;LEFTY1;WNT6;GDF11;THPO;METRNL;WNT2;BDNF;NTS;WNT4
prerank,steroid hydroxylase activity (GO:0008395),0.3479770652799627,0.9597170915970183,0.5092592592592593,0.8894742361184786,1.0,4/16,15.55%,CYP46A1;CYP27A1;CYP11B1;CYP1A1
prerank,aspartic-type peptidase activity (GO:0070001),-0.4023845268398988,-0.9582768092358185,0.546112115732369,0.7981398159399454,1.0,2/10,11.70%,DDI2;PSEN1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.30094108727023267,-0.95709287837833,0.5190562613430127,0.7983105734176553,1.0,5/31,5.49%,SLC12A7;PKD2;SLC12A2;ABCC9;KCNK5
prerank,mRNA 3'-UTR binding (GO:0003730),-0.24857324055857513,-0.9569449906740439,0.5646630236794171,0.7957764847565333,1.0,36/79,33.03%,RBMS1;HNRNPA0;LARP1;RNF40;RBMS2;PUM1;SECISBP2;TP53;CELF1;SERBP1;LARP4B;RC3H1;PARN;RPL5;PABPC4L;EXOSC8;ANGEL2;RNPS1;RPS7;RBM24;CCT5;FXR1;CARHSP1;HNRNPU;PABPC1;UTP23;SECISBP2L;IGF2BP2;BOLL;ZFP36L1;RPL41;CPEB4;PABPC5;PABPC1L;RNF20;PUM2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3588776645784936,-0.9565650198859601,0.5126705653021443,0.7939165202170982,1.0,4/15,15.06%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.38899817718312224,0.9516588756851846,0.5152224824355972,0.9067172901008742,1.0,3/10,15.61%,DPYSL5;DPEP1;DPYSL2
prerank,metalloendopeptidase activity (GO:0004222),-0.25007481216138827,-0.9501928695679955,0.5506003430531733,0.807011806662106,1.0,16/76,12.66%,ADAMTSL3;TRABD2B;ADAMTS2;ADAM9;MMP2;ECE1;AFG3L2;ADAM10;ADAMTS9;ADAMTS4;THSD4;ADAMTS10;ADAMTS17;ADAMTS20;ADAMTS5;ADAM33
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2628850891688592,-0.9499489990667178,0.5480427046263345,0.8047397652612263,1.0,15/54,18.00%,ACER2;MIER1;HDAC1;SIRT5;TGM2;NADSYN1;ACER3;NTAN1;HDAC4;ASAH1;HDAC6;MIER2;HDAC10;HINT1;MIER3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.2848146870247108,0.9449082057849663,0.5475113122171946,0.9203539659771871,1.0,10/35,11.98%,MPPED2;ENPP2;PLCXD3;SMPD3;SMPDL3B;ENPP3;MPPE1;PDE11A;PLD3;GPLD1
prerank,chloride channel inhibitor activity (GO:0019869),0.38388349329437044,0.9447899174087433,0.5098039215686274,0.9150247414384012,1.0,3/10,10.66%,WNK2;WNK3;VTI1B
prerank,P-type ion transporter activity (GO:0015662),0.3642883455602438,0.9409376285716474,0.5353075170842825,0.9205723277828014,1.0,2/12,3.12%,ATP2B4;ATP2B2
prerank,retinoic acid binding (GO:0001972),-0.3837983036532275,-0.9398940110191784,0.5503731343283582,0.826948695777716,1.0,3/12,23.41%,RXRA;RARA;NR2F2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.373276946944735,-0.9398316930963442,0.553415061295972,0.824186162377158,1.0,3/13,11.03%,SLC9A2;SLC9B2;SLC9A5
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.36681161892786396,-0.9397218690339283,0.5543478260869565,0.8216031903284718,1.0,7/13,29.53%,SLC7A1;SLC38A5;SLC7A7;SLC66A1;SLC3A1;SLC7A3;SLC7A2
prerank,kinase activity (GO:0016301),0.22405212840263358,0.9388073080668736,0.5867237687366167,0.9209402717972668,1.0,23/109,15.21%,DGKK;DGKI;PKMYT1;DGKQ;ITPKA;CDK5;CDKL5;POMK;BCKDK;SPHK1;ETNK1;GK;SPHK2;PI4KA;IP6K2;PIK3C2G;IPPK;CKMT2;CHKA;TAF1;FCSK;CDC7;FN3K
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3005930775188586,0.9383414872547522,0.5807962529274004,0.9165953199860798,1.0,6/25,8.66%,AKR1D1;CYP46A1;AKR1C1;CYP26B1;SQLE;CYP27A1
prerank,telomerase RNA binding (GO:0070034),-0.3221591523484826,-0.9376518606272439,0.5446428571428571,0.823716523583131,1.0,10/22,28.77%,TENT4B;XRN1;PARN;TEP1;TERT;SMG6;NAF1;PINX1;HNRNPU;GAR1
prerank,gap junction channel activity (GO:0005243),-0.3141969850743248,-0.9332837803062062,0.5448028673835126,0.8316472912553556,1.0,2/22,1.37%,GJD3;GJC1
prerank,sodium:proton antiporter activity (GO:0015385),-0.3930358960257706,-0.9331276908359843,0.5843694493783304,0.8291747635437423,1.0,3/11,11.03%,SLC9A2;SLC9B2;SLC9A5
prerank,ionotropic glutamate receptor binding (GO:0035255),0.38615724572925486,0.9329476003587182,0.51931330472103,0.9267132592559186,1.0,5/10,20.84%,IGSF11;SHANK1;DLG4;SHANK2;SQSTM1
prerank,single-stranded DNA helicase activity (GO:0017116),0.32003240623534096,0.932496461138229,0.5735930735930735,0.9224551279269079,1.0,2/19,3.70%,WRNIP1;HELQ
prerank,phosphate ion binding (GO:0042301),0.37580329030493165,0.9319613118992304,0.5144766146993318,0.9184810277363495,1.0,3/10,10.88%,RPH3A;ADSS2;ADSS1
prerank,four-way junction DNA binding (GO:0000400),-0.33645984415866126,-0.9305956133443232,0.5466417910447762,0.8324547336088028,1.0,8/17,29.61%,ABL1;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51D
prerank,ADP binding (GO:0043531),-0.3069877671679148,-0.929607267278977,0.5565529622980251,0.8320615888883779,1.0,4/25,7.41%,MYH9;MIEF1;ERN1;MYO18A
prerank,GABA receptor binding (GO:0050811),-0.38333897118429117,-0.9291103641076798,0.5626072041166381,0.8304460461066145,1.0,5/11,34.77%,TRAK1;GABARAP;ARFGEF2;LHFPL4;GABARAPL2
prerank,pyridoxal phosphate binding (GO:0030170),-0.32477967414255526,-0.9276983791816066,0.5642857142857143,0.8309818738989695,1.0,9/20,30.45%,SRR;PDXK;ABAT;ACCS;CTH;PNPO;PSAT1;SHMT1;GLDC
prerank,wide pore channel activity (GO:0022829),-0.30950708299888396,-0.9264750147957088,0.5673249551166966,0.8311987310586613,1.0,2/23,1.37%,GJD3;GJC1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3788151047805792,-0.9252577155241183,0.5879218472468917,0.8312921137033441,1.0,3/12,11.03%,SLC9A2;SLC9B2;SLC9A5
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3780252628509553,-0.9202444891139367,0.5539568345323741,0.8413180497044512,1.0,2/11,16.08%,PPP1R2;PPP1R1A
prerank,GDP binding (GO:0019003),-0.24957268230223,-0.9190209948290894,0.5933456561922366,0.8414757576607287,1.0,29/63,31.78%,GNAI3;RAB7A;RASL12;MIEF1;RAB2A;RAB5B;RAP1A;RAB27A;RAP1B;RAB5A;RRAS;RAB8B;RERG;NRAS;KRAS;RAP2C;RRAS2;RAP2A;RALB;RHEB;RAB9B;RAN;RAB22A;RAP2B;RAB18;ARL8B;RAB31;RAB21;DIRAS1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.26038171569078195,-0.9186650251023318,0.6199324324324325,0.839568386132291,1.0,15/51,20.14%,SLCO2A1;SLCO1C1;SLC7A5;SLCO3A1;SLC5A6;SLCO2B1;MFSD2A;SLC25A11;SLC35E4;SLC35E3;SLC20A2;ANKH;SLCO4A1;SLC35D1;SLC5A5
prerank,general transcription initiation factor binding (GO:0140296),-0.30105385765767706,-0.9185385432409817,0.5855018587360595,0.8370793017959096,1.0,8/25,22.72%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2;TAF13;RELA
prerank,endopeptidase activity (GO:0004175),-0.20231490409879466,-0.9173925944190294,0.735144312393888,0.8368933614163379,1.0,52/257,17.79%,ADAMTSL3;TRABD2B;SENP1;USP9X;PCSK7;CTSC;ADAMTS2;PSMA2;DDI2;USP24;ACE;ADAM9;MMP2;TASP1;PSEN2;ECE1;RHBDF2;RHBDD3;PSMB4;USP2;AFG3L2;ADAM10;PCSK5;USP13;ADAMTS9;CASP8;ADAMTS4;TPP2;THSD4;ADAMTS10;ADAMTS17;ADAMTS20;PSEN1;USP15;ADAMTS5;USP40;USP18;ADAM33;HGF;PIK3IP1;PSMB2;PDIA3;LGMN;USP34;USP10;CTSZ;PSMB1;PRSS12;ZMPSTE24;CTSH;PSMA8;PREP
prerank,glutathione transferase activity (GO:0004364),-0.3120456130803137,-0.9153462279210832,0.5857142857142857,0.8387049388205458,1.0,12/23,43.94%,GSTT1;GSTT2;GSTM2;HPGDS;GSTK1;MGST2;ALOX5AP;GSTM5;GSTA4;GSTM4;LTC4S;GSTP1
prerank,ATPase binding (GO:0051117),-0.2407825398576971,-0.9142041790137238,0.6236559139784946,0.8386773269149933,1.0,16/71,17.94%,CAV1;PKD2;ESR1;EGFR;EZR;CHMP4A;PSEN1;SLC2A13;PTPN3;ATXN3;S100A1;ATP6V1E1;DNAJC10;BBC3;ATP6V0A1;PLN
prerank,cardiolipin binding (GO:1901612),0.37080544936396387,0.9141657378099038,0.5604395604395604,0.9628856527959396,1.0,1/10,2.02%,MME
prerank,Hsp90 protein binding (GO:0051879),-0.28172177070020155,-0.9139339973878335,0.6109154929577465,0.8364580971479108,1.0,10/33,18.62%,NR3C1;KDR;SLC12A2;PPEF2;ERN1;UNC45B;PTGES3;HDAC6;NOD2;RPS3
prerank,omega peptidase activity (GO:0008242),0.22994658322175543,0.9135295280602621,0.6457831325301204,0.9590454079230094,1.0,15/89,10.54%,USP29;OTUD7A;ASRGL1;USP28;USP25;USP21;CYLD;USP38;USP48;USP31;MPND;OTUD7B;PSMD14;USP11;USP50
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2962940009953433,-0.912314838292052,0.581981981981982,0.8373348673239934,1.0,12/28,34.09%,DICER1;DBR1;ENDOV;AGO2;EDC3;DROSHA;ELAC2;RPP30;EXO1;POP4;MRPL44;RPP40
prerank,phospholipase A2 activity (GO:0004623),0.28816212636402555,0.9077351712706537,0.5793991416309013,0.9695153961150914,1.0,4/26,10.56%,PLA2G7;PLA2G3;PLA2G4E;PLA2G6
prerank,leucine zipper domain binding (GO:0043522),-0.3904534823869703,-0.9066439701301535,0.5774647887323944,0.8479236385762093,1.0,3/10,14.31%,ERC1;AATF;ATF4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.3545013730301397,0.9057996125423645,0.6013667425968109,0.9688150585950945,1.0,2/12,7.90%,ARSI;ARSG
prerank,snRNA binding (GO:0017069),0.2602937329177245,0.905125408519287,0.6264236902050114,0.964991683869597,1.0,14/42,21.25%,LSM7;SF3B3;TUT1;SNRPB2;HEXIM1;CCNT1;SNRNP70;SNRPC;SNRPD3;LSM8;PRPF8;NCBP2;LSM4;CDK9
prerank,ribosome binding (GO:0043022),-0.2608787600619492,-0.9043856198504758,0.6392857142857142,0.8503785126925466,1.0,9/46,16.62%,NAA16;EIF3C;NOMO1;RPSA;NAA15;SERBP1;EEF2;MRPS27;NCLN
prerank,RNA methyltransferase activity (GO:0008173),-0.32213513537063443,-0.9043660723883825,0.6159554730983302,0.8476740893152545,1.0,5/19,19.89%,METTL4;TGS1;TRMT9B;TRDMT1;TRMT12
prerank,RNA cap binding (GO:0000339),0.3285370671144515,0.9021450041330199,0.5852017937219731,0.9674026910688237,1.0,8/16,24.85%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4A1;EIF4E3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2272768189357592,0.8997150843546312,0.6658823529411765,0.9684268375861967,1.0,15/83,11.86%,USP29;OTUD7A;USP28;USP25;USP21;CYLD;USP38;USP48;USP31;MPND;OTUD7B;PSMD14;USP11;USP50;USP22
prerank,cation transmembrane transporter activity (GO:0008324),-0.2517223476165182,-0.8996604827896801,0.6547008547008547,0.8556084845365785,1.0,17/48,29.53%,SLC6A6;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC1A1;SLC6A7;PKD2L1;SLC1A4;SLC3A2;SLC66A1;SLC38A6;SLC7A3;SLC22A3;SLC22A2;SLC7A2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.23095959514111714,0.8990439212607274,0.6722689075630253,0.9645088523484178,1.0,12/74,10.85%,DGKK;DGKI;DGKQ;POMK;SPHK1;ETNK1;GK;PKM;SPHK2;PI4KA;PIK3C2G;IPPK
prerank,phospholipase activity (GO:0004620),-0.24231464738552938,-0.8988622034381887,0.6574585635359116,0.8547432015640108,1.0,27/67,36.73%,PLCB4;PLA2G4A;PLCB3;PLCE1;NAPEPLD;GDPD1;MGLL;LPL;GDPD3;PDIA3;SMPD2;PLA2G12A;DDHD2;PNPLA8;PLA2G4F;LYPLA1;GDE1;LIPH;PLAAT1;SEC23IP;PLCB2;PLBD1;PLCL1;PLB1;PNPLA6;ABHD12;SMPDL3A
prerank,cysteine-type peptidase activity (GO:0008234),-0.23764038844546925,-0.8985983229370146,0.6702702702702703,0.8526453644585974,1.0,25/73,22.46%,USP9X;CTSC;USP24;OTULIN;ATG4A;USP2;USP13;CASP8;CAPN2;USP15;USP40;USP18;PDIA3;LGMN;USP34;USP10;CTSZ;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.3286174805299883,-0.8962816595242111,0.6092362344582594,0.8551190413580867,1.0,5/16,20.25%,SLC1A5;SLC13A3;SLC25A11;SLC1A1;SLC1A4
prerank,growth factor receptor binding (GO:0070851),-0.226825460005088,-0.8958529793905604,0.6952054794520548,0.8533165706929251,1.0,17/95,16.96%,HIP1;IL1R1;PDGFD;PTPRJ;IL6ST;IL6R;FGF1;ERN1;VEGFC;FGF7;PSEN1;JAK2;FGF2;PLSCR1;GRB2;FYN;ERAP1
prerank,LRR domain binding (GO:0030275),0.34109128213938644,0.8933962785968598,0.6029055690072639,0.9737574962640023,1.0,2/14,2.38%,ROBO1;CRX
prerank,alkali metal ion binding (GO:0031420),0.3369049003026707,0.8929174565805312,0.5981735159817352,0.9696233451890692,1.0,7/13,24.41%,ATP1A2;ATP4A;IMPA1;ACAT1;ADPRH;CAPN3;TDG
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3433873302741852,0.8922969489297986,0.6004228329809725,0.9658290446019615,1.0,2/13,3.00%,CCDC88A;RANBP1
prerank,mRNA binding (GO:0003729),-0.19577768887638464,-0.8911376038687203,0.7911714770797963,0.8615690544325494,1.0,96/249,33.30%,RBPMS;RBFOX2;METTL14;RBMS1;DDX3X;HNRNPA0;RBM5;LARP1;THOC2;NOVA2;RPS14;HNRNPR;KHNYN;UPF3B;NUP98;SF3B6;RNF40;RBMS2;HNRNPM;PUM1;SAMD4A;SECISBP2;HNRNPAB;SF3B1;RPL26;TP53;CELF1;SERBP1;SNIP1;LARP4B;RC3H1;RBM20;PARN;MARF1;AGO2;N4BP1;RPL5;PABPC4L;TPR;SYNCRIP;EDC3;ADARB1;RPS3;FUBP1;RBM4B;ANGEL2;RNPS1;DCP1A;TRA2B;PTBP3;RPS7;RBM25;RPL13A;MRPL13;RBM15;RBM24;EIF3A;PCBP1;CCT5;SRBD1;DHX9;FXR1;NCBP3;RPS2;RPS26;CARHSP1;HNRNPU;HNRNPL;NANOS1;RBPMS2;PABPC1;LARP6;DXO;KHDRBS1;RBM47;TDRD7;UTP23;HDLBP;PPIE;SHMT1;RPS13;SSB;SECISBP2L;SRSF6;IGF2BP2;BOLL;LUC7L2;ZFP36L1;RPL41;EIF4G3;CPEB4;PABPC5;PABPC1L;RNF20;PUM2;SHFL
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.35970520786712956,-0.8902163797688023,0.6346863468634686,0.8608999574299026,1.0,3/12,13.65%,TENT4B;TENT4A;TENT2
prerank,MAP kinase activity (GO:0004707),-0.3440363402815979,-0.8897342576723469,0.6238859180035651,0.8592797553807826,1.0,6/14,29.63%,MAPK1;MAPK8;MAPK12;MAPK7;MAPK11;MAPK14
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2635252012550374,0.8885105318283434,0.6391982182628062,0.9701744767275523,1.0,5/38,10.71%,SPOCK1;TFPI2;SERPIND1;SERPING1;SERPINA2
prerank,receptor tyrosine kinase binding (GO:0030971),-0.24638892889039601,-0.88824162936223,0.6637630662020906,0.8597297799609938,1.0,15/56,18.43%,PTPN14;DOCK4;PTPN1;GAS6;CBL;NCK1;PIK3R1;IRS1;GRB14;TP53;DUSP3;ELMO2;ANGPT1;GAB2;HYAL2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.308520047778974,0.8872293203431477,0.6106194690265486,0.9679695726464228,1.0,4/18,13.82%,HSD17B12;FAR1;ALDH1A2;AKR1B10
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3815330884442585,-0.8856984605890004,0.6277372262773723,0.8626775206858619,1.0,3/10,15.09%,KDM2A;RIOX2;KDM7A
prerank,WW domain binding (GO:0050699),0.28229262186976145,0.8856528866002763,0.6742081447963801,0.9669050097741343,1.0,9/26,23.51%,ENAH;TCEAL6;TRAF4;TCEAL3;LITAF;SCNN1A;DAZAP2;TCEAL1;WBP11
prerank,myosin II binding (GO:0045159),0.36239892665825374,0.8854429697023294,0.5887445887445888,0.9621471712469306,1.0,3/10,11.93%,STXBP5L;GSN;LLGL1
prerank,proton transmembrane transporter activity (GO:0015078),0.25671823808892874,0.8834922335672459,0.6515837104072398,0.9618908618619764,1.0,7/39,15.90%,COX6A2;UQCR10;SLC46A1;ATP6V1B2;UQCRH;COX6A1;SLC4A11
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3460651593979196,0.883299427421258,0.5868131868131868,0.9571441411158662,1.0,2/11,14.38%,DCPS;NUDT16
prerank,metalloaminopeptidase activity (GO:0070006),0.32595793666955164,0.8815920494434132,0.6145610278372591,0.956069664222247,1.0,2/16,2.25%,TRHDE;MMP16
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.24142898745376673,0.8805068141837995,0.6643518518518519,0.9537774799960217,1.0,9/53,11.03%,SLC7A11;SLC25A13;SLC7A8;OCA2;SLC1A2;SLC36A2;SLC7A6;SLC17A6;SLC1A3
prerank,serine-type endopeptidase activity (GO:0004252),0.22237097409217915,0.8802621658723263,0.6924829157175398,0.9492728749564203,1.0,12/80,15.16%,C1RL;CELA3A;TYSND1;RHBDL2;RHBDL3;KLK1;KLK6;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.23707348439390058,0.8792615242116819,0.7032967032967034,0.9467769289093545,1.0,13/57,16.62%,COX6A2;UQCR10;NDUFA1;UQCRH;NDUFA10;CYBRD1;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;COX6A1;NDUFB6
prerank,NAD binding (GO:0051287),-0.2869429047971054,-0.876868088121895,0.6439114391143912,0.879386671367124,1.0,5/26,14.01%,ZC3HAV1;SIRT5;BDH2;SIRT3;NUDT6
prerank,frizzled binding (GO:0005109),-0.2727332854309809,-0.8729700912276511,0.6552962298025135,0.8851011972399256,1.0,7/34,13.06%,DVL3;ZNRF3;RNF43;LRP6;WNT16;WNT11;MYOC
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3438595774844583,0.8717589873253719,0.6264236902050114,0.9600579800855342,1.0,7/12,24.85%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3
prerank,heme binding (GO:0020037),0.2248599646095168,0.8711230843023711,0.7377450980392157,0.9565241579566532,1.0,12/65,15.58%,CYP46A1;NR1D1;CYP24A1;CYP26B1;CYP51A1;CYP27A1;PGRMC1;CYP11B1;HCCS;THAP4;EIF2AK1;TDO2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.32548724690175707,-0.8707168108840114,0.6637478108581436,0.8871512072628277,1.0,2/15,4.20%,PLA2G4A;SH3PXD2B
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3104048837421404,0.8687798452554418,0.6409185803757829,0.9570734585749671,1.0,5/16,18.66%,HAAO;ALOX12;TDO2;ALOX5;BCO2
prerank,manganese ion binding (GO:0030145),0.24346272515621217,0.8682588609998513,0.7152317880794702,0.9533470603695314,1.0,13/48,18.43%,MPPED2;B4GALT7;ARG2;MGAT5B;MPPE1;ATP13A2;HMGCL;GALNT3;NUDT16;ADPRM;GALNT2;IMPA1;MGAT1
prerank,exonuclease activity (GO:0004527),-0.24957662914527187,-0.8668367348582062,0.6778398510242085,0.8929178400276666,1.0,17/46,28.51%,MRE11;EXOSC1;EXOSC2;EXOSC3;XRN2;PDE12;EXOSC8;WRN;EXOSC5;EXOG;REXO1;DCLRE1B;REXO5;EXOSC7;DXO;EXO1;APLF
prerank,hexosyltransferase activity (GO:0016758),-0.2151510692503047,-0.8664818735028227,0.7601410934744268,0.8908336784734602,1.0,24/101,22.96%,GBE1;EXT1;TMTC1;GCNT2;CSGALNACT1;TMTC2;A4GALT;B3GNT2;MGAT4B;B4GALT4;ALG12;MFNG;PIGV;HAS1;B4GALT5;GBA2;LARGE1;B4GALT1;POGLUT3;GYG1;POMT1;CHPF2;OGT;HAS2
prerank,hormone receptor binding (GO:0051427),0.31569079859336746,0.8644292400556772,0.6292134831460674,0.9574799841616735,1.0,3/14,10.63%,TYK2;NPPC;CCK
prerank,nuclear import signal receptor activity (GO:0061608),-0.32360781220631174,-0.8641586010170176,0.6265938069216758,0.893056065712512,1.0,3/15,14.39%,KPNA4;KPNA3;KPNA1
prerank,cholesterol transfer activity (GO:0120020),-0.32156903218799643,-0.8641061045054793,0.6703096539162113,0.8904022320511521,1.0,4/16,26.73%,PLTP;STARD4;OSBPL2;STARD5
prerank,cholesterol binding (GO:0015485),0.24342487365410398,0.8611828346985286,0.6921241050119332,0.9599577052486611,1.0,15/47,21.40%,SULT2B1;SYP;CD81;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;GRAMD1B;SOAT2;VDAC1;SOAT1;GRAMD1C;SCARB2;ABCG1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2919346461028072,0.8592920067730947,0.6729957805907173,0.9594418883077297,1.0,4/21,7.56%,AKAP14;AKAP6;GSKIP;RYR2
prerank,chemokine binding (GO:0019956),-0.2724793016803408,-0.8573633073294219,0.6857142857142857,0.9014483498534023,1.0,8/30,24.41%,ITGB1;CCR9;ITGA4;FGF2;ACKR3;ITGB3;ACKR1;HMGB1
prerank,NADPH binding (GO:0070402),0.3325012960661445,0.8572831472297754,0.6514161220043573,0.9589584430445112,1.0,1/13,2.35%,QDPR
prerank,tropomyosin binding (GO:0005523),-0.3184919979036732,-0.8557708896367033,0.6591760299625468,0.9019019279223814,1.0,6/16,26.65%,TMOD3;NEBL;LMOD1;CALD1;TNNT3;SMTNL2
prerank,protease binding (GO:0002020),-0.2160153729320768,-0.8538501855205416,0.7663043478260869,0.9028961747143244,1.0,24/99,21.65%,VWF;ITGB1;GSK3B;ANXA2;DVL3;ITGA3;RNF139;CRADD;TP53;ADAMTS4;CFLAR;TIMP3;SLC2A13;COMP;FLOT1;SERPINC1;SUMO1;TNFAIP3;RAD23A;ADRM1;F3;ANXA9;ITGB3;PTEN
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.2695744250254255,-0.8528307175718142,0.6909090909090909,0.9022224095671622,1.0,5/29,10.71%,SLC26A7;SLC26A2;SLC1A5;SLC13A3;SLC25A11
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.35072860992111166,0.8510518889242857,0.667420814479638,0.9633830546698003,1.0,3/10,16.64%,DUSP4;DUSP8;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.35072860992111166,0.8510518889242857,0.667420814479638,0.9633830546698003,1.0,3/10,16.64%,DUSP4;DUSP8;DUSP7
prerank,phosphatase inhibitor activity (GO:0019212),-0.2970603140375892,-0.8496234229807431,0.7045454545454546,0.9059964621433675,1.0,9/20,32.40%,PPP1R2;SAG;PTN;ARPP19;SET;BOD1L1;STYX;PPP1R1B;BOD1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3524623019030322,0.8483140658667614,0.6508264462809917,0.9647224733291779,1.0,4/10,15.75%,PKP2;CXADR;SIRPA;CD47
prerank,iron ion binding (GO:0005506),0.23717653641166597,0.8456578469300731,0.7461024498886414,0.9659421846063216,1.0,12/48,17.43%,MELTF;FBXL5;ALKBH3;DNAJC24;ISCA2;HAAO;TET1;SCD5;NFU1;ALOX5;ALKBH2;SCD
prerank,kinase activator activity (GO:0019209),-0.2708716024048742,-0.8445046586897177,0.7274368231046932,0.9133188242768859,1.0,12/30,32.30%,GPRC5C;RPLP1;RGCC;RPTOR;WNT11;MARK2;CAB39;WNK1;TREM2;CDK5R1;DUSP19;PRKAG2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3538587835678596,-0.8395362162646659,0.662431941923775,0.9204683563065066,1.0,5/11,25.77%,KCNQ1;KCNJ8;KCNE4;KCNH2;KCND3
prerank,rRNA binding (GO:0019843),0.2413849514047905,0.8392496316409563,0.75,0.9751240939752823,1.0,7/42,10.78%,MTERF4;RPLP0;ANG;MRPL16;ERAL1;PPAN;NOP53
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3401030725432592,0.8264542041498005,0.6872246696035242,0.9969080178060182,1.0,4/10,23.96%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,sterol transfer activity (GO:0120015),-0.30037765727583654,-0.8229845163342555,0.7208029197080292,0.9493882701363973,1.0,4/17,26.73%,PLTP;STARD4;OSBPL2;STARD5
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.33627891524743053,-0.8224576261990879,0.699288256227758,0.9474093201024045,1.0,1/11,0.16%,LEF1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.27646474429781076,0.821720708616621,0.708803611738149,1.0,1.0,7/22,19.67%,ATP6V1B2;ATP6V0C;ATP6V0A2;ATP6V0D2;ATP6V0D1;ATP6V1C1;ATP6V1A
prerank,poly(A) binding (GO:0008143),-0.2836545952307215,-0.8209289585506875,0.7402135231316725,0.9475018222609745,1.0,6/21,15.74%,RBPMS;RBMS1;DDX3X;RBMS2;PABPC4L;ZC3H14
prerank,potassium:proton antiporter activity (GO:0015386),0.33565980716659305,0.8198940187226046,0.6567505720823799,1.0,1.0,2/10,5.04%,SLC9A7;SLC9A9
prerank,UDP-glycosyltransferase activity (GO:0008194),0.21346405293749698,0.8190578236476634,0.815068493150685,0.9973281730576719,1.0,6/70,5.79%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3
prerank,ion gated channel activity (GO:0022839),-0.271067786736887,-0.818118008937386,0.7555147058823529,0.9498228975574863,1.0,6/24,13.46%,ANO1;TRPM4;TTYH2;ANO6;ANO8;TMEM63B
prerank,alpha-actinin binding (GO:0051393),-0.2753099419685317,-0.8175674261485104,0.7389705882352942,0.9479836625380581,1.0,9/24,21.05%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3;RARA;MAGI1;PKD2L1;PPARG
prerank,phospholipase activator activity (GO:0016004),0.3325855045356559,0.8170744829675513,0.7073732718894009,0.996375168028036,1.0,6/10,28.38%,CCL5;ARHGAP6;PDPK1;BTK;STX4;SRC
prerank,transferrin receptor binding (GO:1990459),-0.3516422449473096,-0.8167824268754408,0.7124773960216998,0.9465759032233021,1.0,3/10,18.55%,HFE;IKBKG;IKBKB
prerank,fibroblast growth factor receptor binding (GO:0005104),0.2767506480132959,0.8156177279584451,0.7438202247191011,0.9945275454358546,1.0,3/21,8.91%,FGF6;FGF5;FGF20
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.2925043785296898,-0.8138788005991647,0.7033398821218074,0.9489080907409922,1.0,4/18,15.06%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.29237425973463155,0.8137218123340642,0.732776617954071,0.9931366747525596,1.0,5/17,15.18%,AKR1C1;TECR;DPYD;DHCR24;MECR
prerank,solute:proton symporter activity (GO:0015295),-0.29896609557685383,-0.8123431832630151,0.7268041237113402,0.9488693784278147,1.0,4/16,12.94%,SLC39A8;SLC17A5;SLC2A13;SLC2A9
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28515965011996214,-0.811753721322269,0.7293233082706767,0.9471187820975534,1.0,5/20,15.96%,SETD2;SETD3;EHMT1;KMT5A;ANTKMT
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2591361089010508,-0.8108479977954626,0.7666034155597723,0.9458516057972025,1.0,13/29,33.35%,ACER2;ACER3;OVGP1;GBA2;HYAL2;ENGASE;GLA;HPSE;HYAL3;LCT;ABHD10;GANAB;NEU3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.3434742861853056,-0.8088283179050083,0.7281021897810219,0.94645967702093,1.0,4/10,24.85%,DSE;GNE;FUOM;GALM
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2415538056986289,-0.8047785896412288,0.802158273381295,0.9505886812448012,1.0,14/37,28.95%,SLCO2A1;SLCO1C1;SLCO3A1;UQCR11;SLCO2B1;UQCRFS1;UQCRC1;COX10;SLCO4A1;NDUFA4L2;COX5A;SLCO1B1;SLC22A8;COX4I2
prerank,endopeptidase inhibitor activity (GO:0004866),-0.20628772851035682,-0.8039632209934441,0.8431372549019608,0.9492432514728139,1.0,10/82,11.63%,CAST;ANXA2;APP;SPOCK2;PROS1;NGF;ROCK1;BIRC6;ITIH2;TIMP3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3025030751399721,0.8017968558417823,0.6971677559912854,1.0,1.0,2/14,3.02%,KCNA5;KCNJ3
prerank,serine-type peptidase activity (GO:0008236),0.19575526587439962,0.7994154191107279,0.8781609195402299,1.0,1.0,15/96,16.49%,C1RL;CELA3A;TYSND1;RHBDL2;PRSS57;RHBDL3;KLK1;KLK6;TMPRSS7;PCSK2;HTRA2;PCSK6;ACR;CLPP;TPP1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3186604851755489,-0.7975491118613519,0.7532710280373832,0.9573402132213801,1.0,2/12,9.13%,SLC2A1;MFSD4A
prerank,carboxylic ester hydrolase activity (GO:0052689),0.20474111429948633,0.7971418215061243,0.8866213151927438,1.0,1.0,9/85,10.56%,ENPP2;PGLS;CA2;PGAP1;H6PD;PLA2G7;LIPC;PLA2G4E;PLA2G6
prerank,"DNA binding, bending (GO:0008301)",-0.30400832098893027,-0.795278299785814,0.7710622710622711,0.9583615978187477,1.0,1/14,0.16%,LEF1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.24284191517442466,-0.7917589957263756,0.7868284228769498,0.9613435558171434,1.0,15/34,35.96%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2;UBE2I;UBE2H;CDC34;UBE2A;UBE2T;UBE2G2;UBE2C
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.2894496800042105,-0.7896333752151833,0.7736185383244206,0.958998095932519,1.0,4/16,12.80%,ANO1;TTYH2;ANO6;ANO8
prerank,intracellular chloride channel activity (GO:0061778),-0.2894496800042105,-0.7896333752151833,0.7736185383244206,0.958998095932519,1.0,4/16,12.80%,ANO1;TTYH2;ANO6;ANO8
prerank,anion:anion antiporter activity (GO:0015301),0.2830882533850278,0.7890871366289792,0.7123595505617978,1.0,1.0,4/17,9.10%,SLC26A5;SLC4A2;SLC19A1;SLC25A4
prerank,chemoattractant activity (GO:0042056),-0.2586654808595298,-0.7858974889590861,0.7834507042253521,0.9623169744407964,1.0,6/26,14.99%,BMP4;VEGFC;FGF7;FGF2;HGF;MIF
prerank,motor activity (GO:0003774),0.2120068811259896,0.7857508117340285,0.8733333333333333,1.0,1.0,12/60,15.80%,KIF21A;KIF17;KIF26B;DYNC2H1;KIF5A;KIF3A;DYNC1I1;KIF1C;DYNLRB2;KIF3C;MYO6;KIF21B
prerank,monocarboxylic acid binding (GO:0033293),0.2769929728809577,0.7845501392608227,0.7790697674418605,1.0,1.0,2/18,5.98%,AKR1C1;CYP26B1
prerank,poly-purine tract binding (GO:0070717),-0.2514879078301482,-0.784462703661726,0.7929203539823009,0.9618468878584485,1.0,4/27,7.57%,RBPMS;RBMS1;DDX3X;RBMS2
prerank,endopeptidase regulator activity (GO:0061135),-0.23375042707227867,-0.7842881473794193,0.8306306306306306,0.9593728900087282,1.0,14/40,30.05%,CAST;PROS1;PSME2;ITIH2;VSIR;APH1A;PSME1;TFPI;ADRM1;RECK;ITIH3;PCSK1N;NLRC4;AHSG
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3123111888919805,-0.7831693549992781,0.7789661319073083,0.9583395089175437,1.0,8/14,43.01%,NCF2;NOX4;KMO;MICAL1;AIFM1;NCF1;NCF4;DUOX1
prerank,NADP binding (GO:0050661),-0.24671242150342307,-0.7826786049840401,0.8164794007490637,0.9563574787829319,1.0,7/32,21.77%,NOS3;GMDS;CAT;LBR;DHCR7;NOS1;MTRR
prerank,methyltransferase activity (GO:0008168),-0.22620113404599507,-0.7805637828369109,0.8560747663551402,0.956634140527547,1.0,21/46,38.61%,METTL4;SUV39H1;EHMT1;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PRMT3;METTL27;COQ3;EEF1AKMT3;DNMT3B;PRMT7;EEF1AKMT4;GCSH;NSUN4;COMTD1;NNMT;COMT;NSUN3
prerank,copper ion binding (GO:0005507),-0.23304881994029478,-0.7773831919713592,0.8399280575539568,0.9586635966184935,1.0,19/42,37.24%,ATOX1;LOXL3;PAM;TP53;COX17;AOC3;SOD1;CCS;COA6;SUMF1;TYR;ATP7B;IL1A;SCO2;CUTC;PARK7;MT3;SNCB;AOC2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2553653900834582,-0.7763710861150277,0.7901701323251418,0.9574728454705073,1.0,9/26,32.40%,PPP1R2;SAG;PPP1R1A;PTN;ARPP19;SET;BOD1L1;PPP1R1B;BOD1
prerank,translation elongation factor activity (GO:0003746),-0.2978466314195415,-0.7756558884574153,0.7631103074141049,0.9559721324427207,1.0,6/14,25.50%,EEF2;EIF5A;EIF5AL1;GFM2;EEF1B2;TUFM
prerank,O-acyltransferase activity (GO:0008374),-0.24342728932693292,-0.7740018322764874,0.8339350180505415,0.9556699315151861,1.0,7/30,21.32%,PLA2G4A;LPCAT1;MBOAT1;DGAT2;LCAT;PIGW;LPCAT3
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.25238613903219353,0.7701601969397075,0.8067940552016986,1.0,1.0,4/24,10.66%,CAMK1G;CAMK4;CAMK2B;MYLK3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3172387630160605,0.7696898482679538,0.7505827505827506,1.0,1.0,2/10,11.39%,PKIB;PRKAR1B
prerank,pyrophosphatase activity (GO:0016462),-0.21767251396595616,-0.7696244758049693,0.867513611615245,0.9593749083983679,1.0,5/50,8.41%,ENTPD1;DDX3X;ENTPD6;ALPL;BNIP2
prerank,pre-mRNA binding (GO:0036002),0.2482900096301232,0.7691287526648596,0.8444924406047516,1.0,1.0,3/28,5.41%,CELF5;CELF4;CELF2
prerank,mRNA methyltransferase activity (GO:0008174),-0.3073183504046015,-0.7679911612092273,0.7838345864661654,0.9590226657664036,1.0,8/12,47.29%,METTL14;CMTR2;METTL16;TRMT61A;PCIF1;TRMT10C;NSUN2;RNMT
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.24058768636647787,-0.7676285485576905,0.8003533568904594,0.9568568555006357,1.0,14/31,35.96%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2;UBE2H;CDC34;UBE2A;UBE2T;UBE2G2;UBE2C
prerank,sequence-specific mRNA binding (GO:1990825),-0.329423653885091,-0.7620472054946483,0.7735507246376812,0.9621311811456481,1.0,6/10,34.88%,RBM24;DHX9;LARP6;SSB;SHFL;ETF1
prerank,microtubule motor activity (GO:0003777),0.21471432141942048,0.7618737242603048,0.8638392857142857,1.0,1.0,10/51,15.80%,KIF21A;KIF17;KIF26B;KIF5A;KIF3A;DYNC1I1;KIF1C;DYNLRB2;KIF3C;KIF21B
prerank,adenylyltransferase activity (GO:0070566),-0.2621152904824474,-0.7611899828803268,0.8017699115044248,0.9606963364188797,1.0,4/21,13.65%,TENT4B;ABL1;TENT4A;TENT2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.27514950867341753,0.761121413332352,0.8030634573304157,1.0,1.0,5/16,13.18%,MTMR2;MTMR11;MTMR10;MTMR7;INPP5F
prerank,alpha-tubulin binding (GO:0043014),-0.2367653317774845,-0.7605457152816415,0.8681318681318682,0.9589229998300697,1.0,15/31,30.86%,SETD2;DIP2B;TTLL7;DNAL1;FYN;HDAC6;TRPV4;WASHC1;ARL4C;DLEC1;EML4;INO80;EFHC2;ARL8B;CDK5R1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3137232537854681,0.760415822617158,0.773972602739726,1.0,1.0,2/10,17.95%,SLC6A11;SLC10A1
prerank,CARD domain binding (GO:0050700),-0.2946070229312398,-0.7593905139816814,0.7892976588628763,0.9580289024108805,1.0,4/14,18.60%,NOD1;IRGM;MAVS;NOD2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.2935969868173258,0.7593662796318784,0.7855530474040632,1.0,1.0,12/12,70.66%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;OPN3;RHO;GPR88;OPN1MW;OPN1MW3;RRH;GPR52
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.22788472420608485,0.7593401752108845,0.816414686825054,1.0,1.0,8/34,16.62%,NDUFA1;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.22788472420608485,0.7593401752108845,0.816414686825054,1.0,1.0,8/34,16.62%,NDUFA1;NDUFA10;NDUFS8;NDUFA5;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,fatty acid synthase activity (GO:0004312),0.3122171806497302,0.7591394795613661,0.7714285714285715,1.0,1.0,2/10,9.50%,ELOVL4;OXSM
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.23311135742875855,0.7541499953423595,0.8467153284671532,1.0,1.0,5/29,11.39%,YWHAG;PKIB;SPRED1;HEXIM1;PRKAR1B
prerank,ATPase activator activity (GO:0001671),-0.26490645326101037,-0.7534795942191266,0.8162162162162162,0.9634918359451667,1.0,5/20,17.97%,DNAJA2;DNAJC1;DNAJB6;DNAJC10;DNAJC19
prerank,myosin binding (GO:0017022),-0.20786713879927973,-0.7492018350528379,0.888507718696398,0.9665616514461233,1.0,13/55,18.99%,MYRIP;SHROOM4;TRAK1;SHROOM1;ARFGEF1;RHOA;MYOC;MLPH;RAB11A;RAB39B;KIRREL1;GIPC1;CALD1
prerank,ribonuclease P RNA binding (GO:0033204),-0.319588070190142,-0.7451994669631378,0.7811934900542495,0.9688468626958197,1.0,6/10,48.58%,RPP30;POP4;RPP40;RPP14;RPP25;RPP38
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3060777096973005,-0.744269873041052,0.8305084745762712,0.9674142035625188,1.0,9/11,49.83%,YARS1;CXCL12;CXCL10;ITCH;PPBP;CXCL5;CXCL1;CXCL13;CXCL2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.22063023589674322,-0.7439009937955896,0.8605947955390335,0.9652519571594717,1.0,8/40,16.65%,METTL4;PCMTD1;SUV39H1;SETD3;AS3MT;N6AMT1;DNMT1;ARMT1
prerank,pseudouridine synthase activity (GO:0009982),-0.29009012746900437,-0.7417494756501958,0.8111888111888111,0.9651667753968985,1.0,5/13,28.75%,RPUSD4;PUS10;TRUB1;PUSL1;RPUSD2
prerank,fibroblast growth factor binding (GO:0017134),-0.2558817827196257,-0.7399769238385292,0.8278388278388278,0.9647811080777704,1.0,6/21,20.66%,THBS1;CEP57;FGFBP3;API5;FGFR4;ITGB3
prerank,DNA polymerase binding (GO:0070182),-0.2641356795233,-0.7383617775805199,0.8172413793103448,0.964126511461818,1.0,6/18,25.21%,PTGES3;FANCD2;HSP90AA1;FANCI;HMGB1;SMG6
prerank,glucose transmembrane transporter activity (GO:0005355),0.2617415763936827,0.737100013022447,0.8307349665924276,1.0,1.0,4/17,11.52%,SLC2A4;SLC2A10;SLC2A8;SLC2A5
prerank,hydro-lyase activity (GO:0016836),0.21266381655268918,0.7360465833369603,0.9157175398633257,1.0,1.0,7/41,12.14%,CA2;ECHDC1;HACD1;ACO1;UROS;ENO2;PCBD1
prerank,cytokine activity (GO:0005125),0.17204719526062132,0.7330015671928606,0.9815668202764977,1.0,1.0,17/131,13.59%,NRG1;WNT7B;CXCL16;GDF1;CCL28;CCL7;TIMP1;PF4;VEGFA;IL12A;CCL13;CCL5;CCL2;LEFTY1;WNT6;GDF11;WNT2
prerank,lysophospholipase activity (GO:0004622),-0.2574270698100173,-0.7321676736558543,0.8690909090909091,0.969270292969715,1.0,4/20,14.15%,PLA2G4A;GDPD1;MGLL;GDPD3
prerank,protein phosphatase activator activity (GO:0072542),0.28216685002872766,0.7307540849469205,0.8486997635933806,1.0,1.0,2/13,5.51%,IGFBP3;CALM2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.27223515058202874,0.729015553173795,0.8351648351648352,1.0,1.0,4/14,10.37%,MTMR2;MTMR11;MTMR10;MTMR7
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3112527204372047,-0.7287080156572038,0.8143939393939394,0.9707201554600399,1.0,5/10,33.88%,HADHB;ECHS1;EHHADH;ECI1;ECHDC3
prerank,DNA replication origin binding (GO:0003688),0.23910993232129985,0.7271094819320771,0.8622129436325678,1.0,1.0,4/23,10.06%,DDX11;MCM8;CDC45;POLA1
prerank,endonuclease activity (GO:0004519),-0.20835418081983592,-0.7259819850282755,0.9084380610412927,0.9713442381010946,1.0,14/49,25.57%,KHNYN;ERN1;MRE11;N4BP2;DICER1;OGG1;PNKP;AGO2;RPS3;EXOG;RCL1;NTHL1;SMG6;ENDOU
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.266638347346844,0.7249416646882496,0.8403547671840355,1.0,1.0,2/15,8.56%,PLA2G3;PLA2G4E
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.27493732304629215,0.7220612172270506,0.847682119205298,1.0,1.0,1/13,1.53%,IDI2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.29350269047203126,0.7194256012074183,0.8140096618357487,1.0,1.0,2/11,7.56%,RYR3;RYR2
prerank,channel activity (GO:0015267),0.20680390595010373,0.7148713453458686,0.9375,1.0,1.0,3/41,4.55%,PDPN;BCL2;AQP4
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.2992485450618047,-0.7135007868641773,0.8078994614003591,0.982528436845298,1.0,5/11,31.61%,SLC17A5;SLC2A9;SLC5A3;SLC23A1;SLC23A2
prerank,ribosomal large subunit binding (GO:0043023),-0.2932055909379718,-0.7111057475819426,0.8441330998248686,0.9823531210814449,1.0,4/11,28.91%,LTN1;RBM3;NEMF;NMD3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.22184357914141048,0.708549386089301,0.89171974522293,1.0,1.0,5/28,12.99%,MAPK10;PAK3;MAP2K7;RPS6KB1;SGK1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.2713481061025754,0.7028496142846624,0.8355555555555556,1.0,1.0,2/12,8.98%,BLNK;SHC1
prerank,telomeric DNA binding (GO:0042162),-0.21724680149164793,-0.7021830328093945,0.8884615384615384,0.9891131131084157,1.0,12/32,27.96%,STN1;UPF2;HMBOX1;RPA1;CTC1;TERF2;WRN;BLM;TERT;SMG6;HNRNPD;SMG1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2175621662872883,-0.7021345891799718,0.9100719424460432,0.9865416468397911,1.0,10/35,24.39%,FTO;DUS1L;DUS4L;MRPL58;PUS10;TRMT9B;TRDMT1;TRMT12;TRPT1;ELAC2
prerank,gated channel activity (GO:0022836),-0.2685133357360225,-0.7006191834080937,0.8672727272727273,0.98538438586684,1.0,3/14,13.46%,PIEZO2;TMEM266;TMEM63B
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.23592684923449933,0.698270446950413,0.8571428571428571,1.0,1.0,4/22,14.48%,SYT1;APOE;CLU;LANCL1
prerank,RNA polymerase binding (GO:0070063),-0.2508256241987429,-0.6977817871647372,0.8964912280701754,0.9855960803211355,1.0,6/18,27.26%,NEDD4;STOM;PKN2;BRCA1;DHX9;PHRF1
prerank,FAD binding (GO:0071949),-0.23360565363514407,-0.6908863520251137,0.9009174311926605,0.9895384636023644,1.0,11/24,38.23%,MICAL2;AGPS;KDM1B;KMO;MTRR;CRY2;MICAL1;STEAP4;AIFM1;DAO;NQO2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.2797765774223056,-0.6889379518926838,0.8594594594594595,0.9887220966520099,1.0,4/12,22.72%,HDAC1;H3-3A;RUVBL2;RELA
prerank,lipase activator activity (GO:0060229),0.27758063019947216,0.6844918267658121,0.8714953271028038,1.0,1.0,4/10,22.49%,CCL5;ARHGAP6;PDPK1;BTK
prerank,microtubule minus-end binding (GO:0051011),-0.2655481603624368,-0.6842342157333603,0.8590831918505942,0.9902446942909371,1.0,3/13,16.19%,MACF1;TUBGCP5;TUBGCP4
prerank,sulfotransferase activity (GO:0008146),-0.21166683594520633,-0.6840299498907566,0.9425087108013938,0.9878679528264721,1.0,8/33,20.30%,CHST15;TPST2;HS3ST1;SULT1A1;CHST11;GAL3ST2;HS6ST1;CHST7
prerank,peptidase inhibitor activity (GO:0030414),-0.2108648454348589,-0.6832644537672892,0.9214285714285714,0.9860652011478735,1.0,9/33,26.87%,CAST;PROS1;ITIH2;SIMC1;TFPI;GPC3;RECK;ITIH3;PCSK1N
prerank,MAP kinase phosphatase activity (GO:0033549),0.26919378399782923,0.6824314616268718,0.8507109004739336,1.0,1.0,3/12,16.64%,DUSP4;DUSP8;DUSP7
prerank,tRNA binding (GO:0000049),0.1918123092104949,0.6806003439776422,0.9562363238512035,1.0,1.0,9/43,18.73%,TRMT10B;SARS2;PTCD1;TRMT10A;CARS1;EEF1A1;PUS1;AARS2;ELP1
prerank,cAMP response element binding (GO:0035497),-0.2904194698797067,-0.6805354642559814,0.8618181818181818,0.9859020962352111,1.0,2/10,7.70%,JUN;CREB3L2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.277907531653691,-0.6797960120229555,0.8705179282868526,0.9840130794110912,1.0,3/12,14.60%,AOX1;FDX1;ISCA1
prerank,inward rectifier potassium channel activity (GO:0005242),0.22367174004427176,0.6796285399574533,0.92152466367713,1.0,1.0,4/24,11.96%,KCNJ3;KCNN2;KCNJ6;KCNN3
prerank,N-methyltransferase activity (GO:0008170),-0.23895373159065514,-0.6763501757204395,0.9180327868852459,0.9843549333100244,1.0,8/20,31.04%,SETD3;ZCCHC4;N6AMT1;METTL5;TRMT1;METTL15;PEMT;METTL18
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.17361684704205854,0.6750437310891377,0.973741794310722,1.0,1.0,13/75,17.93%,AKR1C1;DCXR;H6PD;HSD17B7;NSDHL;CBR1;LDHB;UGDH;AKR1B10;PHGDH;PGD;MDH1;KCNAB1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.2691598852377783,-0.6748393270522856,0.8888888888888888,0.983104991502017,1.0,2/12,14.78%,TRAF5;BABAM2
prerank,hexosaminidase activity (GO:0015929),-0.26835417483827884,-0.6748248975426488,0.8790170132325141,0.9806053887391625,1.0,10/12,54.19%,CEMIP2;HYAL2;HEXA;HYAL3;CEMIP;OGA;NAGA;HYAL1;HYAL4;SPAM1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22477434426820464,0.6721254539589688,0.9073170731707317,1.0,1.0,7/22,19.15%,DUSP4;MTMR2;SBF1;DUSP8;DUSP15;DUSP7;DUSP18
prerank,methylation-dependent protein binding (GO:0140034),-0.18714697177276968,-0.669695643956511,0.9675675675675676,0.9823693199239244,1.0,22/57,36.00%,CHD1;KMT2E;CDYL;SUZ12;SGF29;TDRD3;ZMYND8;KDM7A;ZMYND11;ATRX;WDR5;MBTD1;RBBP5;PHF19;GLYR1;KDM4A;ING5;CHD8;BPTF;CBX5;TRIM24;MORC3
prerank,titin binding (GO:0031432),0.25959683404540884,0.6693636268387357,0.9047619047619048,1.0,1.0,5/13,28.05%,CALM2;MYBPC1;CAPN3;CALM3;CALM1
prerank,methylated histone binding (GO:0035064),0.17799255885059415,0.6680457160683788,0.9749430523917996,1.0,1.0,14/62,19.19%,ZCWPW1;CHD5;TTLL12;UHRF1;KDM8;CXXC1;JMJD7;THAP7;TAF1;CBX8;PHF13;L3MBTL2;MORC4;ING1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2137654853732052,0.6637443949426919,0.925,1.0,1.0,7/27,16.66%,SLC9A7;SLC9A9;SLC8A2;SLC8A1;SLC8A3;SLC4A11;SLC8B1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2198122838004178,-0.6613574460408446,0.9283088235294118,0.9861325845892026,1.0,9/24,33.57%,ZDHHC6;ZDHHC3;ZDHHC1;ZDHHC4;GLUL;ZDHHC12;GOLGA7B;ZDHHC9;ZDHHC22
prerank,beta-tubulin binding (GO:0048487),0.20142110038265798,0.6605158476160434,0.9569160997732427,1.0,1.0,6/31,15.41%,PACRG;MAP1S;BBS4;GJB6;RACGAP1;HTT
prerank,purinergic nucleotide receptor activity (GO:0001614),0.2417563312589199,0.6571807493734392,0.9098712446351931,1.0,1.0,3/15,19.31%,P2RX3;P2RX5;PTAFR
prerank,carboxy-lyase activity (GO:0016831),-0.22070009008769126,-0.6555969775903228,0.9378427787934186,0.9877029891078329,1.0,7/23,26.36%,CSAD;BCKDHA;AZIN1;PPCDC;DDC;MVD;FAHD1
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.23144039394453364,-0.6542012151746456,0.924908424908425,0.9837456134685354,1.0,7/21,23.51%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.23144039394453364,-0.6542012151746456,0.924908424908425,0.9837456134685354,1.0,7/21,23.51%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.20491356154237728,-0.6495427458776175,0.9500891265597148,0.9845018283453233,1.0,13/32,30.97%,KDM2A;TET2;FTO;RIOX2;KDM7A;TMLHE;TET3;ALKBH4;BBOX1;ALKBH5;HSPBAP1;RIOX1;KDM4A
prerank,protein phosphatase regulator activity (GO:0019888),0.17655971171793178,0.6479196589720952,0.9685393258426966,1.0,1.0,7/53,10.49%,PPP2R2B;PPP1R7;PPP2R2C;CALM2;PPME1;PPP1R16A;RCAN2
prerank,deoxyribonuclease activity (GO:0004536),0.2440340301832012,0.6477825864835114,0.9075268817204301,1.0,1.0,6/14,25.71%,MAP1S;DNASE1L1;APEX1;ERCC5;DNASE1L2;ZRANB3
prerank,ATPase regulator activity (GO:0060590),-0.19255409442943555,-0.6475440056834003,0.9558303886925795,0.9834427479696721,1.0,8/38,17.97%,DNAJA2;DNAJC1;DNAJB6;FNIP2;DNAJC10;SIL1;PLN;DNAJC19
prerank,ubiquitin binding (GO:0043130),0.16799268259355934,0.647318636174075,0.988479262672811,1.0,1.0,22/73,21.95%,OTULINL;GGA3;USP25;TSG101;RBCK1;USP5;UBAP1;USPL1;AUP1;MVB12B;UCHL3;RNFT1;CKS2;CXCR4;USP33;DNAJB2;SHARPIN;OTUB2;SQSTM1;UBAP1L;FBXO7;NSFL1C
prerank,U6 snRNA binding (GO:0017070),0.23795292426729545,0.6472870376263865,0.9166666666666666,1.0,1.0,5/14,21.06%,LSM7;TUT1;LSM8;PRPF8;LSM4
prerank,lipoprotein particle receptor binding (GO:0070325),0.20634491994494614,0.6456214494074306,0.9395248380129589,1.0,1.0,4/27,14.48%,SYT1;APOE;CLU;LANCL1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.25612660359263706,-0.6428129825383209,0.9166666666666666,0.9840111654562521,1.0,1/12,0.77%,PIEZO2
prerank,antiporter activity (GO:0015297),-0.22229766072146304,-0.6406194209272977,0.9514388489208633,0.9829938271262706,1.0,4/20,19.98%,SLC25A11;SLC35E4;SLC35E3;SLC35D1
prerank,tRNA methyltransferase activity (GO:0008175),0.2340397741217405,0.6405044236421326,0.9237668161434978,1.0,1.0,7/16,25.53%,TRMT13;FTSJ1;METTL2B;METTL2A;THUMPD3;TRMT5;THUMPD2
prerank,ribonuclease P activity (GO:0004526),0.26031008725127125,0.6363008226367064,0.9102844638949672,1.0,1.0,11/11,73.99%,PRORP;POP7;POP5;POP1;RPP21;RPP38;RPP25;RPP14;RPP40;POP4;RPP30
prerank,endoribonuclease activity (GO:0004521),-0.19987648378989237,-0.6347371625216257,0.9589552238805971,0.9840688361954862,1.0,9/32,25.57%,KHNYN;ERN1;DICER1;ENDOV;AGO2;EXOG;RCL1;SMG6;ENDOU
prerank,adenyl nucleotide binding (GO:0030554),0.2508557407989095,0.6334962211073828,0.9194630872483222,0.997189258339767,1.0,2/11,13.13%,PFN1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.2508557407989095,0.6334962211073828,0.9194630872483222,0.997189258339767,1.0,2/11,13.13%,PFN1;BAG1
prerank,CCR chemokine receptor binding (GO:0048020),0.19942299885003212,0.6286103812101871,0.9541284403669725,0.9960609749331801,1.0,4/28,12.36%,CCL7;CCL13;CCL5;CCL2
prerank,chemokine receptor activity (GO:0004950),-0.2123079426988274,-0.6250969474094262,0.9593345656192237,0.9873284980501091,1.0,12/24,47.40%,CCR9;ACKR3;CMKLR1;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2;GPR35
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.23530889000502261,-0.618271522493345,0.9398625429553265,0.9887748668152719,1.0,14/14,76.50%,CAPN2;CAPN15;CAPN11;CAPN12;CAPN10;CAPN8;CAPNS2;CAPN9;CAPN6;CAPN1;CAPN13;CAPN5;CAPNS1;CAPN3
prerank,O-methyltransferase activity (GO:0008171),-0.2525299178428807,-0.604708851686059,0.9423076923076923,0.9931125005413166,1.0,4/10,46.84%,CMTR2;COQ3;COMT;HENMT1
prerank,hyaluronic acid binding (GO:0005540),-0.25769090643582476,-0.6039806450952094,0.9411764705882353,0.990966245899473,1.0,3/10,20.47%,LAYN;HYAL2;LYVE1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.22976983556671984,0.5991440984078459,0.9410480349344978,1.0,1.0,2/13,10.18%,ALDH1L2;ALDH1A2
prerank,receptor antagonist activity (GO:0048019),0.21180499574788125,0.5961217609674728,0.954248366013072,1.0,1.0,16/17,62.29%,CCL5;ESR2;DKK3;DKK4;IL18BP;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;LRPAP1;AGTR2;PXDN;WFIKKN1;FST;IGSF1
prerank,ferrous iron binding (GO:0008198),0.19477232875056583,0.584949754767389,0.9534883720930233,1.0,1.0,3/21,10.36%,ALKBH3;DNAJC24;HAAO
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.23145317791807224,-0.5841710794598448,0.9512195121951219,0.9970237022260143,1.0,9/14,51.59%,TSEN34;ELAC2;RPP30;POP4;RPP40;RPP14;RPP25;RPP38;TSEN2
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.18894142590414723,-0.5812245472253197,0.9831460674157303,0.995589664154778,1.0,12/27,36.31%,POLR2G;TENT2;POLR3F;TERT;MED20;POLR2C;POLR2L;POLR3K;POLR1H;POLR2E;POLR3A;POLR2A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.2121015661648153,0.5795166122381125,0.9492273730684326,1.0,1.0,2/15,10.18%,ALDH1L2;ALDH1A2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.25026109736768903,-0.5769054497222231,0.9583333333333334,0.994869523947919,1.0,2/10,16.87%,NCF2;NOX4
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.24075261957650512,-0.5593441802307426,0.9623655913978495,0.9979650094411127,1.0,3/10,27.22%,DCLRE1B;DCLRE1A;EXO1
prerank,carbohydrate kinase activity (GO:0019200),-0.2258110361007506,-0.5517483965414289,0.9542124542124543,0.9978085240732387,1.0,3/11,17.67%,GALK2;GNE;GALK1
prerank,potassium ion leak channel activity (GO:0022841),0.20024133424487534,0.5504044434703597,0.982532751091703,1.0,1.0,3/15,15.22%,KCNK12;KCNK9;KCNK10
prerank,CoA hydrolase activity (GO:0016289),-0.20145709076896434,-0.547454701597476,0.9802158273381295,0.9965395143856337,1.0,10/16,48.26%,ACOT9;ACOT6;ACOT11;NUDT7;ACOT13;HIBCH;ACOT12;ABCD1;BAAT;ACOT4
prerank,palmitoyltransferase activity (GO:0016409),-0.16911580823966862,-0.5330174971692321,0.989010989010989,0.9976636254680734,1.0,2/28,4.45%,ZDHHC6;ZDHHC3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.20273388330224734,-0.5271838728441522,0.9927140255009107,0.9964772319635351,1.0,4/15,34.25%,CCR9;CMKLR1;GPR17;CCRL2
prerank,cytochrome-c oxidase activity (GO:0004129),0.18697808752432973,0.5019968092834152,0.9910913140311804,1.0,1.0,15/15,81.32%,COX6A2;COX6A1;CYB5A;NDUFA4;COX4I1;COX7A2L;COX8A;COX5B;COX6B1;COX15;COX7A1;COX4I2;COX5A;NDUFA4L2;COX10
prerank,leak channel activity (GO:0022840),0.17234426389520296,0.4980370289716973,0.9954954954954955,1.0,1.0,5/18,22.30%,KCNK12;KCNK9;KCNK10;NALCN;KCNK4
prerank,gamma-tubulin binding (GO:0043015),-0.1692161208945499,-0.49040265180496284,0.9839857651245552,1.0,1.0,11/21,39.22%,DDX3X;NDRG1;TUBGCP5;TUBGCP4;RAB11FIP5;TUBGCP3;RAD51D;MARK4;BLOC1S2;GIT1;TUBGCP6
prerank,acyl-CoA hydrolase activity (GO:0047617),0.17303231103299127,0.48391149264342836,0.9883449883449883,1.0,1.0,3/17,14.02%,PLA2G6;ACOT2;ACOT7
prerank,C-C chemokine receptor activity (GO:0016493),-0.16367966932784206,-0.46558187029450954,0.994392523364486,1.0,1.0,9/21,46.18%,CCR9;ACKR3;GPR75;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.16028701456384686,0.46514391941168204,0.9953271028037384,1.0,1.0,3/21,14.36%,POLD4;POLA1;POLE4
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.14597216017525552,0.46348664691360997,0.9978768577494692,1.0,1.0,5/27,17.61%,POLR3H;POLR2D;POLR1A;POLRMT;POLR1B
prerank,ubiquitin-specific protease binding (GO:1990381),0.16115053695911558,0.4607110337204684,0.9933035714285714,1.0,1.0,19/19,83.90%,LCOR;SELENOS;RHBDD2;DERL2;AMFR;BAG6;SYVN1;SART3;PRKN;SPATA2;DERL3;DERL1;CLTC;VCP;PARK7;CHMP3;PTEN;RAD23A;SUMO1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.18617789215993996,0.4607007687387899,0.9935760171306209,1.0,1.0,11/11,81.40%,HMCES;APEX1;HMGA2;NEIL2;APEX2;NEIL1;NEIL3;ALKBH1;APLF;NTHL1;RPS3
prerank,C-C chemokine binding (GO:0019957),-0.1563997327399159,-0.454085112671298,0.9943396226415094,0.9990774239952931,1.0,9/22,46.18%,CCR9;ACKR3;ACKR1;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,DNA polymerase activity (GO:0034061),0.14013959829102357,0.4109964848937486,1.0,0.9991188593471074,1.0,3/22,14.36%,POLD4;POLA1;POLE4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.14328995831444194,-0.3910784084208089,1.0,0.9995059532631787,1.0,1/16,4.42%,CD38
